UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-K
(Mark One)
x | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended October 2, 2011
OR
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number # 000-08866
MICROSEMI CORPORATION
(Exact name of Registrant as specified in its charter)
Delaware | 95-2110371 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
One Enterprise, Aliso Viejo, California 92656
(Address of principal executive offices) (Zip Code)
(949) 380-6100
Registrants telephone number, including area code
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Name of each exchange on which registered | |
Common Stock, $0.20 par value; | NASDAQ Stock Market LLC (NASDAQ Global Select Market) |
Securities registered pursuant to Section 12(g) of the Act:
None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No ¨
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ¨ No x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such filed). Yes x No ¨
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large Accelerated Filer x | Accelerated Filer ¨ | |
Non-Accelerated Filer ¨ | Smaller Reporting Company ¨ |
(Do not check if a smaller reporting company)
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act. Yes ¨ No x
The aggregate market value of Common Stock held by non-affiliates of the registrant, based upon the closing sale price on April 1, 2011 was approximately $1,775,000,000.
The number of outstanding shares of Common Stock on November 14, 2011 was 86,851,848.
Documents Incorporated by Reference
Part III: Incorporated by reference are portions of the definitive Proxy Statement for the Annual Meeting of Stockholders to be held on or about January 31, 2012. This proxy statement will be filed not later than 120 days after the close of the registrants fiscal year ended October 2, 2011.
Item |
Page | |||||
PART I | ||||||
1 |
Business | 4 | ||||
1A |
Risk Factors | 11 | ||||
1B |
Unresolved Staff Comments | 27 | ||||
2 |
Properties | 27 | ||||
3 |
Legal Proceedings | 28 | ||||
4 |
Removed and Reserved | 28 | ||||
PART II | ||||||
5 |
29 | |||||
6 |
31 | |||||
7 |
Managements Discussion and Analysis of Financial Condition and Results of Operations |
32 | ||||
7A. |
47 | |||||
8 |
49 | |||||
9 |
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure |
82 | ||||
9A. |
82 | |||||
9B. |
83 | |||||
PART III | ||||||
10 |
84 | |||||
11 |
84 | |||||
12 |
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |
84 | ||||
13 |
Certain Relationships and Related Transactions, and Director Independence |
84 | ||||
14 |
84 | |||||
PART IV | ||||||
15 |
85 |
2
IMPORTANT FACTORS RELATED TO FORWARD-LOOKING STATEMENTS AND ASSOCIATED RISKS
This Annual Report on Form 10-K must be read in its entirety and contains forward-looking statements within the meaning of the federal securities laws. Any statements that do not relate to historical or current facts or matters are forward-looking statements. You can identify some of the forward-looking statements by the use of forward-looking words, such as can, may, will, could, should, project, believe, anticipate, expect, plan, estimate, forecast, potential, intend, maintain, continue and variations of these words and comparable words. In addition, all of the information herein that does not state a historical fact is forward-looking, including any statement or implication about an estimate or a judgment, or an expectation as to a future time, future result or other future circumstance. Statements concerning current conditions may also be forward-looking if they imply a continuation of current conditions. Examples of forward-looking statements in this Annual Report on Form 10-K include, but are not limited to, statements concerning:
| expectations that we will be able to successfully integrate acquired companies and personnel with our existing operations; |
| expectations that plant consolidations will result in anticipated cost savings without unanticipated costs or expenses; |
| demand, growth and sales expectations for our products; |
| expectations regarding tax exposures and future tax rates and ability to realize deferred tax assets; |
| expectations regarding competitive conditions; |
| new market opportunities and emerging applications for our products; |
| the uncertainty of litigation, the costs and expenses of litigation, and the potential material adverse effect litigation could have on our business and results of operations; |
| beliefs that our customers will not cancel orders or terminate or renegotiate their purchasing relationships with us; |
| expectation that we will not suffer production delays as a result of a suppliers inability to supply parts; |
| the effect of events such as natural disasters and related disruptions on our operations, including, without limitation, the impact of recent flooding in Thailand; |
| beliefs that we stock adequate supplies of all materials; |
| beliefs that we will be able to successfully resolve any disputes and other business matters as anticipated; |
| beliefs that we will be able to meet our operating cash and capital commitment requirements in the foreseeable future; |
| critical accounting estimates; |
| expectations regarding our financial and operating results; |
| expectations regarding our liquidity and capital resources, including our loan covenants; |
| expectations regarding our performance and competitive position in future periods; and |
| expectations regarding our outlook for our end markets. |
Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the results that the forward-looking statements suggest. You are urged to carefully review the disclosures we make in this report concerning risks and other factors that may affect our business and operating results, including those made under the heading Item 1A. RISK FACTORS included below in this Annual Report on Form 10-K, as well as in our other reports filed with the Securities and Exchange Commission (SEC). Forward-looking statements are not a guarantee of future performance and should not be regarded as a representation by us or any other person that all of our estimates will necessarily prove correct or that all of our objectives or plans will necessarily be achieved. You are cautioned, therefore, not to place undue reliance on these forward-looking statements, which are made only as of the date of this report. We do not intend, and undertake no obligation, to update or revise the forward-looking statements to reflect events or circumstances after the date of this report, whether as a result of new information, future events or otherwise.
3
ITEM 1. BUSINESS |
INTRODUCTION
Microsemi Corporation was incorporated in Delaware in 1960. Our name was changed from Microsemiconductor Corporation in February 1983. Unless the context otherwise requires, the Company, Microsemi, we, our, ours and us refer to Microsemi Corporation and its consolidated subsidiaries. Our principal executive offices are located at One Enterprise, Aliso Viejo, California 92656 and our telephone number is (949) 380-6100.
We are a leading designer, manufacturer and marketer of high-performance analog and mixed-signal semiconductor solutions differentiated by power, security, reliability and performance. Our semiconductors manage and control or regulate power, protect against transient voltage spikes and transmit, receive and amplify signals. We offer one of the industrys most comprehensive portfolios of semiconductor technology. Our products include high-performance, high-reliability radio frequency (RF) and power components, analog and RF integrated circuits (ICs), standard and customizable system-on-chip solutions (SoCs/cSoCs),and mixed-signal and radiation-tolerant FPGAs. We also offer subsystems and modules that include application-specific power modules and PowerDsine® midpsans.
Our products include individual components as well as IC solutions that enhance customer designs by improving performance, reliability and battery optimization, reducing size or protecting circuits. The principal end markets that we serve include Defense & Security, Aerospace, Enterprise & Communications and Industrial & Alternative Energy, and applications where security is non-negotiable and reliability is vital.
We have implemented a growth strategy through continuous innovation complemented by strategic acquisitions to strengthen our product and technology portfolio with the intent of broadening our customer base and increasing our technology footprint in customers end designs in high-value, high barrier-to-entry markets where power matters, security is non-negotiable, and reliability is vital. This allows us to offer an increased value proposition, gather a larger portion of the bill of materials, and engage with customers as a strategic partner as opposed to a socket provider. We believe this strategy strengthens our position in the industry as it protects and grows our share within those markets with the highest barriers to entry, and increases our served available market.
Recent industry leading innovations include:
| High power silicon carbide RF power device for use in ultra high frequency radar, military power conversion and high speed switching applications; |
| Secure storage memory solutions for defense, IT and surveillance products; |
| Enhanced reliability cold cathode fluorescent lamp (CCFL) backlight inverters for use in mission-critical medical and industrial LCD displays; |
| High reliability metal-oxide-semiconductor field-effect-transistors (MOSFET) products for use in power conversion, motor control and power switching applications; |
| Extended temperature grade flash-based FPGA devices and SmartFusion® customizable system-on-chip (cSoC) with temperature screening from -55 degrees C to +100 degrees C that permit the integration of our products in military, avionics and defense applications where highly reliable operation at extreme temperatures is needed; |
| Transient voltage suppression devices that meet new avionics safety standards that are designed to protect avionics in composite-skinned aircraft; |
| An advanced 65-nanometer platform for flash-based customizable system-on-chips (cSoCs), featuring a new IP-friendly architecture that offers more functionality and lower power consumption; |
4
| Precision target-seeking and secure guidance solutions resulting in substantial improvements in size, accuracy, and cost efficient weaponry; |
| Application specific integrated circuit devices for use in smart meter and smart grid applications; |
| Leading edge wireless and wired network solutions for 80.2.11n Wi-Fi and power-over-ethernet (PoE) technology; |
| Global positioning system (GPS) receiver modules incorporating anti-tamper technology; |
| Defense Supply Center Columbus (DSCC)-certified radiation-hardened power MOSFETs for space applications; and |
| The industrys first family of 120 volt, 50 watt high-reliability single, dual and triple output radiation-hard DC-DC converters. |
We operate in a single industry segment as a manufacturer of semiconductors in different geographic areas.
Our website address is http://www.microsemi.com. Our filings with the SEC of annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, and all amendments to such forms, are made accessible on such website as soon as reasonably practicable after such documents are electronically filed with or furnished to the SEC and are always available free of charge. Also accessible on our website are our code of ethics, governance guidelines and charters for the Executive Committee, Governance and Nominating Committee, Compensation Committee and Audit Committee of our Board of Directors. Such website is not intended to constitute any part of this report.
Please read the information under the heading IMPORTANT FACTORS RELATED TO FORWARD-LOOKING STATEMENTS AND ASSOCIATED RISKS above, which describes and refers to some of the important risks and uncertainties that could affect Microsemis future business and prospects.
We report results of operations on the basis of fifty-two and fifty-three week periods. The fiscal year ended on October 2, 2011 consisted of fifty-two weeks, the fiscal year ended on October 3, 2010 consisted of fifty-three weeks, and the September 27, 2009 consisted of fifty-two weeks. In referencing a year, we are referring to the fiscal year ended on the Sunday closest to September 30.
ACQUISITIONS
We have in the past acquired a number of businesses or companies, additional product lines and assets. We currently expect to continue to expand and diversify our operations with additional acquisitions.
In October 2011, we completed the acquisition of Zarlink Semiconductor Inc. (Zarlink), an international semiconductor supplier that designs, manufactures and distributes microelectronic components for the communications and medical industries. We expect that Zarlinks timing, synchronization and voice products, which complement our existing communications products, will significantly increase our consolidated net sales in 2012.
During 2011, we acquired Actel Corporation (Actel), a leading supplier of low-power FPGAs, mixed-signal FPGAs, and system-critical FPGAs. We sometimes refer to this division herein as Microsemi SoC. We also acquired AML Communications, Inc., a designer, manufacturer, and marketer of microelectronic assemblies for the defense industry, Asic Advantage, Inc. (Asic Advantage), a fabless semiconductor company that designs and manufactures a broad portfolio of high-performance, high-voltage and radiation-hardened mixed-signal integrated circuit solutions for the aerospace, automotive, communications, industrial and medical markets and substantially all the assets of Brijot Imaging Systems, Inc. (Brijot) and its passive millimeter wave imaging solutions technology.
5
During 2010, we acquired White Electronic Designs Corporation (White Electronic), a defense electronics manufacturer and supplier that designs, develops and manufactures innovative electronic components and systems for inclusion in high technology products for the defense and aerospace markets. We also acquired substantially all the assets of VT Silicon, a designer and manufacturer of multi-band radio frequency integrated circuit (RFIC) solutions for the mobile wireless broadband market and all the shares of Arxan Defense Systems, Inc., a leading provider of anti-tamper solutions, providing full-service support to defense clients in securing systems against tampering, piracy and reverse engineering.
During 2009, we acquired Electro Module, Inc. and its wholly-owned subsidiary, Babcock, Inc. Babcock, Inc. is a leading manufacturer of high-reliability power supplies, relays and flat panel displays and supplies. We subsequently renamed Babcock, Inc., Microsemi Corp. Power Management Group (PMG). Also during 2009, we entered into an asset purchase agreement in which we acquired substantially all the assets of the Defense and Security business of Endwave Corporation. This business designs, manufactures and markets radio frequency modules that enable the transmission, reception and processing of high frequency signals. Markets for these products include defense electronics, homeland security systems and other applications that require high frequency radio frequency circuitry and subsystems. We subsequently renamed the Defense and Security business of Endwave Corporation, Microsemi Corp. RF Integrated Solutions. Our final acquisition of 2009 was the purchase of substantially all the assets of Nexsem, Inc., a designer and marketer of high-voltage DC to DC conversion devices for applications such as in LCD televisions, set top boxes, notebooks and netbooks.
PRODUCTS
Our products include individual components as well as IC solutions that enhance customer designs by improving performance, reliability and battery optimization, reducing size or protecting circuits. The principal end markets that we serve include Defense & Security, Aerospace, Enterprise & Communications and Industrial & Alternative Energy, and applications where security is non-negotiable and reliability is vital.
Our products offer light, sound and power management for desktop and mobile computing platforms, LCD TVs and other power control applications. Power management generally refers to a class of standard linear integrated circuits (SLICs) that perform voltage regulation and reference in most electronic systems. The definition of power management has broadened in recent years to encompass other devices and modules, often application-specific standard products (ASSPs), which address particular aspects of power management, such as audio or display related ICs. This business is composed of both a core platform of traditional SLICs, such as low dropout regulators (LDOs) and pulse width modulators (PWMs), and differentiated ASSPs such as backlight inverters, audio amplification ICs and small computer standard interface terminators. Our IC products are used in notebook computers, data storage, wireless local area network (LAN), LCD backlighting, LCD TVs, LCD monitors, automobiles, telecommunications, test instruments, defense and aerospace equipment, high-quality sound reproduction and data transfer equipment.
Our individual component semiconductor products include silicon rectifiers, zener diodes, low leakage and high voltage diodes, temperature compensated zener diodes, transistors, subminiature high power transient suppressor diodes and pin diodes used in magnetic resonance imaging (MRI) machines. We also manufacture semiconductors for commercial applications, such as automatic surge protectors, transient suppressor diodes used for telephone applications and switching diodes used in computer systems. A partial list of these products includes: implantable cardioverter defibrillator and heart pacer switching, charging and transient shock protector diodes, low leakage diodes, transistors used in jet aircraft engines and high performance test equipment, high temperature diodes used in oil drilling sensing elements operating at 200 degrees centigrade, temperature compensated zener or rectifier diodes used in missile systems and power transistors.
6
MARKETING
Our products include individual components as well as IC solutions that enhance customer designs by improving performance, reliability and battery optimization, reducing size or protecting circuits. The principal end markets that we serve include:
| Defense & Security Products in this end market include mixed-signal analog integrated circuits, JAN, JANTX, JANTXV and JANS high-reliability semiconductors and modules including diodes, zeners, diode arrays, transient voltage suppressors, bipolar transistors, MOSFETs, insulated gate bipolar transistors (IGBTs), small signal analog integrated circuits, small signal transistors, relays, silicon-controlled rectifiers (SCRs), RF transceivers and subsystems and FPGAs. These products are utilized in a variety of applications including radar and communications, defense electronics, homeland security, threat detection, targeting and fire control and other power conversion and related systems in military platforms. |
| Aerospace Products in this end market include offerings such as JAN, JANTX, JANTXV and JANS high-reliability semiconductors and modules and analog mixed-signal products including diodes, zeners, diode arrays, transient voltage suppressors, bipolar transistors, small signal analog integrated circuits, relays, small signal transistors, SCRs, MOSFETs, IGBTs and FPGAs. These products are utilized in a variety of applications including electronic applications for large aircraft and regional jets, commercial radar and communications, satellites, cockpit electronics, and other power conversion and related systems in space and aerospace platforms. |
| Enterprise & Communications Products in this end market include broadband power amplifiers and monolithic microwave integrated circuits (MMICs) targeted at 802.11 a/b/g/n/e, FGPAs, multiple-in multiple-out (MIMO), light emitting diode (LED), cold cathode fluorescent lamp (CCFL) controllers, visible light sensors, PWM controllers, voltage regulators, EMI/RFI filters, transient voltage suppressors and class-D audio circuits. Applications for these products include wi-max and wireless LAN devices, PoE devices, portable devices, set top box and telecom applications, notebook computers, monitors, storage devices and televisions. |
| Industrial & Alternative Energy Products in this end market include MOSFETs, IGBTs, FPGAs, power modules, ultra thin bypass diodes, bridge rectifiers, and high-voltage assemblies for use in industrial equipment, semiconductor capital equipment and solar power applications. Industrial applications also include zener diodes, high-voltage diodes, MOSFETs, IGBTs, transient voltage suppressors and thyristor surge protection devices that are designed into implantable defibrillators, pacemakers and neurostimulators and PIN diode switches, dual diode modules and switched-most power supplies (SMPS) for use in MRI systems. |
Our products are marketed through electronic component distributors and independent sales representatives, as well as our inside sales personnel. We have direct sales offices in many metropolitan areas around the world.
Net sales were $835.9 million, $518.3 million and $453.0 million in 2011, 2010 and 2009. Net sales by originating geographic area and end market are disclosed in Note 12 of the notes to the consolidated financial statements included in this Annual Report on Form 10-K, which information is incorporated herein by reference. A discussion of the risks attendant to our international operations are included in Item 1A, Risk Factors, under the heading, International operations and sales expose us to material risks and may increase the volatility of our operating results, which information is incorporated herein by reference.
RESEARCH AND DEVELOPMENT
We believe that continuing timely development and introduction of new products is essential to maintaining our competitive position. We currently conduct most of our product development effort in-house. We also employ outside consultants to assist with product design.
7
We expense the cost of research and development as incurred. Research and development expenses principally comprise payroll and related costs, consulting costs, supplies, and the cost of prototypes.
We spent approximately $114.2 million, $55.4 million and $41.4 million in 2011, 2010 and 2009 respectively, for research and development. The principal focus of our research and development activities has been to improve processes and to develop new products that support the growth of our businesses.
The spending on research and development was principally to develop new higher-margin application-specific products, including, among others, PoE, CCFL and LED drivers, class-D audio amplifiers, InGaP RF power amplifiers for wireless LAN applications, development and adoption of silicon carbide technology, ASICs, VDMOS products for high frequency communications and S-band products for RF applications.
PATENTS, LICENSES, AND OTHER INTELLECTUAL PROPERTY RIGHTS
We have registered several of our trademarks with the U.S. Patent and Trademark Office and in foreign jurisdictions. We rely to some extent upon confidential trade secrets and patents to develop and maintain our competitive position. It is our policy to seek patent protection for significant inventions that may be patented, though we may elect, in appropriate cases, not to seek patent protection even for significant inventions if other protection, such as maintaining the invention as a trade secret, is considered more advantageous or cost-effective. We believe that patent and mask work protection could grow in significance but presently is of less significance in our business than experience, innovation, and management skill. No individual patent contributed significantly to our 2011, 2010 or 2009 net sales.
Due to the many technological developments and the technical complexity of the semiconductor industry, it is possible that certain of our designs or processes may involve infringement of patents or other intellectual property rights held by others. From time to time, we have received, and in the future may receive, notice of claims of infringement by our products on intellectual property rights of third parties. If any such infringements were alleged to exist, we might be obligated to seek a license from the holder of the rights and might have liability for past infringement. In the past, it has been common semiconductor industry practice for patent holders to offer licenses on reasonable terms and rates. Although in some situations, typically where the patent directly relates to a specific product or family of products, patent holders have refused to grant licenses, the practice of offering licenses appears to be generally continuing. However, no assurance can be given that we will be able to obtain licenses as needed in all cases or that the terms of any license that may be offered will be acceptable to us. In those circumstances where an acceptable license is not available, we would need either to change the process or product so that it no longer infringes or stop manufacturing the product or products involved in the infringement, which might be costly and could adversely affect our revenues and operating results.
Please see the information that is set forth under the subheading Any failure by us to protect our proprietary technologies or maintain the right to use certain technologies may negatively affect our ability to compete, within the section below entitled ITEM 1A. RISK FACTORS.
MANUFACTURING AND SUPPLIERS
Our principal domestic manufacturing operations are located in Garden Grove, La Mirada, Folsom, Santa Clara, Mountain View, Camarillo, and Sunnyvale, California; Bend, Oregon; Phoenix, Arizona and Lawrence and Lowell, Massachusetts. We have assembly, testing and screening facilities at these locations and wafer processing at most domestic manufacturing locations. In addition, we have manufacturing operations in China, France; Ireland and the Philippines. Following the acquisition of Zarlink in October 2011, we added a manufacturing facility in the United Kingdom.
At our plants with wafer processing capabilities, we manufacture and process products, starting from purchased silicon wafers. At our locations without wafer processing capabilities, processed wafers are sourced from third parties or our other facilities. Processed silicon wafers are separated into individual dice that are then
8
assembled in packages and tested in accordance with our test procedures. A major portion of our semiconductor manufacturing effort takes place after the semiconductor is assembled. Parts are tested a number of times, visually screened and environmentally subjected to shock, vibration, burn in and electrical tests in order to prove and assure reliability. Certain subcontract suppliers provide packaging and testing for our products necessary to deliver finished products. We pay those suppliers for assembled or fully-tested products meeting predetermined specifications. Manufacturing and processing operations are controlled in accordance with military as well as other rigid commercial and industrial specifications.
In 2009, we approved consolidation plans that resulted in the closure of our manufacturing facility in Scottsdale, Arizona (Scottsdale), which ceased production in the second quarter of 2011. Scottsdale occupied a 135,000 square foot leased facility and shipped approximately 1%, 6% and 14% of net sales in 2011, 2010 and 2009, respectively.
We purchase silicon wafers, other semiconductor materials and packaging piece parts from domestic and foreign suppliers generally on long-term purchase commitments, that are cancelable on 30 to 90-days notice. Significantly all materials are available from multiple sources. In the case of sole source items, we have never suffered production delays as a result of suppliers inability to supply the parts. We believe that we stock adequate supplies for all materials, based upon backlog, delivery lead-time and anticipated new business. In the ordinary course of business, we enter into cancelable purchase agreements with some of our major suppliers to supply products over periods of up to 18 months. We also purchase a portion of our finished wafers from several foundry sources.
RAW MATERIALS
Our manufacturing processes use certain key raw materials critical to our products. These include silicon wafers, certain chemicals and gases, ceramic and plastic packaging materials and various precious metals. We also rely on subcontractors to supply finished or semi-finished products that are marketed through our various sales channels. We obtain raw materials and semi-finished or finished products from various sources, although the number of sources for any particular material or product may be limited. We feel that our current supply of essential materials is adequate; however, shortages have occurred from time to time and could occur again.
SEASONALITY
Generally, we are affected by the seasonal trends of the semiconductor and related industries. The impacts of seasonality are to some extent dependent on product and market mix of products shipped. These impacts can change from time to time and are not predictable. Factors that increase seasonality include, for example, holiday work schedules during our first fiscal quarter that tend to limit production and holiday demand that tends to increase net sales in the Enterprise & Communication end market during our fiscal first and fourth quarters.
COMPETITIVE CONDITIONS
The semiconductor industry, including the areas in which we do business, is highly competitive. We expect intensified competition from existing competitors and new entrants. Competition is based on price, product performance, product availability, quality, reliability and customer service. We compete in various markets with companies of various sizes, many of which are larger and have greater financial and other resources than we have, and thus may be better able to pursue acquisition candidates and to withstand adverse economic or market conditions. In addition, companies not currently in direct competition with us may introduce competing products in the future. Some of our current major competitors are Freescale Semiconductor, Inc., Texas Instruments, Inc., Koninklijke Philips Electronics, ON Semiconductor Corp., Fairchild Semiconductor International, Inc., Micrel Incorporated, International Rectifier Corp., Semtech Corp., Linear Technology Corp., Maxim Integrated Products, Inc., Skyworks Solutions, Inc., Diodes, Inc., Vishay Intertechnology, Inc., O2Micro International, Ltd., Semicoa Corporation, Supertex, Inc. and Monolithic Power Systems, Inc. Some of our competitors in developing
9
markets are Triquint Semiconductor, Inc., Mitel Corporation, RF Micro Devices, Inc., Anadigics, Inc. and Skyworks Solutions, Inc. We may not be able to compete successfully in the future or competitive pressures may harm our financial condition, operating results or cash flows.
We have implemented a growth strategy through continuous innovation complemented by strategic acquisitions with the intent of increasing our technology footprint in customers end designs in high-value, high barrier-to-entry markets. This allows us to offer an increased value proposition, gather a larger portion of the bill of materials, and engage with customers as a strategic partner as opposed to a socket provider. We believe this strategy strengthens our position in the industry as it protects and grows our share within those markets with the highest barriers to entry.
SALES TO U.S. GOVERNMENT
Approximately 36% of total net sales in 2011 were in the defense & security end market, with a very significant amount to customers whose principal sales are to the U.S. Government or to subcontractors whose material sales are to the U.S. Government. We, as a subcontractor, sell our products to higher-tier subcontractors or to prime contractors based upon purchase orders that usually do not contain all of the conditions included in the prime contract with the U.S. Government. However, these sales are usually subject to termination and/or price renegotiations by virtue of their reference to a U.S. Government prime contract. Therefore, we believe that all of our product sales that ultimately are sold to the U.S. Government may be subject to termination, at the convenience of the U.S. Government or to price renegotiations under the Renegotiation Act. While one of our contracts was terminated in the past due to the termination of the underlying government contracts, we have never experienced a material loss due to termination of a U.S. Government contract. We have never had to renegotiate our price under any government contract. There can be no assurance that we will not have contract termination or price renegotiation in the future.
ENVIRONMENTAL REGULATIONS
To date, our compliance with federal, state and local laws or regulations that have been enacted to regulate the environment has not had a material adverse effect on our capital expenditures, earnings, or competitive or financial position.
Federal, state and local laws and regulations impose various restrictions and controls on the discharge of materials, chemicals and gases used in semiconductor manufacturing processes. In addition, under some laws and regulations, we could be held financially responsible for remedial measures if our properties are contaminated or if we send waste to a landfill or recycling facility that becomes contaminated, even if we did not cause the contamination. Also, we may be subject to common law claims if we release substances that damage or harm third parties. Further, future changes in environmental laws or regulations may require additional investments in capital equipment or the implementation of additional compliance programs in the future. Any failure to comply with environmental laws or regulations could subject us to serious liabilities and could have material adverse effects on our operating results and financial condition.
In the conduct of our manufacturing operations, we have handled and do handle materials that are considered hazardous, toxic or volatile under federal, state or local laws. The risk of accidental release of such materials cannot be completely eliminated. In addition, we operate or own facilities located on or near real property that was formerly owned and operated by others. These properties were used in ways that involved hazardous materials. Contaminants may migrate from or within or through property. These risks may give rise to claims. We may be financially responsible for third parties, who are responsible for contamination, if they do not have funds, or if they do not make funds available when needed, to pay remediation costs imposed under environmental laws and regulations.
In Broomfield, Colorado, the owner of a property located adjacent to a manufacturing facility owned by one of our subsidiaries, Microsemi Corp. Colorado had notified the subsidiary and other parties of a claim that
10
contaminants migrated to his property, thereby diminishing its value. In August 1995, the subsidiary, together with Coors Porcelain Company, FMC Corporation and Siemens Microelectronics, Inc. (former owners of the manufacturing facility), agreed to settle the claim and to indemnify the owner of the adjacent property for remediation costs. Although trichloroethylene (TCE) and other contaminants previously used by former owners at the facility are present in soil and groundwater on the subsidiarys property, we vigorously contest any assertion that the subsidiary caused the contamination. In November 1998, we signed an agreement with the three former owners of this facility whereby they have 1) reimbursed us for $0.5 million of past costs, 2) assumed responsibility for 90% of all future clean-up costs, and 3) promised to indemnify and protect us against any and all third-party claims relating to the contamination of the facility. An Integrated Corrective Action Plan was submitted to the State of Colorado. Sampling and management plans were prepared for the Colorado Department of Public Health & Environment. State and local agencies in Colorado are reviewing current data and considering study and cleanup options. The most recent forecast estimated that the total project cost, up to the year 2020, would be approximately $5.3 million; accordingly, we recorded a one-time charge of $0.5 million for this project in 2003. There has not been any significant development since September 28, 2003.
EMPLOYEES
At the end of the most recently completed fiscal year, we employed approximately 1,800 persons domestically and 900 persons at our international facilities. None of our employees are represented by a labor union; however, some employees in Europe are represented by an employee works council pursuant to local regulations. We have experienced no work stoppages and believe our employee relations are good.
ITEM 1A. RISK | FACTORS |
Negative or uncertain worldwide economic conditions could prevent us from accurately forecasting demand for our products, which could adversely affect our operating results or market share.
Recent negative worldwide economic conditions and market instability have made it increasingly difficult for us, our customers and our suppliers to accurately forecast future product demand trends. If signs of improvement in the global economy do not progress as expected and global economic conditions worsen, our forecasts of product demand trends could prove to be incorrect and could cause us to produce excess products that can depress product prices, increase our inventory carrying costs and result in obsolete inventory. Alternatively, this forecasting difficulty could cause a shortage of products, or materials used in our products, that could result in an inability to satisfy demand for our products and a loss of market share.
Negative or uncertain worldwide economic conditions may adversely affect our business, financial condition, cash flow and results of operations.
Recent domestic and global economic conditions have presented unprecedented and challenging conditions reflecting continued concerns about the availability and cost of credit, downgrades and continued negative pressure on sovereign credit ratings, the mortgage market, declining real estate values, increased energy costs, decreased consumer confidence and spending and added concerns fueled by the federal governments interventions in the financial and credit markets. These conditions have contributed to instability in both the domestic and international capital and credit markets, potentially increased the cost of credit and diminished expectations for the global economy. In addition, these conditions make it extremely difficult for our customers to accurately forecast and plan future business activities and could cause businesses to slow spending on our products, which could cause our sales to decrease or result in an extension of our sales cycles. If signs of improvement in the global economy do not progress as expected and global economic conditions worsen, our customers may have difficulties obtaining capital at adequate or historical levels to finance their ongoing business and operations, which could impair their ability to make timely payments to us. If that were to occur, we may be required to increase our allowance for doubtful accounts and our days sales outstanding would be negatively impacted. We cannot predict the timing, strength or duration of any economic slowdown or
11
subsequent economic recovery, worldwide or within our industry. If signs of improvement in the global economy do not progress as expected and economic conditions worsen, our business, financial condition, cash flows and results of operations will be adversely affected.
The concentration of the facilities that service the semiconductor industry, including facilities of current or potential vendors or customers, makes us more susceptible to events or disasters affecting the areas in which they are most concentrated.
Relevant portions of the semiconductor industry, and the facilities that serve or supply this industry, tend to be concentrated in certain areas of the world. Events such as natural disasters and related disruptions, epidemics and health advisories like those related to Sudden Acute Respiratory Syndrome, Avian Influenza or the H1N1 Virus, flooding, tsunamis, power outages and infrastructure disruptions, and civil unrest and political instability in those areas, have from time to time in the past, and may again in the future, adversely affect the semiconductor industry. In particular, events such as these could adversely impact our ability to manufacture or deliver our products and result in increased costs and a loss of revenue. Similarly, a localized risk affecting our employees or the staff of our suppliers could impair the total volume of products that we are able to manufacture, which could adversely affect our results of operations and financial condition.
In the first quarter of fiscal year 2012, severe flooding in certain regions of Thailand forced a shutdown of our operations in two subcontracted facilities in Thailand. The two Thailand facilities together can account for as much as 5% of our total quarterly revenues. We currently expect to relocate our operations to other facilities outside the affected area. However, should circumstances change or we are not able to execute our relocation plans, we may experience disruptions for the affected products that could have an adverse effect on our ability to timely deliver certain products and have a material adverse impact on our results of operations. In addition, unforeseen impacts on our customers, suppliers or subcontractors as a result of the flooding in Thailand could further affect our revenue, consolidated financial position, results of operations and cash flows.
Our operating results may fluctuate in future periods, which could cause our stock price to decline.
We have experienced, and expect to experience in future periods, fluctuations in net sales and operating results from period to period. Our projections and results may be subject to significant fluctuations as a result of a number of factors including:
| the timing of orders from and shipment of products to major customers; |
| an unexpected reduction in sales to, or loss of, key customers; |
| our product mix; |
| changes in the prices of our products; |
| manufacturing delays or interruptions; |
| delays or failures in testing and processing products for defense, security and aerospace applications; |
| inventory obsolescence or write-downs; |
| restructuring charges; |
| variations in the cost of components for our products; |
| limited availability of components that we obtain from a single or a limited number of suppliers; and |
| seasonal and other fluctuations in demand for our products. |
12
We may be unable to successfully implement our acquisitions strategy or integrate acquired companies and personnel with existing operations.
We have in the past acquired a number of businesses or companies, additional product lines and assets, and we may continue to expand and diversify our operations with additional acquisitions. We may be unable to identify or complete prospective acquisitions for many reasons, including competition from other companies in the semiconductor industry and high valuations of business candidates. In addition, applicable antitrust laws and other regulations may limit our ability to acquire targets or force us to divest an acquired business, such as occurred with our attempt to acquire SEMICOA. If we are unable to identify suitable targets or complete acquisitions, our growth prospects may suffer, and we may not be able to realize sufficient scale advantages to compete effectively in all markets. To the extent that we are successful in making acquisitions, if we are unsuccessful in integrating acquired companies or product lines with existing operations, or if integration is more difficult or more costly than anticipated, we may experience disruptions that could have a material adverse effect on our business, financial condition and results of operations. In addition, the market price of our common stock could be adversely affected if the effect of any acquisitions on the Microsemi consolidated groups financial results is dilutive or is below the markets or financial analysts expectations. Some of the risks that may affect our ability to integrate or realize any anticipated benefits from acquired companies, businesses or assets include those associated with:
| unexpected losses of key employees or customers of the acquired company; |
| conforming the acquired companys standards, processes, procedures and controls with our operations; |
| coordinating new product and process development; |
| hiring additional management and other critical personnel; |
| increasing the scope, geographic diversity and complexity of our operations; |
| difficulties in consolidating facilities and transferring processes and know-how; |
| other difficulties in the assimilation of acquired operations, technologies or products; |
| diversion of managements attention from other business concerns; and |
| adverse effects on existing business relationships with customers. |
In connection with acquisitions, we may:
| use a significant portion of our available cash; |
| issue equity securities, which would dilute current stockholders percentage ownership; |
| incur substantial debt; |
| incur or assume contingent liabilities, known or unknown, including potential lawsuits, infringement actions and similar liabilities; |
| incur impairment charges related to goodwill or other intangibles; |
| incur large, immediate accounting write-offs; and |
| face antitrust or other regulatory inquiries or actions. |
There can be no assurance that the benefits of any acquisitions will outweigh the attendant costs, and if they do not, our results of operations and stock price may be adversely affected.
13
Provisions in our credit facility and our current leverage could adversely affect our consolidated financial position and our ability to operate our business.
Our credit facility requires that we comply with financial and restrictive covenants. Although we are currently in compliance with these covenants, unexpected downturns in our business may trigger certain covenants that increase our cost of borrowing, decrease the amounts available under our credit facility, or both. The current amount outstanding on our credit facility exceeds our current cash and cash equivalents balance, and we may incur additional debt in the future. Some of the risks that are associated with our leverage include the following:
| our ability to obtain additional financing in the future for acquisitions, capital expenditures, general corporate purposes or other purposes may be impaired; |
| our current credit facility only permits borrowing on variable rates of interest and increases in certain benchmark interest rates will increase the cost of borrowing; |
| leverage will increase our vulnerability to declining economic conditions, particularly if the decline is prolonged; |
| failure to comply with any of our debt covenants may result in an event of default which, if not cured or waived, could have a material adverse effect on us; |
| financial and restrictive covenants may adversely affect our ability to implement business plans, react to changes in economic conditions or benefit from changes in tax regulations; and |
| debt service payments will continue to have a negative impact on our cash flows. |
We have closed, combined, sold or disposed of certain of our manufacturing operations, which in the past has reduced our sales volume and resulted in significant restructuring costs.
In September 2009, we approved consolidation plans that resulted in the closure of our manufacturing facility in Scottsdale, Arizona during the quarter ended April 3, 2011. Scottsdale represented approximately 1% of our annual net sales in fiscal year 2011 and occupied a 135,000 square foot leased facility. We face major technical challenges in regard to transferring component manufacturing between locations. Before a transfer of manufacturing, we must be finished qualifying the new facility appropriately with the U.S. government or certain customers. In addition, to mitigate the potential for manufacturing disruptions following a closure, we typically build inventory to support the transition process. While we plan generally to retain revenues and income of those operations by transferring the manufacturing elsewhere within Microsemis subsidiaries, our plans may change at any time based on reassessment of the alternatives and consequences. While we hope to benefit overall from increased gross margins and increased capacity utilization rates at remaining operations, the remaining operations will need to bear the corporate administrative and overhead costs, which are charges to income that had been allocated to the discontinued business units. Moreover, delays in effecting our consolidations could result in changes in the timing of realized costs savings and in greater than anticipated costs incurred to achieve the hoped for longer-range savings.
In October 2003, we announced the consolidation of the manufacturing operations of Microsemi Corp. Santa Ana, of Santa Ana, California into some of our other facilities. The Santa Ana facility, whose manufacturing represented approximately 13% of our annual net sales in fiscal year 2004, had approximately 380 employees and occupied 123,000 square feet. In April 2005, we announced the consolidation of the high-reliability products operations of Microsemi Corp. Colorado of Broomfield, Colorado (Broomfield) into some of our other facilities. Broomfield represented approximately 5% of our annual net sales in fiscal year 2009, had approximately 50 employees and occupied a 130,000 square foot owned facility.
14
We may make further specific determinations to consolidate, close or sell additional facilities, which could be announced at any time. Possible adverse consequences from current and future consolidation activities may include various accounting charges such as for workforce reduction, including severance and other termination benefits and for excess facilities, including lease termination fees, future contractual commitments to pay lease charges, facility remediation costs and moving costs to remove property and equipment from facilities. We may also be adversely impacted from inventory buildup in preparation for the transition of manufacturing, disposition costs, impairments of goodwill, a possible immediate loss of revenues, and other items in addition to normal or attendant risks and uncertainties. We may be unsuccessful in any of our current or future efforts to consolidate our business into a smaller number of facilities. Our plans to minimize or eliminate any loss of revenues during consolidation may not be achieved.
Unanticipated changes in our tax provisions or exposure to additional income tax liabilities could affect our financial results.
We are subject to income taxes in the United States and numerous foreign jurisdictions. Our tax liabilities are affected by the amounts we record in intercompany transactions for inventory, services, licenses, funding and other items. We are subject to ongoing tax audits in various jurisdictions. Tax authorities may disagree with our intercompany charges or other matters and assess additional taxes. We regularly assess the likely outcomes of these audits in order to determine the appropriateness of our tax provision. However, there can be no assurance that we will accurately predict the outcomes of these audits, and the actual outcomes of these audits could have a material impact on our financial condition. In addition, our effective tax rate in the future could be adversely affected by changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, changes in tax laws, especially tax laws related to foreign operations, and the discovery of new information in the course of our tax return preparation process. Any of these changes could affect our operating results, cash flows and financial condition.
Reliance on government contracts for a portion of our sales could have a material adverse effect on results of operations.
Some of our sales are or may be derived from customers whose principal sales are to the United States government. These sales are or may be derived from direct and indirect business with the U.S. Department of Defense and other U.S. government agencies. Future sales are subject to the uncertainties of governmental appropriations and national defense policies and priorities and potential changes in these policies and priorities. If we experience significant reductions or delays in procurements of our products by the U.S. government or terminations of government contracts or subcontracts, our operating results could be materially and adversely affected. Generally, the U.S. government and its contractors and subcontractors may terminate their contracts with us for cause or for convenience. We have in the past experienced one termination of a contract due to the termination of the underlying government contracts. All government contracts are also subject to price renegotiation in accordance with the U.S. Government Renegotiation Act. By reference to such contracts, all of the purchase orders we receive that are related to government contracts are subject to these possible events. There is no guarantee that we will not experience contract terminations or price renegotiations of government contracts in the future.
In addition, we are required to maintain compliance with government regulations, particularly for our facilities and products that service the defense and security markets. Maintaining compliance requires that we devote resources to matters that include training, personnel, information technology and facilities. Failure to maintain compliance may result in the loss of certifications, fines and penalties that may materially and adversely affect our operating results.
15
Microsemis aggregate net sales to the defense & security end market represented approximately 36% of total net sales in 2011. From time to time, we have experienced declining security- and defense-related sales, primarily as a result of contract award delays and reduced security and defense program funding. We may be unable to adequately forecast or respond to the timing of and changes to demand for security- and defense-related products. In the past, defense-related spending on programs that we participate in has increased at a rate that has been slower than expected, been delayed or declined. Our prospects for additional security- and defense-related sales may be adversely affected in a material manner by numerous events or actions outside our control.
We must commit resources to research and development, design, and production prior to receipt of purchase commitments and could lose some or all of the associated investment.
We sell products primarily pursuant to purchase orders for current delivery, rather than pursuant to long-term supply contracts. Many of these purchase orders may be revised or cancelled without penalty. As a result, we must commit resources to the research, design and production of products without any advance purchase commitments from customers. Any inability to sell a product after we devote significant resources to it could have a material adverse effect on our business, financial condition, results of operations and cash flows.
International operations and sales expose us to material risks and may increase the volatility of our operating results.
Net sales from international markets represent a significant portion of total net sales. Our net sales to international customers represented approximately 46% in 2011. These sales were principally to customers in Europe and Asia. Foreign sales are classified as shipments to foreign destinations. We maintain facilities or contracts with entities in several foreign countries, including Canada, Korea, Japan, China, Ireland, Thailand, the Philippines, Malaysia, France, Taiwan, Macau, Israel and India. There are risks inherent in doing business internationally, including:
| legislative or regulatory requirements and potential changes in or interpretations of requirements in the United States and in the countries in which we manufacture or sell our products; |
| tax regulations and treaties and potential changes in regulations and treaties in the United States and in and between countries in which we manufacture or sell our products; |
| fluctuations in income tax expense and net income due to differing statutory tax rates in various domestic and international jurisdictions; |
| trade restrictions; |
| availability of transportation services, including disruptions related to work stoppages, security incidents or natural events at manufacturing, shipping or receiving points or along transportation routes; |
| work stoppages or disruption of local labor supply; |
| communication interruptions; |
| economic and political instability, including the recent uncertainty in the global financial markets; |
| acts of war or terrorism, or health issues (such as Sudden Acute Respiratory Syndrome, Avian Influenza or the H1N1 Virus), which could disrupt our manufacturing and logistical activities; |
| compliance with and changes in import/export regulations; |
| changes in tariffs and freight rates; |
| difficulties in collecting receivables and enforcing contracts generally; |
| restrictions in the transfer or repatriation of funds; and |
16
| currency exchange rate fluctuations, devaluation of foreign currencies, hard currencies shortages and exchange rate fluctuations. |
International sales of our products that service the defense and security markets are subject to U.S. and local government regulations and procurement policies and practices including regulations relating to import-export control. Violations of export control regulations could result in suspension of our ability to export our products. Depending on the scope of the suspension, this could have a material effect on our ability to perform certain international contracts. In addition, failure to maintain compliance with government regulations may result in fines and penalties that may materially and adversely affect our operating results.
If political, military, transportation, health or other issues in foreign countries result in cancellations of customer orders or contribute to a general decrease in economic activity or corporate spending, or directly impact Microsemis marketing, manufacturing, financial and logistics functions, our consolidated results of operations and financial condition could be materially adversely affected. In addition, the laws of certain foreign countries may not protect our products, assets or intellectual property rights to the same extent as do U.S. laws. Therefore, the risk of piracy of our technology and products, which could result in a material adverse effect on our financial condition, operating results and cash flows, may be greater in those foreign countries.
There may be unanticipated costs associated with appropriately scaling our manufacturing capacity to meet expected changes in customer demand.
We may incur unanticipated costs as we scale our manufacturing capacity to meet expected changes in customer demand. During periods of anticipated increases in customer demand, we may determine that our business will require increased manufacturing capacity on our part and on the part of certain outside foundries, assembly shops, or testing facilities for some of our integrated circuit products or other products. Expansion activities are subject to a number of risks, including:
| unavailability or late delivery of the advanced, and often customized, equipment used in the production of our specialized products; |
| availability of qualified manufacturing personnel; |
| delays in bringing new production equipment on-line; |
| delays in supplying satisfactory designs or products to our existing customers; |
| unforeseen environmental, engineering or manufacturing qualification problems relating to existing or new facilities; and |
| overexpansion may result in unfavorable manufacturing variances, restructuring costs and impairments. |
These and other risks may affect the ultimate cost and timing of any expansion of our capacity.
Downturns in the highly cyclical semiconductor industry have in the past adversely affected our operating results, cash flows and the value of our business, and may continue to do so in the future.
The semiconductor industry is highly cyclical and is characterized by constant technological change, rapid product obsolescence and price erosion, short product life-cycles and fluctuations in product supply and demand. During recent years we, as well as many others in our industry, have experienced significant declines in the pricing of, as well as demand for, products during the down portions of these cycles, which have sometimes been severe and prolonged. In the future, these downturns may prove to be as, or possibly even more, severe than past ones. Our ability to sell our products depends, in part, on continued demand in each of our diverse end markets. Each of these end markets has in the past experienced reductions in demand, and current and future downturns in any of these markets may continue to adversely affect our revenues, operating results, cash flows and financial condition.
17
The semiconductor business is subject to downward price pressure.
The market for our products has been characterized by declining selling prices, and we anticipate that our average selling prices will decrease in future periods, although the timing and amount of these decreases cannot be predicted with any certainty. The pricing pressure in the semiconductor industry in past years has been due to a large number of factors, many of which were not easily foreseeable, such as the Asian currency crisis, industry-wide excess manufacturing capacity, weak economic growth, the slowdown in capital spending that followed the dot-com collapse, the reduction in capital spending by telecom companies and satellite companies, and the effects of the tragic events of terrorism on September 11, 2001. Similar to past years, recent unfavorable economic conditions have resulted in a tightening of the credit markets. If signs of improvement in the global economy do not progress as expected and global economic conditions worsen, we may experience a decline in our average selling prices. In addition, our competitors have in the past, and may again in the future, lower prices in order to increase their market share. Continued downward price pressure in the industry may reduce our operating results and harm our financial and competitive position.
The semiconductor industry is highly competitive.
The semiconductor industry, including most of the markets in which we do business, is highly competitive. We have numerous competitors in the various markets in which we sell products. Some of our current major competitors are Freescale Semiconductor, Inc., Texas Instruments, Inc., Koninklijke Philips Electronics, ON Semiconductor Corp., Fairchild Semiconductor International, Inc., Micrel Incorporated, International Rectifier Corp., Semtech Corp., Linear Technology Corp., Maxim Integrated Products, Inc., Skyworks Solutions, Inc., Diodes, Inc., Vishay Intertechnology, Inc., O2Micro International, Ltd. and Monolithic Power Systems, Inc. Some of our competitors in developing markets are Triquint Semiconductor, Inc., RF Micro Devices, Inc., Anadigics, Inc. and Skyworks Solutions, Inc. Many of these companies are larger than we are and have greater resources than we have and may therefore be better able than we are to penetrate new markets, pursue acquisition candidates, and withstand adverse economic or market conditions. We expect intensified competition from both these existing competitors and new entrants into our markets. To the extent we are not able to compete successfully in the future, our financial condition, operating results or cash flows could be harmed.
We may not be able to develop new technologies and products to satisfy changes in customer demand, and our competitors could develop products that decrease the demand for our products.
Rapidly changing technologies and industry standards, along with frequent new product introductions, characterize the semiconductor industry. Our financial performance depends, in part, on our ability to design, develop, manufacture, assemble, test, market and support new products and enhancements on a timely and cost-effective basis. If we are unable to continue to reduce package sizes, improve manufacturing yields and expand sales, we may not remain competitive. The competitiveness of designs that we have introduced, including integrated circuits and subsystems such as class D audio subsystems for newly-introduced home theatre DVD players supporting surround sound, power-over-ethernet, PDA backlighting subsystems, backlight control and power management solutions for the automotive notebook computer, monitors and the LCD TV market, LED driver solutions and power amplifiers for certain wireless LAN components, are subject to various risks and uncertainties that we are not able to control, including changes in customer demand and the introduction of new or superior technologies by others. Moreover, any failure by us in the future to develop new technologies or timely react to changes in existing technologies could materially delay our development of new products, which could result in product obsolescence, decreased revenues and a loss of our market share to our competitors. New technologies or products that we may develop may not lead to an incremental increase in revenues, and there is a risk that these new technologies or products will decrease the demand for our existing products and result in an offsetting reduction in revenues. In addition, products or technologies developed by others may render our products or technologies obsolete or non-competitive. A fundamental shift in technologies in our product markets could have a material adverse effect on our competitive position within the industry.
18
Compound semiconductor products may not successfully compete with silicon-based products.
Our choices of technologies for development and future implementation may not reflect future market demand. The production of gallium arsenide (GaAs), indium gallium phosphide (InGaP), silicon germanium (SiGe), indium gallium arsenide phosphide (InGaAsP) or silicon carbide (SiC) integrated circuits is more costly than the production of silicon circuits, and we believe it will continue to be more costly in the future. The costs differ because of higher costs of raw materials, lower production yields and higher unit costs associated with lower production volumes. Silicon semiconductor technologies are widely used in process technologies for integrated circuits, and these technologies continue to improve in performance. As a result, we must offer compound semiconductor products that provide vastly superior performance to that of silicon for specific applications in order for our products to be competitive with silicon products. If we do not offer compound semiconductor products that provide sufficiently superior performance to offset the cost differential and otherwise successfully compete with silicon-based products, our revenues and operating results may be materially and adversely affected.
Production delays related to new compound semiconductors could adversely affect our future results.
We utilize process technology to manufacture compound semiconductors such as GaAs, InGaP, SiGe, SiC and InGaAsP primarily to manufacture semiconductor components. We are pursuing this development effort internally as well as with third party foundries. Our efforts sometimes may not result in commercially successful products. Certain of our competitors offer this capability and our customers may purchase our competitors products instead of ours for this reason. In addition, the third party foundries that we use may delay delivery of, or even completely fail to deliver, technology and products to us. Our business and financial prospects could be materially and adversely affected by any failure by us to timely produce these products.
We may be unable to retain our customers due in part to our inability to fulfill our customer demand and other factors.
Our ability to fulfill our customers demand for our products is and will continue to be dependent in part on our order volumes and long lead times with regard to our manufacturing and testing of certain high-reliability products. The lead time for manufacture and testing of high-reliability products can be many months. In response to this current demand, we have recently increased our capital expenditures for production equipment as well as increased expenses for personnel at certain manufacturing locations. We may have delays or other difficulties in regard to increasing our production and in hiring and retaining qualified personnel. In addition, we have raised prices on certain products, primarily in our Aerospace, Defense & Security and Industrial & Alternative Energy end markets. Manufacturing delays and price increases may result in our customers reducing their purchase levels with us and/or seeking alternative solutions to meet their demand. In addition, the current demand may not continue in the future. Decreased sales as a result of a loss of one or more significant customers could materially and adversely impact our business and results of operations.
Unfavorable or uncertain conditions in certain retail markets that our OEM customers address may cause fluctuations in our rate of revenue growth or financial results.
Some of the principal markets we serve include consumer markets, such as mobile/connectivity and notebooks, monitors and LCD televisions. If domestic and global economic conditions worsen, overall consumer spending may be reduced or shifted to products other than those made by our customers, which would adversely impact demand for products in these market. Reduced sales by our customers in these end markets will adversely impact demand by our customers for our products and could also slow new product introductions by our customers and by us. Lower net sales of our products would have an adverse effect on our revenue, cash flow and results of operations.
19
Fluctuations in sales of high-reliability products for use in implantable defibrillators may adversely affect our financial results.
Although the market for implantable defibrillators is growing, customers in this market could reduce their reliance on outside suppliers. The implantable defibrillator market also fluctuates based on several other factors, such as product recalls and the need to secure regulatory approvals. Product recalls can from time to time accelerate sales to levels that cannot be sustained for long periods of time. The timing and qualification of new generations of products brought to market by OEMs can also result in fluctuations in order rates.
Variability of our manufacturing yields may affect our gross margins and profits.
Our manufacturing yields vary significantly among products, depending on the complexity of a particular products design and our experience in manufacturing that type of product. We have in the past experienced difficulties in achieving planned yields, which have adversely affected our gross margins and profits.
The fabrication of semiconductor products is a highly complex and precise process. Problems in the fabrication process can cause a substantial percentage of wafers to be rejected or numerous circuits on each wafer to be non-functional, thereby reducing yields. These difficulties include:
| defects in masks, which are used to transfer circuit patterns onto our wafers; |
| impurities in the materials used; |
| contamination of the manufacturing environment; and |
| equipment failure. |
Because a large portion of our costs of manufacturing is relatively fixed and average selling prices for our products tend to decline over time, it is critical for us to improve the number of shippable circuits per wafer and increase the production volume of wafers in order to maintain and improve our results of operations. Yield decreases can result in substantially higher unit costs, which could materially and adversely affect our operating results and have done so in the past. Moreover, our process technologies have primarily utilized standard silicon semiconductor manufacturing equipment, and production yields of compound integrated circuits have been relatively low compared with silicon circuit devices. We may be unable to continue to improve yields in the future, and we may suffer periodic yield problems, particularly during the early production of new products or introduction of new process technologies. In either case, our results of operations could be materially and adversely affected.
Some of our facilities are located near major earthquake fault lines.
Our headquarters, our major operating facilities, and certain other critical business operations are located near known major earthquake fault lines. We presently do not have earthquake insurance. We could be materially and adversely affected in the event of a major earthquake.
Delays in beginning production, implementing production techniques, resolving problems associated with technical equipment malfunctions, or issues related to government or customer qualification of facilities could adversely affect our manufacturing efficiencies and our ability to realize cost savings.
Microsemis consolidated manufacturing efficiency will be an important factor in our future profitability, and we may be unsuccessful in our efforts to maintain or increase our manufacturing efficiency. Our manufacturing processes, and those utilized by our third-party subcontractors, are highly complex, require advanced and costly equipment and are sometimes modified in an effort to improve yields and product performance. We have from time to time experienced difficulty in transitions of manufacturing processes to different facilities or adopting new manufacturing processes. As a consequence, we have at times experienced
20
delays in product deliveries and reduced yields. Every silicon wafer fabrication facility utilizes very precise processing, and processing difficulties and reduced yields commonly occur, often as a result of contamination of the material. Reduced manufacturing yields can often result in manufacturing and shipping delays due to capacity constraints. Therefore, manufacturing problems can result in additional operating expense and delayed or lost revenues. In one instance, which occurred in fiscal year 2005, Microsemi scrapped nonconforming inventory at a cost of approximately $1 million and experienced a delay of approximately two months in realizing approximately $1.5 million of net sales. In an additional instance, which occurred in fiscal year 2004, Microsemi encountered a manufacturing problem concerning contamination in a furnace that resulted in the quarantine of approximately one million units at a cost of approximately $2 million. The identification and resolution of that manufacturing issue required four months of effort to investigate and resolve, which resulted in a concurrent delay in realizing approximately $2 million of net sales. Microsemi may experience manufacturing problems in achieving acceptable yields or experience product delivery delays in the future as a result of, among other things, upgrading existing facilities, relocating processes to different facilities, or changing its process technologies, any of which could result in a loss of future revenues or an increase in manufacturing costs.
Interruptions, delays or cost increases affecting our materials, parts, equipment or subcontractors may impair our competitive position.
Our manufacturing operations, and the outside manufacturing operations that we use increasingly, in some instances depend upon obtaining a governmental qualification of the manufacturing process, and in all instances, adequate supplies of materials including wafers, parts and equipment (including silicon, mold compounds and lead frames) on a timely basis from third parties. Some of the outside manufacturing operations we use are based in foreign countries. Our results of operations could be adversely affected if we are unable to obtain adequate supplies of materials, parts and equipment in a timely manner or if the costs of materials, parts or equipment increase significantly. From time to time, suppliers may extend lead times, limit supplies or increase prices due to capacity constraints or other factors. Although we generally use materials, parts and equipment available from multiple suppliers, we have a limited number of suppliers for some materials, parts and equipment. In addition, if signs of improvement in the global economy do not progress as expected and global economic conditions worsen, our suppliers may cease operations or be unable to obtain capital at adequate or historical levels to finance their ongoing business and operations, which could impair their ability to continue to supply us. If alternate suppliers for these materials, parts and equipment are not available, our operations could be interrupted, which would have a material adverse effect on our operating results, financial condition and cash flows.
Some of our products are manufactured, assembled and tested by third-party subcontractors, some of whom are based in foreign countries. We generally do not have any long-term agreements with these subcontractors. As a result, we may not have direct control over product delivery schedules or product quality. Outside manufacturers generally will have longer lead times for delivery of products as compared with our internal manufacturing, and therefore, when ordering from these suppliers, we will be required to make longer-term estimates of our customers current demand for products, and these estimates are difficult to make accurately. Also, due to the amount of time typically required to qualify assemblers and testers, we could experience delays in the shipment of our products if we are forced to find alternate third parties to assemble or test our products. Any product delivery delays in the future could have a material adverse effect on our operating results, financial condition and cash flows. Our operations and ability to satisfy customer obligations could be adversely affected if our relationships with these subcontractors were disrupted or terminated. In addition, these subcontractors must be qualified by the U.S. government or customers for high-reliability processes. Historically the Defense Supply Center Columbus (DSCC) has rarely qualified any foreign manufacturing or assembly lines for reasons of national security; therefore, our ability to move certain manufacturing offshore may be limited or delayed.
21
We depend on third party subcontractors in Asia for wafer fabrication, assembly and packaging of an increasing portion of our products. On a unit basis, we currently utilize third-party subcontractors for approximately 79% of our assembly and packaging requirements and 22% of our wafer fabrication. We expect that these percentages may increase due, in part, to the manufacture of our next-generation products by third party subcontractors in Asia. The packaging of our products is performed by a limited group of subcontractors and some of the raw materials included in our products are obtained from a limited group of suppliers. Disruption or termination of any of these sources could occur and such disruptions or terminations could harm our business and operating results. In the event that any of our subcontractors were to experience financial, operational, production or quality assurance difficulties resulting in a reduction or interruption in supply to us, our operating results could suffer until alternate qualified subcontractors, if any, were to become available and active. In addition, the cost of product replacements or returns and other warranty matters in connection with qualify assurance problems caused by third party subcontractors could materially adversely affect us.
Fixed costs may reduce operating results if our sales fall below expectations.
Our expense levels are based, in part, on our expectations for future sales. Many of our expenses, particularly those relating to capital equipment and manufacturing overhead, are relatively fixed. We might be unable to reduce spending quickly enough to compensate for reductions in sales. Accordingly, shortfalls in sales could materially and adversely affect our operating results. This challenge could be made even more difficult if lead times between orders and shipments are shortening.
Failure to manage consolidation of operations effectively could adversely affect our margins and earnings.
Our ability to successfully offer and sell our products requires effective planning and management processes. Our consolidations and realignments of operations, and expected future growth, may place a significant strain on our management systems and resources, including our financial and managerial controls, reporting systems, procedures and information technology. In addition, we will need to continue to train and manage our workforce worldwide. Any unmet challenges in that regard could negatively affect our results of operations.
Any failure by us to protect our proprietary technologies or maintain the right to use certain technologies may negatively affect our ability to compete.
We rely heavily on our proprietary technologies. Our future success and competitive position depend in part upon our ability to obtain or maintain protection of certain proprietary technologies used in our principal products. We do not have significant patent protection on many aspects of our technology. The protection of some of our technology as trade secrets will not necessarily protect us from all uses by other persons of our technology, or their use of technology that is similar or superior to that which is embodied in our trade secrets. In addition, others may be able to independently duplicate or exceed our technology in whole or in part. In the instances in which we hold patents or patent licenses, such as with respect to some circuit components for notebook computers and LCD TVs, any patents held by us may be challenged, invalidated or circumvented, or the rights granted under any patents may not provide us with competitive advantages. Patents often provide only narrow protection and require public disclosure of information that may otherwise be subject to trade secret protection. In addition, patents eventually expire and are not renewable.
22
Obtaining or protecting our proprietary rights may require us to defend claims of intellectual property infringement by our competitors. We could also become subject to lawsuits in which it is alleged that we or companies we have acquired have infringed or are infringing upon the intellectual property rights of others with or without our prior awareness of the existence of those third-party rights, if any. Litigation in connection with our intellectual property, whether instituted by us or others, could be very costly and distract management and other resources from our business. We are currently involved in certain patent litigation to protect our patents and patent rights, which could cause legal costs to increase above normal levels over the next several years. It is not possible to estimate the exact amounts of these costs, but it is possible that these costs could have a negative effect on our future results.
Moreover, if any infringement, real or imagined, happens to exist, arise or is claimed in the future, we may be exposed to substantial liability for damages and may need to obtain licenses from the patent owners, discontinue or change our processes or products or expend significant resources to develop or acquire non-infringing technologies. We may not be successful in such efforts, or such licenses may not be available under reasonable terms. Any failure by us to develop or acquire non-infringing technologies or to obtain licenses on acceptable terms could have a material adverse effect on our operating results, financial condition and cash flows.
Our products may be found to be defective or hazardous and we may not have sufficient liability insurance.
There is at any time a risk that our products may be found to be defective or to contain, without the customers knowledge, certain prohibited hazardous chemicals after we have already shipped the products in volume, perhaps requiring a product replacement or recall. We may be subject to product returns that could impose substantial costs and have a material and adverse effect on our business, financial condition and results of operations. Our aerospace, defense, and industrial businesses in particular expose us to potential liability risks that are inherent in the manufacturing and marketing of high-reliability electronic components for critical applications. Production of many of these products is sensitive to minute impurities, which can be introduced inadvertently in manufacture. Any production mistake can result in large and unanticipated product returns, product liability and warranty liability. Environmental regulations have imposed on every major participant in the electronics industry a new burden of determining and tracking the presence and quantity of certain chemicals in the content of supplies we buy and add to our products for sale and to inform our customers about each of our finished goods relevant chemical contents. The management and execution of this process is very challenging, and mistakes in this information gathering process could have a material adverse effect on our business.
We may be subject to product liability claims with respect to our products. Our product liability insurance coverage may be insufficient to pay all such claims. In addition, product liability insurance may become too costly for us to maintain or may become completely unavailable to us in the future. We may not have sufficient resources to satisfy any product liability claims not covered by insurance, which would materially and adversely affect our financial position.
Environmental liabilities could adversely impact our consolidated financial position.
Federal, state and local laws and regulations impose various restrictions and controls on the discharge of materials, chemicals and gases used in our semiconductor manufacturing processes or in our finished goods. Under recent environmental regulations, we are responsible for determining whether certain toxic metals or certain other toxic chemicals are present in any given component we purchase and in each given product we sell. These environmental regulations have required us to expend a portion of our resources and capital on relevant compliance programs. In addition, under other laws and regulations, we could be held financially responsible for remedial measures if our current or former properties are contaminated or if we send waste to a landfill or recycling facility that becomes contaminated, even if we did not cause the contamination. Also, we may be subject to additional common law claims if we release substances that damage or harm third parties. Further, future changes in environmental laws or regulations may require additional investments in capital equipment or the implementation of additional compliance programs in the future. Any failure to comply with existing or future environmental laws or regulations could subject us to significant liabilities and could have a material adverse effect on our operating results, cash flows and financial condition.
23
In the conduct of our manufacturing operations, we have handled and do handle materials that are considered hazardous, toxic or volatile under federal, state and local laws. The risk of accidental release of such materials cannot be completely eliminated. In addition, we operate or own facilities located on or near real property that was formerly owned and operated by others. These properties were used in ways that involved hazardous materials. Contaminants may migrate from, within or through any such property, which may give rise to claims against us. Third parties who are responsible for contamination may not have funds, or may not make funds available when needed, to pay remediation costs imposed upon us jointly with them under environmental laws and regulations.
In Broomfield, Colorado, the owner of a property located adjacent to a manufacturing facility owned by one of our subsidiaries, Microsemi Corp. Colorado, had notified the subsidiary and other parties of a claim that contaminants migrated to his property, thereby diminishing its value. In August 1995, the subsidiary, together with Coors Porcelain Company, FMC Corporation and Siemens Microelectronics, Inc. (former owners of the manufacturing facility), agreed to settle the claim and to indemnify the owner of the adjacent property for remediation costs. Although TCE and other contaminants previously used by former owners at the facility are present in soil and groundwater on the subsidiarys property, we vigorously contest any assertion that our subsidiary caused the contamination. In November 1998, we signed an agreement with the three former owners of this facility whereby they have 1) reimbursed us for $0.5 million of past costs, 2) assumed responsibility for 90% of all future clean-up costs, and 3) promised to indemnify and protect us against any and all third-party claims relating to the contamination of the facility. An Integrated Corrective Action Plan was submitted to the State of Colorado. Sampling and management plans were prepared for the Colorado Department of Public Health & Environment. State and local agencies in Colorado are reviewing current data and considering study and cleanup options. The most recent forecast estimated that the total project cost, up to the year 2020, would be approximately $5.3 million; accordingly, we recorded a one-time charge of $0.5 million for this project in 2003. There has not been any significant development since September 28, 2003.
Litigation could adversely impact our consolidated financial position.
We are and have been involved in various litigation matters, including from time to time, litigation relating to employment matters, commercial transactions, intellectual property matters, contracts, environmental matters and matters related to compliance with governmental regulations. Litigation is inherently uncertain and unpredictable. The potential risks and uncertainties include, but are not limited to, such factors as the costs and expenses of litigation and the time and attention required of management to attend to litigation. An unfavorable resolution of any particular legal claim or proceeding, and/or the costs and expenses incurred in connection with a legal claim or proceeding, could have a material adverse effect on our consolidated financial position or results of operations.
Our future success depends, in part, upon our ability to continue to attract and retain the services of our executive officers or other key management or technical personnel.
We could potentially lose the services of any of our senior management personnel at any time due to a variety of factors that could include, without limitation, death, incapacity, military service, personal issues, retirement, resignation or competing employers. Our ability to execute current plans could be adversely affected by such a loss. We may fail to attract and retain qualified technical, sales, marketing and managerial personnel required to continue to operate our business successfully. Personnel with the expertise necessary for our business are scarce and competition for personnel with proper skills is intense. Also, attrition in personnel can result from, among other things, changes related to acquisitions, retirement and disability. We may not be able to retain existing key technical, sales, marketing and managerial employees or be successful in attracting, assimilating or retaining other highly-qualified technical, sales, marketing and managerial personnel, particularly at such times in the future as we may need to fill a key position. If we are unable to continue to retain existing executive officers or other key employees or are unsuccessful in attracting new highly-qualified employees, our business, financial condition and results of operations could be materially and adversely affected.
24
The volatility of our stock price could affect the value of an investment in our stock and our future financial position.
The market price of our stock has fluctuated widely. Between October 2, 2011 and October 3, 2010, the market sale price of our common stock ranged between a low of $14.49 and a high of $24.96. The historic market price of our common stock may not be indicative of future market prices. We may not be able to sustain or increase the value of our common stock. The trading price of our common stock may be influenced by factors beyond our control, such as the recent unprecedented volatility of the financial markets and the current uncertainty surrounding domestic and foreign economies. Declines in the market price of our stock could adversely affect our ability to retain personnel with stock incentives, to acquire businesses or assets in exchange for stock and/or to conduct future financing activities with or involving our common stock.
We may not make the sales that are suggested by our order rates, backlog or book-to-bill ratio, and our book-to-bill ratio may be affected by product mix.
Prospective investors should not place undue reliance on our book-to-bill ratios or changes in book-to-bill ratios. We determine bookings substantially based on orders that are scheduled for delivery within 12 months. However, lead times for the release of purchase orders depend, in part, upon the scheduling practices of individual customers, and delivery times of new or non-standard products can be affected by scheduling factors and other manufacturing considerations. The rate of booking new orders can vary significantly from month to month. Customers frequently change their delivery schedules or cancel orders. We have in the past experienced long lead times for some of our products, which may have therefore resulted in orders in backlog being duplicative of other orders in backlog, which would increase backlog without resulting in additional revenues. Because of long lead times in certain products, our book-to-bill ratio may not be an indication of sales in subsequent periods. Uncertain worldwide economic conditions and market instability have also resulted in hesitance of our customers to place orders with long delivery schedules, which contributes to limited visibility into our markets.
At times, our working capital levels have risen, which adversely affects cash flow.
At times, our working capital levels have risen and the increase has adversely affected cash flow. A factor contributing to the increase in our working capital has related to acquisitions with increases in accounts receivable and inventory generally exceeding increases in accounts payable and accrued liabilities. Another factor resulting in an increase in working capital has been a buildup of inventory prior to the consolidation of our manufacturing operations. We built inventory cushions during the transition of manufacturing between facilities in order to maintain an uninterrupted supply of product. Obsolescence of any inventory has recently and could in the future result in adverse effects on our future results of operations and future revenue. In 2009, in addition to other inventory write-downs, we recorded inventory write-downs of $10.3 million for product lines that did not meet gross margin targets, products that are being migrated to newer generations, and products that service the large capital spending end markets for which demand has declined and $7.3 million for estimated inventory components that were not expected to be used by the closure date of our Scottsdale facility and that cannot be used by other manufacturing facilities. During the quarter ended April 3, 2011, we recorded a charge of $8.4 million for the write-off of bridging inventory and an additional $8.2 million for the write-off of medical inventory.
There may be some potential effects of system outages.
We face risks from electrical or telecommunications outages, computer hacking or other general system failure. We rely heavily on our internal information and communications systems and on systems or support services from third parties to manage our operations efficiently and effectively. Any of these are subject to failure. System-wide or local failures that affect our information processing could have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, a system failure or data
25
security breach could also result in the unintentional disclosure of confidential information about us, our customers or our employees. Further, insurance coverage does not generally protect from normal wear and tear, which can affect system performance. Any applicable insurance coverage for an occurrence could prove to be inadequate. Coverage may be or become unavailable or inapplicable to any risks then prevalent. We are upgrading and integrating, and have plans to upgrade and integrate further our enterprise information systems, and these efforts may cause additional strains on personnel and system resources or may result in potential system outages.
Our investments in securities subject us to principal, liquidity and counterparty risks that could adversely affect our financial results.
We invest cash balances in excess of projected liquidity needs primarily in money market funds. All of our investments to date are highly rated; however, current credit market disruptions may adversely the value and liquidity of these investments.
We may have increasing difficulty attracting and retaining qualified outside Board members.
The directors and management of publicly traded corporations are increasingly concerned with the extent of their personal exposure to lawsuits and shareholder claims, as well as governmental and creditor claims that may be made against them in connection with their positions with publicly-held companies. Outside directors are becoming increasingly concerned with the availability of directors and officers liability insurance to pay on a timely basis the costs incurred in defending shareholder claims. Directors and officers liability insurance is expensive and difficult to obtain. The SEC and the NASDAQ Stock Market have also imposed higher independence standards and certain special requirements on directors of public companies. Accordingly, it may become increasingly difficult to attract and retain qualified outside directors to serve on our Board.
Delaware law and our charter documents contain provisions that could discourage or prevent a potential takeover of Microsemi that might otherwise result in our stockholders receiving a premium over the market price for their shares.
Provisions of Delaware law and our certificate of incorporation and bylaws could make more difficult an acquisition of Microsemi by means of a tender offer, a proxy contest, or otherwise, and the removal of incumbent officers and directors. These provisions include:
| Section 203 of the Delaware General Corporation Law, which prohibits a merger with a 15%-or-greater stockholder, such as a party that has completed a successful tender offer, without board approval until three years after that party became a 15%-or-greater stockholder; |
| The authorization in the certificate of incorporation of undesignated preferred stock, which could be issued without stockholder approval in a manner designed to prevent or discourage a takeover or in a way that may dilute an investment in our common stock; and |
| Certain provisions of our charter documents, including provisions eliminating the ability of stockholders to take action by written consent or call special meetings and limiting the ability of stockholders to raise matters at a meeting of stockholders without giving advance notice, may have the effect of delaying or preventing changes in control or management of Microsemi. In addition, our charter documents do not permit cumulative voting, which may make it more difficult for a third party to gain control of our Board of Directors. |
26
Our accounting policies and estimates have a material effect on the financial results we report.
Critical accounting policies and estimates have a material effect on our calculations and estimations of amounts in our financial statements. Our operating results and balance sheets may be adversely affected either to the extent that actual results prove to be materially lower than previous accounting estimates or to the extent that accounting estimates are revised adversely. We base our critical accounting policies, including our policies regarding revenue recognition, reserves for returns, rebates, price protections, and bad debt and inventory valuation, on various estimates and subjective judgments that we may make from time to time. The judgments made can significantly affect net income and our balance sheets. We are required to make significant judgments concerning inventory, and whether it becomes obsolete or excess, and concerning impairments of long-lived assets and of goodwill. Our judgments, estimates and assumptions are subject to change at any time. In addition, our accounting policies may change at any time as a result of changes in generally accepted accounting principles as they apply to us or changes in other circumstances affecting us. Changes in accounting policy have affected and could further affect, in each case materially and adversely, our results of operations or financial position.
If, in the future, we conclude that our internal control over financial reporting is not effective, investors could lose confidence in the reliability of our financial statements, which could result in a decrease in the value of our common stock.
As directed by Section 404 of the Sarbanes-Oxley Act of 2002, the SEC adopted rules requiring public companies to include a report of management on the companies internal control over financial reporting in their annual reports on Form 10-K, including an assessment by management of the effectiveness of the filing companys internal control over financial reporting. In addition, the independent registered public accounting firm auditing a public companys financial statements must attest to the effectiveness of the companys internal control over financial reporting. There is a risk that in the future we may identify internal control deficiencies that suggest that our controls are no longer effective. This could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements, which could cause the market price of our common stock to decline and make it more difficult for us to finance our operations.
ITEM 1B. UNRESOLVED | STAFF COMMENTS |
None.
ITEM 2. PROPERTIES |
Our headquarters are located in a leased building in Aliso Viejo, California that contains general office and engineering space. We own office, engineering and production facilities in Lawrence, Massachusetts; Garden Grove, California; and Ennis, Ireland. We also lease engineering and/or production facilities in Mountain View, Camarillo, Cupertino, La Mirada, Folsom and Santa Clara, California; Phoenix, Arizona; West Lafayette, Indiana; Atlanta, Georgia; Lowell, Massachusetts; Bend, Oregon; Austin, Texas; Ottawa, Canada; China; the Philippines; Israel; the United Kingdom; Sweden; and France. We also lease sales offices throughout the world. We believe that our existing facilities are well maintained and in good operating condition and that they are adequate for our foreseeable business needs.
27
ITEM 3. LEGAL | PROCEEDINGS |
In Broomfield, Colorado, the owner of a property located adjacent to a manufacturing facility owned by one of our subsidiaries, Microsemi Corp. Colorado had notified the subsidiary and other parties of a claim that contaminants migrated to his property, thereby diminishing its value. In August 1995, the subsidiary, together with Coors Porcelain Company, FMC Corporation and Siemens Microelectronics, Inc. (former owners of the manufacturing facility), agreed to settle the claim and to indemnify the owner of the adjacent property for remediation costs. Although TCE and other contaminants previously used by former owners at the facility are present in soil and groundwater on the subsidiarys property, we vigorously contest any assertion that the subsidiary caused the contamination. In November 1998, we signed an agreement with the three former owners of this facility whereby they have 1) reimbursed us for $0.5 million of past costs, 2) assumed responsibility for 90% of all future clean-up costs, and 3) promised to indemnify and protect us against any and all third-party claims relating to the contamination of the facility. An Integrated Corrective Action Plan was submitted to the State of Colorado. Sampling and management plans were prepared for the Colorado Department of Public Health & Environment. State and local agencies in Colorado are reviewing current data and considering study and cleanup options. The most recent forecast estimated that the total project cost, up to the year 2020, would be approximately $5.3 million; accordingly, we recorded a one-time charge of $0.5 million for this project in fiscal year 2003. There has not been any significant development since September 28, 2003.
On December 8, 2010, Intellectual Ventures I LLC and Intellectual Ventures II LLC filed a complaint in the United States District Court for the District of Delaware (the Complaint) against Altera Corporation, Microsemi, and Lattice Semiconductor Corporation. On February 15, 2011, the plaintiffs filed an amended complaint adding Xilinx, Inc. as a defendant. The complaint alleges, inter alia, that programmable logic devices manufactured and sold by our subsidiary Microsemi SoC infringe United States Patent Numbers 5,687,325, 6,260,087 and 6,272,646 assigned to Intellectual Ventures II LLC, and seeks damages and other relief at law or in equity as the court deems appropriate. We have responded to the complaint. On April 26, 2011, the defendants filed a motion to transfer the case to the United States District Court for the Northern District of California. On August 8, 2011, the defendants filed a motion to stay the litigation pending conclusion of reexamination of the patents-in-suit by the United States Patent & Trademark Office. The Court has not yet decided the motion to transfer or motion to stay. Discovery has not yet commenced and no trial date has been set. While material losses are reasonably possible, given the early stages of this matter, we cannot reasonably estimate the amount of any loss in the event of an unfavorable outcome.
We are also involved in other pending litigation matters arising out of the normal conduct of our business, including litigation relating to acquisitions, employment matters, commercial transactions, contracts, environmental matters and matters related to compliance with governmental regulations. Although the ultimate aggregate amount of monetary liability or financial impact with respect to these matters is subject to many uncertainties and is therefore not predictable with assurance. In the opinion of management, the final outcome of these matters, if they are adverse, will not have a material adverse effect on our financial position, results of operations or cash flows. However, there can be no assurance with respect to such result, and monetary liability or financial impact on us from these litigation matters could differ materially from those projected.
ITEM 4. REMOVED | AND RESERVED |
28
ITEM 5. | MARKET FOR REGISTRANTS COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES |
(a) Market Information
Our Common Stock is traded on the NASDAQ Global Select Market under the symbol MSCC. The following table sets forth the high and low sales prices at which our Common Stock traded as reported on the NASDAQ Global Select Market.
Fiscal Year ended October 2, 2011 |
HIGH | LOW | ||||||
1st Quarter |
$ | 24.68 | $ | 18.08 | ||||
2nd Quarter |
$ | 24.96 | $ | 19.35 | ||||
3rd Quarter |
$ | 23.81 | $ | 19.55 | ||||
4th Quarter |
$ | 22.01 | $ | 14.49 | ||||
Fiscal Year ended October 3, 2010 |
HIGH | LOW | ||||||
1st Quarter |
$ | 17.99 | $ | 12.85 | ||||
2nd Quarter |
$ | 18.50 | $ | 14.67 | ||||
3rd Quarter |
$ | 18.00 | $ | 14.18 | ||||
4th Quarter |
$ | 17.65 | $ | 13.83 |
POSSIBLE VOLATILITY OF STOCK PRICES
The market prices of securities issued by technology companies, including ours, have been and will be volatile. The securities of many technology companies have experienced extreme price and volume fluctuations, which have often not necessarily been related to their respective operating performances. Quarter to quarter variations in operating results, changes in earnings estimates by analysts, announcements of technological innovations or new products, announcements of major contract awards, events involving other companies in or out of the industry, economic conditions, events involving war or terrorism, and other events or factors may have a significant impact (positive or negative) on the market price of our Common Stock.
(b) Approximate Number of Common Equity Security Holders
Title of Class |
Approximate Number of Record Holders (as of November 14, 2011) |
|||
Common Stock, $0.20 Par Value |
521 |
The number of stockholders of record treats all of the beneficial holders of shares held in one nominee or street name as a unit.
(c) Dividends
We have not paid cash dividends in the last five years and have no current plans to do so. Our credit facility contains covenants that restrict the amount of cash dividends we may pay.
29
(d) Performance Graph
The following graph, which is furnished rather than filed, compares the five-year cumulative total return on the Companys Common Stock to the total returns of 1) NASDAQ Stock Market and 2) NASDAQ Stock Market Electronics & Electrical Equipment & Components Index, excluding Computer Equipment. This comparison assumes in each case that $100 was invested on or about September 30, 2006 and all dividends were reinvested. The Companys fiscal year ends on the Sunday closest to September 30 each year.
COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*
Among Microsemi Corporation, The NASDAQ Composite Index
And the NASDAQ Electronic Components Index
* | $100 invested on October 1, 2006 in stock or on September 30, 2006 in index including reinvestment of dividends. Indexes calculated on month-end basis. |
30
ITEM 6. | SELECTED FINANCIAL DATA |
For the five fiscal years in the period ended on or
about October 2, 2011 (Amounts in thousands, except per share data) |
||||||||||||||||||||
2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||
Selected Consolidated Income Statement Data: |
||||||||||||||||||||
Net sales |
$ | 835,854 | $ | 518,268 | $ | 452,972 | $ | 514,067 | $ | 442,252 | ||||||||||
Gross profit |
$ | 441,171 | $ | 248,211 | $ | 180,407 | $ | 228,972 | $ | 181,038 | ||||||||||
Operating expenses |
$ | 386,190 | $ | 192,330 | $ | 190,477 | $ | 165,429 | $ | 159,850 | ||||||||||
Net income (loss) |
$ | 54,447 | $ | 59,038 | $ | (26,823 | ) | $ | 49,654 | $ | 9,818 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Earnings (loss) per share: |
||||||||||||||||||||
Basic |
$ | 0.65 | $ | 0.73 | $ | (0.33 | ) | $ | 0.64 | $ | 0.13 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Diluted |
$ | 0.63 | $ | 0.72 | $ | (0.33 | ) | $ | 0.62 | $ | 0.13 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Weighted-average shares outstanding |
||||||||||||||||||||
Basic |
83,916 | 80,797 | 80,943 | 77,897 | 74,027 | |||||||||||||||
Diluted |
85,747 | 81,541 | 80,943 | 79,859 | 76,154 | |||||||||||||||
Selected Consolidated Balance Sheet Data: |
||||||||||||||||||||
Working capital |
$ | 424,201 | $ | 360,846 | $ | 353,953 | $ | 351,460 | $ | 267,671 | ||||||||||
Total assets |
$ | 1,470,473 | $ | 879,886 | $ | 811,130 | $ | 760,608 | $ | 637,280 | ||||||||||
Long-term liabilities |
$ | 425,960 | $ | 42,120 | $ | 34,010 | $ | 20,212 | $ | 6,630 | ||||||||||
Stockholders equity |
$ | 890,824 | $ | 766,443 | $ | 676,351 | $ | 673,170 | $ | 569,405 |
The selected financial data should be read in conjunction with the Consolidated Financial Statements and Notes thereto, and Managements Discussion and Analysis of Financial Condition and Results of Operations in Item 7 of this Form 10-K.
31
ITEM 7. | MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
This Annual Report on Form 10-K includes current beliefs, expectations and other forward looking statements, the realization of which may be adversely impacted by any of the factors discussed or referenced throughout this Form 10-K, including but not limited to, factors under the heading, Item 1A. Risk Factors in Part I above. This Form 10-K must be read in its entirety.
Overview
We are a leading designer, manufacturer and marketer of high-performance analog and mixed-signal semiconductor solutions differentiated by power, security, reliability and performance. Our semiconductors manage and control or regulate power, protect against transient voltage spikes and transmit, receive and amplify signals. We offer one of the industrys most comprehensive portfolios of semiconductor technology. Our products include high-performance, high-reliability radio frequency (RF) and power components, analog and RF integrated circuits (ICs), standard and customizable system-on-chip solutions (SoCs/cSoCs), and mixed-signal and radiation-tolerant FPGAs. We also offer subsystems and modules that include application-specific power modules and PowerDsine® midpsans.
Our products include individual components as well as IC solutions that enhance customer designs by improving performance, reliability and battery optimization, reducing size or protecting circuits. The principal end markets that we serve include Defense & Security, Aerospace, Enterprise & Communications and Industrial & Alternative Energy, and applications where security is non-negotiable and reliability is vital.
We have implemented a growth strategy through continuous innovation complemented by strategic acquisitions to strengthen our product and technology portfolio with the intent of broadening our customer base and increasing our technology footprint in customers end designs in high-value, high barrier-to-entry markets where power matters, security is non-negotiable, and reliability is vital. This allows us to offer an increased value proposition, gather a larger portion of the bill of materials, and engage with customers as a strategic partner as opposed to a socket provider. We believe this strategy strengthens our position in the industry as it protects and grows our share within those markets with the highest barriers to entry, and increases our served available market.
Recent industry leading innovations include:
| High power silicon carbide RF power device for use in ultra high frequency radar, military power conversion and high speed switching applications; |
| Secure storage memory solutions for defense, IT and surveillance products; |
| Enhanced reliability cold cathode fluorescent lamp (CCFL) backlight inverters for use in mission-critical medical and industrial LCD displays; |
| High reliability metal-oxide-semiconductor field-effect-transistors (MOSFET) products for use in power conversion, motor control and power switching applications; |
| Extended temperature grade flash-based FPGA devices and SmartFusion® customizable system-on-chip (cSoC) with temperature screening from -55 degrees C to +100 degrees C that permit the integration of our products in military, avionics and defense applications where highly reliable operation at extreme temperatures is needed; |
| Transient voltage suppression devices that meet new avionics safety standards that are designed to protect avionics in composite-skinned aircraft; |
| An advanced 65-nanometer platform for flash-based customizable system-on-chips (cSoCs), featuring a new IP-friendly architecture that offers more functionality and lower power consumption; |
| Precision target-seeking and secure guidance solutions resulting in substantial improvements in size, accuracy, and cost efficient weaponry; |
32
| Application specific integrated circuit devices for use in smart meter and smart grid applications; |
| Leading edge wireless and wired network solutions for 80.2.11n Wi-Fi and power-over-ethernet (PoE) technology; |
| Global positioning system (GPS) receiver modules incorporating anti-tamper technology; |
| Defense Supply Center Columbus (DSCC)-certified radiation-hardened power MOSFETs for space applications; and |
| The industrys first family of 120 volt, 50 watt high-reliability single, dual and triple output radiation-hard DC-DC converters. |
Our growth strategy is dependent on our ability to successfully develop new technologies and products, and complemented by our ability to implement our selective acquisitions strategy. New technologies or products that we may develop may not lead to an incremental increase in revenues, and there is a risk that these new technologies or products will decrease the demand for our existing products and result in an offsetting reduction in revenues. There can be no assurance that the benefits of any acquisition will outweigh the attendant costs, and if they do not, our results of operations and stock price may be adversely affected.
In October 2011, we completed the acquisition of Zarlink Semiconductor Inc., an international semiconductor supplier that designs, manufactures and distributes microelectronic components for the communications and medical industries. We expect that Zarlinks timing, synchronization and voice products, which complement our existing communications products, will significantly add to our consolidated net sales in 2012. However, uncertain macroeconomic conditions worldwide and the devastating flooding and ongoing impacts in Thailand, which shut down our operations at two subcontracted facilities, subject us to certain risks (see Part II, Item 1A, Risk Factors, Negative or uncertain worldwide economic conditions may adversely affect our business, financial condition, cash flow and results of operations and The concentration of the facilities that service the semiconductor industry, including facilities of current or potential vendors or customers, makes us more susceptible to events or disasters affecting the areas in which they are most concentrated.
Net sales increased $317.6 million or 61% between 2011 and 2010 to $835.9 million for 2011 from $518.3 million for 2010 with increases in each of our reported end markets. Sales in each of our end markets were favorably impacted both in 2011 and 2010 by contributions from products we added from recent acquisitions. Our defense & security end market increased $91.4 million or 44% driven by contributions from the ramping of millimeter wave scan subsystems used in whole-body scanners, missile defense and in military RF applications. Our aerospace end market increased $104.5 million or 97% driven by demand and order rates for commercial aircraft at aircraft manufacturers and tier one suppliers, growing electronic content in current aircraft, refurbishment programs for older aircraft and demand for the high-reliability radar and avionics solutions we provide. The aerospace end market also benefited from sales into satellite applications, especially system-level products, power management ICs and DC/DC converter solutions. Our industrial & alternative energy end market increased $89.2 million or 103% driven by growth in products for semiconductor capital equipment, an area which experienced substantial declines in 2009 and part of 2010 due to decreased capital spending during the recent economic downturn. Our enterprise & communications end market increased $32.4 million or 28% due to increased sales of our PoE offerings, RF power amplifier and DC-DC products and benefited from a recovery in enterprise demand.
Operating income decreased $0.9 million to $55.0 million in 2011 from $55.9 million in 2010. The favorable impact of higher sales were offset by $42.3 million higher amortization of acquired intangibles, $20.0 million higher restructuring costs, related to severance expenses and the closure of our Scottsdale facility and incremental costs from our acquisitions.
While each of our acquisitions contributed to higher sales and operating income, we immediately implement an integration plan in functional areas such as sales and operations. We have actively taken steps to integrate the management of our various operations, including management of our recent acquisitions. Sales offices, personnel and efforts are combined. Production has been transferred among our facilities to share resources and technology,
33
as well as to increase efficiency. We strive to make the best possible use of our engineering capabilities by sharing research and production methods across our divisions and, where appropriate, assigning engineers to the same projects, regardless of which facility records personnel expense. Due to this commingling of activities, we do not practically measure the impact of any particular acquisition.
We closed our Scottsdale facility during the second quarter of 2011 and we may make further specific determinations to consolidate, close or sell additional facilities, which could be announced at any time. Possible adverse consequences from current and future consolidation activities may include various accounting charges such as for workforce reduction, including severance and other termination benefits and for excess facilities, including lease termination fees, future contractual commitments to pay lease charges, facility remediation costs and moving costs to remove property and equipment from facilities. We may also be adversely impacted from inventory buildup in preparation for the transition of manufacturing, disposition costs, impairments of goodwill, a possible immediate loss of revenues, and other items in addition to normal or attendant risks and uncertainties. We may be unsuccessful in any of our current or future efforts to consolidate our business into a smaller number of facilities. Our plans to minimize or eliminate any loss of revenues during consolidation may not be achieved.
Marketing
Our products include individual components as well as IC solutions that enhance customer designs by improving performance, reliability and battery optimization, reducing size or protecting circuits. The principal end markets that we serve include:
| Defense & Security Products in this end market include mixed-signal analog integrated circuits, JAN, JANTX, JANTXV and JANS high-reliability semiconductors and modules including diodes, zeners, diode arrays, transient voltage suppressors, bipolar transistors, MOSFETs, insulated gate bipolar transistors (IGBTs), small signal analog integrated circuits, small signal transistors, relays, silicon-controlled rectifiers (SCRs), RF transceivers and subsystems and FPGAs. These products are utilized in a variety of applications including radar and communications, defense electronics, homeland security, threat detection, targeting and fire control and other power conversion and related systems in military platforms. |
| Aerospace Products in this end market include offerings such as JAN, JANTX, JANTXV and JANS high-reliability semiconductors and modules and analog mixed-signal products including diodes, zeners, diode arrays, transient voltage suppressors, bipolar transistors, small signal analog integrated circuits, relays, small signal transistors, SCRs, MOSFETs, IGBTs and FPGAs. These products are utilized in a variety of applications including electronic applications for large aircraft and regional jets, commercial radar and communications, satellites, cockpit electronics, and other power conversion and related systems in space and aerospace platforms. |
| Enterprise & Communications Products in this end market include broadband power amplifiers and monolithic microwave integrated circuits (MMICs) targeted at 802.11 a/b/g/n/e, FGPAs, multiple-in multiple-out (MIMO), light emitting diode (LED), cold cathode fluorescent lamp (CCFL) controllers, visible light sensors, PWM controllers, voltage regulators, EMI/RFI filters, transient voltage suppressors and class-D audio circuits. Applications for these products include wi-max and wireless LAN devices, PoE devices, portable devices, set top box and telecom applications, notebook computers, monitors, storage devices and televisions. |
| Industrial & Alternative Energy Products in this end market include MOSFETs, IGBTs, FPGAs, power modules, ultra thin bypass diodes, bridge rectifiers, and high-voltage assemblies for use in industrial equipment, semiconductor capital equipment and solar power applications. Industrial applications also include zener diodes, high-voltage diodes, MOSFETs, IGBTs, transient voltage suppressors and thyristor surge protection devices that are designed into implantable defibrillators, pacemakers and neurostimulators and PIN diode switches, dual diode modules and switched-most power supplies (SMPS) for use in MRI systems. |
34
During the year ended October 2, 2011, we have actively taken steps to integrate the management of our various operations, including management of our recent acquisitions. Production has been transferred among our facilities to share resources and technology, as well as to increase efficiency. We strive to make the best possible use of our engineering capabilities by sharing research and production methods across our divisions and, where appropriate, assigning engineers to the same projects, regardless of the facility that incurs the personnel expense.
Acquisitions
We have in the past acquired a number of businesses or companies, additional product lines and assets. We currently expect to continue to expand and diversify our operations with additional acquisitions.
In October 2011, we completed the acquisition of Zarlink Semiconductor Inc., an international semiconductor supplier that designs, manufactures and distributes microelectronic components for the communications and medical industries. We expect that Zarlinks timing, synchronization and voice products, which complement our existing communications products, will significantly increase our consolidated net sales in 2012.
During 2011, we acquired Actel Corporation (Actel), a leading supplier of low-power FPGAs, mixed-signal FPGAs, and system-critical FPGAs. We sometimes refer to this division herein as Microsemi SoC. We also acquired AML Communications, Inc., (AML) a designer, manufacturer, and marketer of microelectronic assemblies for the defense industry, Asic Advantage, Inc. (Asic Advantage), a fabless semiconductor company that designs and manufactures a broad portfolio of high-performance, high-voltage and radiation-hardened mixed-signal integrated circuit solutions for the aerospace, automotive, communications, industrial and medical markets and substantially all the assets of Brijot Imaging Systems, Inc. (Brijot) and its passive millimeter wave imaging solutions technology. AML and Brijot were integrated into Microsemi Corp. RF Integrated Solutions. Asic Advantage was integrated into Microsemi Corp. Analog Mixed Signal Group.
During 2010, we acquired White Electronic Designs Corporation (White Electronic), a defense electronics manufacturer and supplier that designs, develops and manufactures innovative electronic components and systems for inclusion in high technology products for the defense and aerospace markets. We also acquired substantially all of the assets of VT Silicon, a designer and manufacturer of multi-band radio frequency integrated circuit (RFIC) solutions for the mobile wireless broadband market and all the shares of Arxan Defense Systems, Inc., a leading provider of anti-tamper solutions, providing full-service support to defense clients in securing systems against tampering, piracy and reverse engineering.
During 2009, we acquired Electro Module, Inc. and its wholly-owned subsidiary, Babcock, Inc. Babcock, Inc. is a leading manufacturer of high-reliability power supplies, relays and flat panel displays and supplies. We subsequently renamed Babcock, Inc., Microsemi Corp. Power Management Group (PMG). Also during 2009, we entered into an asset purchase agreement in which we acquired substantially all the assets of the Defense and Security business of Endwave Corporation. This business designs, manufactures and markets radio frequency modules that enable the transmission, reception and processing of high frequency signals. Markets for these products include defense electronics, homeland security systems and other applications that require high frequency radio frequency circuitry and subsystems. We subsequently renamed the Defense and Security business of Endwave Corporation, Microsemi Corp. RF Integrated Solutions. Our final acquisition of 2009 was the purchase of substantially all the assets of Nexsem, Inc., a designer and marketer of high-voltage DC to DC conversion devices for applications such as in LCD televisions, set top boxes, notebooks and netbooks. This acquisition was integrated into the existing operations of Microsemi Corp. Analog Mixed Signal Group.
35
Restructuring and Severance Charges
In 2009, we approved consolidation plans that resulted in the closure of our manufacturing facility in Scottsdale, Arizona (Scottsdale), which ceased production during the quarter ended April 3, 2011. The Scottsdale facility occupied a 135,000 square foot leased facility. Employee severance is expected to be paid through 2013. Facility termination costs relate primarily to remaining obligations under facility and equipment leases and are expected to be paid through 2016. The following table reflects the restructuring activities for the Scottsdale facility and the accrued liabilities in the consolidated balance sheets at the dates below (amounts in thousands):
Employee Severance |
Facility Termination Costs |
Total | ||||||||||
Balance at October 3, 2010 |
$ | 4,124 | $ | | $ | 4,124 | ||||||
Provisions |
(1,903 | ) | 8,200 | 6,297 | ||||||||
Cash expenditures |
(1,866 | ) | (1,718 | ) | (3,584 | ) | ||||||
|
|
|
|
|
|
|||||||
Balance at October 2, 2011 |
$ | 355 | $ | 6,482 | $ | 6,837 | ||||||
|
|
|
|
|
|
At October 3, 2010, we had recorded severance accruals of $1.6 million from reductions in force at our various facilities other than Scottsdale. We recorded additional provisions, primarily related to activities at Microsemi SoC, for severance and retention payments totaling $15.8 million in 2011. Severance covered approximately 200 individuals in manufacturing, engineering and sales. Substantially all accrued amounts are expected to be paid within twelve months. The following table reflects the restructuring activities and the accrued liabilities in the consolidated balance sheets at the dates below (amounts in thousands):
Employee Severance |
||||
Balance at October 3, 2010 |
$ | 1,642 | ||
Provisions |
15,784 | |||
Cash expenditures |
(14,586 | ) | ||
Other non-cash settlement |
(116 | ) | ||
|
|
|||
Balance at October 2, 2011 |
$ | 2,724 | ||
|
|
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States that require us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and revenues and expenses during the periods reported. Actual results could differ from those estimates. Additional information with respect to our critical accounting policies that we believe could have significant effect on our reported results and require subjective or complex judgments is contained in Note 1 of our consolidated financial statements.
Accounts Receivable and Allowance for Doubtful Accounts
Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The accounts receivable amount shown in the balance sheet are trade accounts receivable balances at the respective dates, net of allowance for doubtful accounts. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance based in part on our historical write-off experience and specific review of account balances due. Past due balances over 90 days and over a specified amount are reviewed individually for collectability. All other balances are reviewed on a pooled basis by type of receivable. Account balances are charged off against the allowance when we determine that it is probable the receivable will not be recovered. We review our allowance for doubtful accounts quarterly. We do not have any off-balance-sheet credit exposure related to our customers. To date, our allowance for doubtful accounts has generally been within managements estimates.
36
Inventories
Inventories are stated at the lower of cost, as determined using the first-in, first-out (FIFO) method, or market. Costs include materials, labor and manufacturing overhead. We evaluate the carrying value of our inventories taking into account such factors as historical and anticipated future sales compared with quantities on hand and the price we expect to obtain for our products in their respective markets. We also evaluate the composition of our inventories to identify any slow-moving or obsolete products. Additionally, inventory write-downs are made based upon such judgments for any inventories that are identified as having a net realizable value less than their cost, which is further reduced by related selling expenses. To date, the net realizable value of our inventories has generally been within managements estimates.
Fair Value of Financial Assets and Liabilities
Accounting Standards Codification 825 (ASC 825) permits entities to elect the fair value option for certain financial assets and financial liabilities. For financial assets or financial liabilities for which an entity elects the fair value option, ASC 825 requires that the entity record the financial asset or financial liability at fair value rather than at historical cost with changes in fair value recorded in the income statement. ASC 825-25-3 requires that upfront costs and fees related to items for which the fair value option is elected shall be recognized in earnings as incurred and not deferred. We have elected the fair value option on our credit facility that we entered into in 2011.
Long-Lived Assets
We assess the impairment of property, plant and equipment and amortizable intangible assets whenever events or changes in circumstances indicate that their carrying value may not be recoverable from the undiscounted estimated future cash flows expected to result from their use.
We are required to make judgments and assumptions in identifying those events or changes in circumstances that may trigger impairment. Some of the factors we consider include:
| Significant decrease in the market value of an asset. |
| Significant changes in the extent or manner for which the asset is being used or in its physical condition including manufacturing plant closures. |
| A significant change, delay or departure in our business strategy related to the asset. |
| Significant negative changes in the business climate, industry or economic conditions. |
| Current period operating losses or negative cash flow combined with a history of similar losses or a forecast that indicates continuing losses associated with the use of an asset. |
If events or circumstances indicate that the carrying amount of a long-lived asset or asset group may not be recoverable and the expected undiscounted future cash flows attributable to the asset group are less than the carrying value, an impairment loss equal to the excess of the carrying value of the assets within the asset group over their fair value is recorded. The appropriate asset group is determined based on the lowest level of largely independent cash inflows and outflows for the related assets. Depending on the nature of the primary assets in the asset group, fair value is estimated using one of several approaches including replacement cost, appraised values, market quotes or estimated expected future cash flows using a discount rate commensurate with the risk involved. During 2009, we recorded a held for sale impairment of $1.7 million related to the real estate and building for our closed manufacturing facility in Broomfield, Colorado and a held and used impairment of $4.5 million for the closure of our manufacturing facility in Scottsdale, Arizona to reflect our long-lived assets at their lower fair value.
37
Goodwill and Intangible Assets
We account for goodwill on an impairment-only approach and amortize intangible assets with definite useful lives over their respective useful lives. At least annually, and whenever events or changes in circumstances indicate that it is more likely than not that an impairment loss has been incurred, we are required to reassess goodwill. Whenever we determine that there has been an impairment of goodwill or other intangible assets with indefinite lives, we will record an impairment charge against earnings. We operate as one reporting unit and an impairment charge would equal the excess of the carrying value of goodwill in our one reporting unit over its then fair value. The identification of intangible assets and determination of the fair value and useful lives are subjective in nature and often involve the use of significant estimates and assumptions. The judgments made in determining the estimated useful lives assigned to each class of assets can significantly affect net income. We perform our annual review for goodwill impairment in the fourth quarter of each fiscal year.
Revenue Recognition, Sales Returns and Allowances
We primarily recognize revenue from customers, including distributors, when title and risk of loss have passed to the customer provided that: 1) evidence of an arrangement exists; 2) delivery has occurred; 3) the fee is fixed or determinable; and 4) collectability is reasonably assured. For substantially all sales, revenue is recognized at the time the product is shipped.
We enter into contracts with certain distributors, and these contracts may permit limited stock rotation returns. We provide an estimated allowance for such returns, and corresponding reductions in revenue are concurrently recorded, based on several factors including past history and notification from customers of pending returns. Actual returns have been within managements expectations. Estimated reductions to revenue are also recorded for customer incentive programs consisting of price protection and volume purchase rebates. Such programs are limited and actual reductions to revenue have been within managements expectations.
We also derive a portion of our revenue from fixed-price contracts. Revenue for these contracts are recorded under a percentage of completion method, which is based on the ratio of total costs incurred to date to estimated total costs at completion. Gross profit expected to be realized on fixed-price contracts are based on periodic estimates of total revenues and costs for each contract. Losses on contracts are accrued when estimated total costs exceed total revenues. Occasionally, we will enter into contracts on a cost plus fee basis. We recognize revenue based on reimbursements for actual expenses plus the contractually agreed upon fee with the customer.
Restructuring Charges
We recognize a liability for restructuring costs when the liability is incurred. The restructuring accruals are based upon management estimates at the time they are recorded and can change depending upon changes in facts and circumstances subsequent to the date the original liability is recorded. The main components of our restructuring charges are workforce reductions and elimination of excess facilities. Workforce-related charges are accrued when it is determined that a liability exists, which is generally when individuals have been notified of their expected termination dates and expected severance payments or when formal severance plans exist, when the severance payments are probable and reasonably estimable. The elimination of excess facilities results in charges for lease termination fees, future contractual commitments to pay lease charges net of estimated sublease income, facility remediation costs and moving costs to remove property and equipment from the facilities. We recognize charges for elimination of excess facilities when we have vacated the premises or ceased use of the facility.
38
Stock-Based Compensation
Compensation expense for stock options was calculated based on the date of grant or conversion using the Black-Scholes option pricing model with exercise prices equal to the closing price of our common stock on the date of grant. Restricted stock awards were granted to employees with compensation expense determined based on the closing price of our common stock on the date of grant. Stock options and restricted stock awards are subject to forfeiture if length of service requirements are unmet. Expected life was estimated based on historical exercise data that was stratified between members of the Board of Directors, executive employees and all other recipients. Expected volatility was estimated based on historical volatility using equally weighted daily price observations over a period approximately equal to the expected life of each option. The risk free interest rate is based on the implied yield currently available on U.S. Treasury securities with an equivalent remaining term. No dividends are expected to be paid.
Accounting For Income Taxes
We account for income taxes under the asset and liability method, whereby deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. We evaluate the need to establish a valuation allowance for deferred tax assets based upon the amount of existing temporary differences, the period in which they are expected to be recovered and expected levels of taxable income. A valuation allowance to reduce deferred tax assets is established when it is more likely than not that some or all of the deferred tax assets will not be realized. We recognize uncertain tax positions when they meet a more-likely-than-not threshold. We recognize potential accrued interest and penalties related to unrecognized tax benefits within operations as income tax expense.
We file U.S. federal, state and foreign income tax returns in jurisdictions with varying statutes of limitations. Fiscal years 2007 to 2011 generally remain subject examination by federal and most state tax authorities. In significant foreign jurisdictions, the 2008 to 2011 tax years generally remain subject to examination by tax authorities. We establish liabilities for possible assessments by tax authorities resulting from known tax exposures including, but not limited to, international tax issues and certain tax credits. We do not believe the results of any audits would have a material impact on our financial position, results of operations or cash flows.
Segment Information
We use the management approach for segment disclosure, which designates the internal organization that is used by management for making operating decisions and assessing performance as the source of our reportable segments. We manage our business on the basis of one reportable segment, as a manufacturer of semiconductors in different geographic areas, including the United States, Europe and Asia.
39
RESULTS OF OPERATIONS
Net sales increased $317.6 million or 61% between 2011 and 2010 to $835.9 million for 2011 from $518.3 million for 2010. Net sales increased $65.3 million or 14% between 2010 and 2009 to $518.3 million for 2010 from $453.0 million for 2009. Sales in each end market were favorably impacted both in 2011 and 2010 by contributions from products we added from recent acquisitions. Estimated sales by end markets are based on our understanding of end market uses of our products. We believe an estimated breakout of net sales by end markets for the last three fiscal years is approximately as follows (amounts in thousands):
2011 | 2010 | 2009 | ||||||||||
Defense & Security |
$ | 299,503 | $ | 208,098 | $ | 170,653 | ||||||
Aerospace |
212,127 | 107,587 | 112,847 | |||||||||
Enterprise & Communications |
148,792 | 116,369 | 70,102 | |||||||||
Industrial & Alternative Energy |
175,432 | 86,214 | 99,370 | |||||||||
|
|
|
|
|
|
|||||||
Total |
$ | 835,854 | $ | 518,268 | $ | 452,972 | ||||||
|
|
|
|
|
|
Net sales in the Defense & Security end market increased $91.4 million to $299.5 million in 2011 from $208.1 million in 2010 and increased $37.4 million between 2010 and 2009 from $170.7 million. Sales in this end market were favorably impacted by contributions from the ramping of millimeter wave scan subsystems used in whole-body scanners, missile defense and in military RF applications. Over the near term, we believe the Department of Defense and Homeland Security budgets for electronic content, an area of Microsemi focus, will continue to expand and contribute to growth in this end market. We also believe that international defense sales will increase, enabled in part by our security product offerings, and that Microsemis dollar content in defense programs will increase as our products move up the value chain. However, we recognize that the current U.S. federal budget situation will result in short-term delays in defense programs and potentially defer growth beyond the upcoming quarter.
Net sales in the Aerospace end market increased $104.5 million to $212.1 million in 2011 from $107.6 million in 2010 and decreased $5.2 million between 2010 and 2009 from $112.8 million. After a period where this end market was negatively impacted by global economic conditions, net sales between 2011 and 2010 increased and was driven by demand and order rates for commercial aircraft at aircraft manufacturers and tier one suppliers, growing electronic content in current aircraft, refurbishment programs for older aircraft and demand for the high-reliability radar and avionics solutions we provide. Sales into satellite applications have grown as we have increased our product portfolio, especially system-level products, power management ICs and DC/DC converter solutions. Generally space-related applications are in a less economically sensitive market though we currently expect a moderation of growth. Combined with expected growth from commercial air applications, we expect that this end market will grow in the upcoming quarter.
Net sales in the Enterprise & Communications end market increased $32.4 million to $148.8 million in 2011 from $116.4 million in 2010 and increased $46.3 million between 2010 and 2009 from $70.1 million. Net sales in 2010 recovered from 2009, a period that was negatively impacted as enterprise demand waned in a challenging economic environment and demand for parts used in automotive navigation systems and notebook storage products declined. This recovery continued in 2011 as we experienced steady sales of our PoE offerings, RF power amplifier and DC-DC products. We believe that rapid market adoption of PoE technology, especially by enterprise customers, has increased our market share and our wireless LAN products are well accepted. We expect additional contribution from our display products such as LED drivers for solid state lighting and television backlighting. While this end market is sensitive to macroeconomic conditions, based on current and expected backlog, we expect that net sales from products prior to the acquisition of Zarlink will grow in the upcoming quarter. We also expect significant contribution from Zarlink, as approximately 85% of its net sales are expected to be in this end market.
40
Net sales in the Industrial & Alternative Energy end market increased $89.2 million to $175.4 million in 2011 from $86.2 million in 2010 and decreased $13.2 million between 2010 and 2009 from $99.4 million. The increases in 2011 were driven by growth in products for semiconductor capital equipment, an area which experienced substantial declines in 2009 and part of 2010 due to decreased capital spending during the recent economic downturn. We have also noted growth in plasma cutting and welding applications where our high power proficiency differentiates our products and also contributions from Microsemi SoC. The declines in 2010 were due to products in medical applications that were impacted by lower procurement levels of ICD products that were in line with moderating growth in the ICD space. Sales into medical applications in 2009 also benefited from our support of a product launch schedule of a principal ICD customer. Declines in this end market in 2010 were partially offset by growth in products for semiconductor capital equipment. We expect cyclicality in the semiconductor capital equipment, as well as well as a slowdown in products solar applications will adversely impact this end market. In addition, due to the impact of flooding at our subcontractors facilities in Thailand, we expect that sales in this end market will decline in the upcoming quarter. We do expect contribution from Zarlink in this end market as approximately 15% of its net sales are expected to be in this end market.
An estimated breakout of net sales by originating geographic area for 2011, 2010 and 2009 is approximately as follows (amounts in thousands):
2011 | 2010 | 2009 | ||||||||||
United States |
$ | 508,145 | $ | 243,822 | $ | 215,611 | ||||||
Europe |
132,145 | 125,209 | 135,844 | |||||||||
Asia |
195,564 | 149,237 | 101,517 | |||||||||
|
|
|
|
|
|
|||||||
Total |
$ | 835,854 | $ | 518,268 | $ | 452,972 | ||||||
|
|
|
|
|
|
Gross profit increased $193.0 million between 2011 and 2010, to $441.2 million (52.8% of sales) for 2011 from $248.2 million (47.9% of sales) for 2010 and increased $67.8 million between 2010 and 2009, from $180.4 million (39.8% of sales) for 2009. Gross profit percentage for 2011 was favorably impacted by higher margin products related to Microsemi SoC, cost optimization programs, transfer of manufacturing to lower cost and more efficient facilities (including the closure of our Scottsdale facility) and reductions in personnel. During the second quarter of 2011, we recorded a charge of $8.4 million for the write-off of bridging inventory that we intended to complete at other locations and $8.2 million for the write-off of medical inventory that did not meet our corporate gross margin targets. We also recorded a charge in the second quarter of 2011 of $5.6 million for Scottsdale remediation and fixed assets that we abandoned as part of our Scottsdale facility closure. In addition, we recorded non-cash purchase accounting expenses of $5.9 million in 2011 related to manufacturing profit in acquired inventory. Gross profit percentage for 2010 was favorably impacted by cost optimization programs, which included the closure of our facility in Colorado, ramp down of our Scottsdale facility, transfer of manufacturing to lower cost and more efficient facilities and reductions in personnel. In 2009, gross profit percentage was impacted 400 basis points from inventory write-downs related to product lines that do not meet gross margin targets, products that are being migrated to newer generations, products that service large capital spending end markets for which demand has declined and inventory at our Scottsdale facility that we announced we are closing. The remaining decline in gross profit percentage in 2009 was due substantially to the effects of fixed costs allocated over lower sales volume.
Selling, general and administrative expenses increased $72.8 million between 2011 and 2010 to $187.5 million for 2011 from $114.7 million for 2010 and increased $1.6 million between 2010 and 2009 from $113.1 million in 2009. While selling, general and administrative expenses in 2011 were favorably impacted by restructuring and cost control measures, these expenses increased overall primarily due to the incremental costs incurred from acquisitions we added over the last year. Selling, general and administrative expenses in 2010 were favorably impacted from restructuring and cost control measures. Selling, general and administrative expense in 2011 and 2010 also included acquisition-related costs such as investment advisor, transaction and legal fees of
41
$11.8 million and $4.8 million, respectively, while in 2009, these costs were allocated to the fair value of net assets acquired in accordance with GAAP then in effect. We expect selling, general and administrative expenses to increase next quarter, related to incremental costs from Zarlink, offset by cost controls we have implemented in response to the current economic environment.
Research and development expense increased $58.8 million between 2011 and 2010 to $114.2 million in 2011 from $55.4 million in 2010 and increased $14.0 million between 2010 and 2009 from $41.4 million in 2009. The increase in 2011 was due to additional product development to support our organic growth and attributable to additional research and development activities from 2011 acquisitions. The increase between 2010 and 2009 was due to higher purchases of materials, masks and other supplies related to new product development for both high-reliability and analog mixed signal products, as well as additional spending related to 2010 acquisitions. The principal focus of our research and development activities has been to improve processes and to develop new products that support the growth of our businesses. The spending on research and development was principally to develop new higher-margin application-specific products, including, among others, PoE, CCFL and LED drivers, class-D audio amplifiers, InGaP RF power amplifiers for wireless LAN applications, development and adoption of silicon carbide technology, VDMOS products for high frequency communications and S-band products for RF applications. We expect research and development expense to increase next quarter related to incremental costs from Zarlink and to support our product development efforts as we intend to continue to make product investments that deliver continued organic growth.
Amortization of intangible assets increased $42.3 million between 2011 and 2010 to $62.4 million in 2011 from $20.2 million in 2010 and increased $5.0 million between 2010 and 2009 from $15.2 million in 2009. The increases reflect additional amortization expense related to identifiable intangibles resulting from acquisitions consummated in 2011 and 2010.
Restructuring charges amounted to $22.1 million in 2011 compared to $2.1 million in 2010 and $13.3 million in 2009. The 2011 restructuring charges included $8.1 million related to our Scottsdale facility lease termination costs accrued at the cease use date and $14.0 million in charges for severance and termination benefits, primarily at facilities that we acquired in 2011 or at locations where we integrated recent acquisitions, principally Actel. Restructuring charges in 2010 related to costs incurred to optimize our personnel levels. Restructuring charges in 2009 consisted of $13.1 million in severance and $0.2 million in other related costs and included amounts from the closure of our Scottsdale manufacturing facility.
Operating income decreased $0.9 million to $55.0 million in 2011 from $55.9 million in 2010. The favorable impact of higher sales were offset by $42.3 million higher amortization of acquired intangibles, $20.0 million higher restructuring costs related to severance expenses and the closure of our Scottsdale facility, and incremental costs from our acquisitions.
Impairment charges in 2009 related to facility closures represented the held for sale impairment for the building and real estate related to our closed Broomfield, Colorado facility amounting to $1.7 million and the held and used impairment for our Scottsdale manufacturing facility amounting to $4.5 million to reflect our long-lived assets at their lower fair value.
Interest expense was $16.7 million in 2011, $0.8 million in 2010 and $0.4 million in 2009. The increase in interest expense in 2011 was related to term loan borrowings under our Credit Agreement.
42
Other income (expense), net, was ($16.7) million in 2011 compared to ($0.5) million in 2010 and $0.3 million in 2009. We elected the fair value option in accounting for the term loan balance outstanding under our Credit Agreement and changes in fair value of the loan balances are reflected as adjustments to the income statement. In connection with the Credit Agreement, we entered into interest rate swap agreements for the purpose of minimizing the variability of cash flows in the interest rate payments of our variable rate borrowings. In connection with the acquisition of Zarlink, we entered into a foreign currency forward agreement in the fourth quarter of 2011 to minimize our foreign currency risk associated with the transaction that we funded in Canadian Dollars (CAD). We reflect the change in fair value of our term loan balances, swaps and forward contract through other income or expense. We recorded expense of $3.3 million related to these adjustments. In addition, upon election of the fair value option, we were required to immediately expense up front debt issuance and refinancing costs that totaled $14.2 million in 2011. Finally, in 2011 we recorded a gain of $2.0 million related to the sale of a facility.
We recorded a benefit for income taxes of $32.4 million on pretax income of $22.0 million in 2011 compared to a benefit for income taxes of $4.0 million on pre-tax income of $55.0 million in 2010. The benefit for income taxes of $32.4 million included the release of $16.4 million of the remaining valuation allowance related to our Israel operations deferred tax assets, release of $5.2 million of our U.S. valuation allowance and recognition of $20.8 million in current year tax benefits from net operating losses and tax credits as a result of the excess deferred tax liabilities resulting from our acquisitions of Actel Corporation, AML Corporation, and ASIC Advantage, Inc. These benefits were partially offset by foreign tax expense of $10.0 million. We had cumulative operating losses for our U.S. operations. During the fourth quarter of 2009, we determined that it was more likely than not that the benefits of certain U.S. deferred tax assets would not be realized. Key positive and negative evidence we considered in making this determination included recent history of cumulative operating losses for our U.S. operations; future estimates of operating results for our U.S. operations; and our ability to carry back our U.S. operating losses, tax credits and reversing temporary differences to recover previously paid taxes. Based on this assessment, we determined that a valuation allowance was required for the deferred tax assets related to our U.S. operations that could not be carried back due to lower availability of previously paid taxes. Accordingly, we recorded a $28.4 million valuation allowance on a substantial portion of our U.S. deferred tax assets, which was included in the total tax provision of $17.9 million for fiscal year 2009.
During fiscal year 2011 we released the remaining valuation allowance related to our Israel operation based on an evaluation of key positive and negative evidence including the history of substantial losses in past years but cumulative income for the past three year period, and the indefinite carryforward period for the Israeli net operating loss carryforwards which are the principal component of our deferred tax assets in Israel.
CAPITAL RESOURCES AND LIQUIDITY
We had $266.6 million and $200.0 million in cash and cash equivalents at October 2, 2011 and October 3, 2010, respectively. During 2011, we financed our operations with cash generated from operations.
43
Net cash provided by operating activities increased $31.6 million to $139.2 million in 2011 from $107.6 million in 2010. A summary of net cash provided by operating activities in 2011, 2010 and 2009 are as follows (amounts in thousands):
2011 | 2010 | 2009 | ||||||||||
Net income |
$ | 54,447 | $ | 59,038 | $ | (26,823 | ) | |||||
Depreciation and amortization |
91,482 | 39,436 | 33,145 | |||||||||
Provision for doubtful accounts |
171 | (324 | ) | 571 | ||||||||
Deferred income taxes |
(19,442 | ) | 21,561 | (18,610 | ) | |||||||
Valuation allowance on deferred income taxes |
(21,604 | ) | (15,616 | ) | 39,389 | |||||||
Stock-based compensation |
21,138 | 24,672 | 26,844 | |||||||||
Net change in working capital accounts |
14,153 | (19,612 | ) | 57,297 | ||||||||
Net change in other long term assets and liabilities |
(1,111 | ) | (1,544 | ) | (4,613 | ) | ||||||
|
|
|
|
|
|
|||||||
Net cash provided by operating activities |
$ | 139,234 | $ | 107,611 | $ | 107,200 | ||||||
|
|
|
|
|
|
Accounts receivable increased $32.2 million to $110.9 million at October 2, 2011 from $78.7 million at October 3, 2010. The increase in accounts receivable was primarily due to higher sales, including incremental sales from operations we acquired in 2011. Days sales outstanding at the end of 2011 was 42 days compared to 46 days at the end of 2010 reflecting increased collection efforts.
Inventories increased $14.6 million to $140.8 million at October 2, 2011 from $126.2 million at October 3, 2010. The increase was due primarily to inventory balances at operations we acquired in 2011. Days of inventory at the end of 2011 was 134 days compared to 145 days at the days at the end of 2010 reflecting additional inventory management efforts.
Current liabilities increased $82.4 million to $153.7 million at October 2, 2011 from $71.3 million at October 3, 2010. The increase was due primarily to current liability balances at operations we acquired in the current fiscal year and an increase in current maturities of long term debt from our term loan balances.
Net cash used in investing activities was $460.5 million in 2011 compared to $82.0 million for 2010 and $47.2 million for 2009. Net cash used in investing activities in 2011 primarily consisted of $436.8 million in net cash consideration for four acquisitions and purchases of property and equipment of $25.8 million, offset by $2.2 million in proceeds for the sale of assets. Net cash used in investing activities in 2010 primarily consisted of $112.4 million in net cash consideration for three acquisitions, purchases of property and equipment of $16.4 million, partially offset by $46.6 million from the disposition of investments in available for sale securities. The increase in purchases of property and equipment between 2010 and 2009 was due primarily to the start up of our Philippine operations. Net cash used in investing activities in 2009 primarily consisted of $55.9 million in net cash consideration for three acquisitions, and purchases of property and equipment of $12.6 million, partially offset by $15.5 million from the disposition of investments in available for sale securities and $5.9 million in net proceeds from the divesture of assets.
Net cash (used in) provided by financing activities was $388.0 million in 2011, $(42.4) million in 2010 and $49.5 million in 2009. Net cash provided by financing activities in 2011 consisted of net borrowings of $372.2 million under our Credit Agreement and $33.0 million related to proceeds from stock awards, offset by $17.2 million in credit facility issuance and refinancing costs. Net cash used in financing activities in 2010 consisted of $5.2 million related to stock award activity offset by $46.6 million used to repay amounts outstanding under our auction rate securities credit facility. Net cash provided by financing activities in 2009 consisted primarily of $46.6 million in proceeds from our auction rate securities credit facility and $2.9 million related to stock award activity.
44
On November 2, 2010, we entered into a Credit Agreement with Morgan Stanley Senior Funding, Inc. (MSSF), Morgan Stanley & Co. Incorporated, East West Bank, Raymond James Bank, FSB and the lenders referred to therein (the Credit Agreement). Pursuant to the Credit Agreement, MSSF has provided $425.0 million senior secured first lien credit facilities (the Facilities), consisting of a term loan facility in an aggregate principal amount of $375.0 million and a revolving credit facility (the Revolving Facility) in an aggregate principal amount of $50.0 million. The Facilities financed the acquisition of Actel and fees and expenses related thereto. The Revolving Facility is also available for working capital requirements and other general corporate purposes. On March 2, 2011, we entered into Amendment No. 1 to the Credit Agreement that provided for new pricing terms, modified reporting requirements for permitted acquisitions and modified prepayment provisions related to the term loan facility. We had, as of October 2, 2011, $372.2 million borrowed under the term loan facility and no direct borrowings and $0.4 million in letters of credit outstanding under the Revolving Facility.
As further described in the subsequent events footnote to our consolidated financial statements, in October 2011, we acquired Zarlink for approximately CAD $640 million. In connection with the acquisition, we entered into Amendment No. 2 to the Credit Agreement (as amended, the Amended and Restated Credit Agreement) which increased the term loan facility to $800.0 million. Following the acquisition of Zarlink, we also borrowed $49.6 million under the Revolving Facility. Based on current amounts outstanding and interest rates, we expect to record quarterly interest payments of approximately $12.6 million.
The Amended and Restated Credit Agreement also provided new pricing terms, which increased the current applicable margin on revolving loans and swingline loans determined at the Base Rate by 75 to 100 basis points to 3.00% to 3.75% and revolving loans and swingline loans determined at the Eurodollar Rate by 75 to 100 basis points to 4.00% to 4.75%, depending on Microsemis consolidated leverage ratio. For term loans, the new pricing terms increased the current applicable margin on term loans determined at the Base Rate by 150 basis points to 3.50% and term loans determined at the Eurodollar Rate by 150 basis points to 4.50%. The Base Rate is defined as a rate per annum equal to the greatest of (a) the prime rate, (b) 1/2 of 1% per annum above the federal funds effective rate, (c) the one-month Eurodollar Rate plus 1%, and (d) in the case of any term loans, 2.25%. The Eurodollar Rate is defined as (a) the rate per annum offered for deposits of dollars for the applicable interest period that appears on Reuters Screen LIBOR01 Page as of 11:00 A.M., London, England time, two (2) business days prior to the first day of such interest period or (b) if no such offered rate exists, such rate will be the rate of interest per annum as determined by the administrative agent (rounded upwards, if necessary, to the nearest 1/100 of 1%) at which deposits of dollars in immediately available funds are offered at 11:00 A.M., London, England time, two (2) business days prior to the first day in the applicable interest period by major financial institutions reasonably satisfactory to the administrative agent in the London interbank market for such interest period and for an amount equal or comparable to the principal amount of the loans to be borrowed, converted or continued as Eurodollar Rate loans on such date of determination. In the case of term loans, the Eurodollar Rate will not be lower than 1.25%.
Pursuant to the Amended and Restated Credit Agreement, Microsemi can request, at any time and from time to time, the establishment of one or more term loan and/or revolving credit facilities with commitments in an aggregate amount not to exceed $200,000,000 (increased from $100,000,000 pursuant to the Existing Agreement).
Microsemi paid upfront fees or original issue discount equal to 2.00% of the Term Loan Facility and an amendment fee on the Existing Revolving Facility of 0.25%. Additionally, Microsemi expects to pay an undrawn commitment fee ranging from 0.25% to 0.625% depending on Microsemis consolidated leverage ratio, on the unused portion of the Existing Revolving Facility. If any letters of credit are issued, then Microsemi expects to continue paying a fronting fee equal to 0.25% per annum of the aggregate face amount of each letter of credit and a participation fee on all outstanding letters of credit at a per annum rate equal to the margin then in effect with respect to Eurodollar Rate-based loans on the face amount of such letter of credit.
45
The Amended and Restated Credit Agreement includes financial covenants requiring a maximum leverage ratio and minimum fixed charge coverage ratio and also contains other customary affirmative and negative covenants and events of default. We were in compliance with all financial covenants as of October 2, 2011.
As of October 2, 2011, we had no material commitments for capital expenditures. Based upon information currently available to us, we believe that we can meet our working capital, cash requirements and capital commitments for the next twelve months with cash balances, internally generated funds from ongoing operations.
Contractual Obligations
The following table summarizes our contractual payment obligations and commitments, excluding liability related to uncertain tax positions, at October 2, 2011 (amounts in thousands):
Payments due by period | ||||||||||||||||||||||||
Total | Less than 1 year |
1-3 years |
3-5 years |
More than 5 years |
Imputed Interest |
|||||||||||||||||||
Credit facility |
$ | 372,186 | $ | 3,750 | $ | 7,500 | $ | 7,500 | $ | 353,436 | $ | | ||||||||||||
Capital leases |
3,373 | 351 | 732 | 586 | 5,266 | (3,562 | ) | |||||||||||||||||
Other long-term liabilities |
4,997 | 61 | 742 | 38 | 4,156 | | ||||||||||||||||||
Operating leases |
64,538 | 11,340 | 20,730 | 13,200 | 19,268 | | ||||||||||||||||||
Purchase obligations |
32,266 | 27,397 | 4,869 | | | | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total |
$ | 477,360 | $ | 42,899 | $ | 34,573 | $ | 21,324 | $ | 382,126 | $ | (3,562 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
As of October 2, 2011, we recorded $14.5 million in long-term liabilities for accrued taxes related to uncertain tax positions and are not able to reasonably estimate the timing of the long-term payments, or the amount by which our liability will increase or decrease over time; therefore, the liability related to uncertain tax positions has not been included in the contractual obligations table.
In acquiring Zarlink, we assumed their contractual payments obligations and commitments. The following table summarizes our current estimate of contractual payment obligations as of October 13, 2011, related to this acquisition (amounts in thousands):
Payments due by period | ||||||||||||||||||||
Total | Less than 1 year |
1-3 years |
3-5 years |
More than 5 years |
||||||||||||||||
Operating leases |
$ | 20,010 | $ | 2,776 | $ | 8,227 | $ | 5,200 | 3,807 | |||||||||||
Purchase obligations |
2,358 | 2,358 | | | | |||||||||||||||
Letters of credit |
702 | 685 | | 17 | | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total |
$ | 23,070 | $ | 5,819 | $ | 8,227 | $ | 5,217 | $ | 3,807 | ||||||||||
|
|
|
|
|
|
|
|
|
|
RECENTLY ISSUED ACCOUNTING STANDARDS
In September 2009, the FASB issued ASU No. 2009-13, that eliminates the criterion for objective and reliable evidence of fair value for undelivered products or services. Instead, revenue arrangements with multiple deliverables should be divided into separate units of accounting provided the deliverables meet certain criteria. ASU No. 2009-13 provides a hierarchy for estimating the selling price for each of the deliverables. ASU No. 2009-13 eliminates the use of the residual method of allocation and requires that arrangement consideration be allocated at the inception of the arrangement to all deliverables based on their relative selling price. ASU No. 2009-13 is effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010 (our fiscal year 2011). The adoption of this standard did not result in a material impact on our consolidated financial position, results of operations or cash flows but may do so in the future depending on the terms included in revenue arrangements we enter into prospectively.
46
In January 2010, the FASB issued ASU No. 2010-06, that requires new fair value disclosures pertaining to significant transfers in and out of Level 1 and Level 2 fair value measurements and the reasons for the transfers and activity. For Level 3 fair value measurements, purchases, sales, issuances and settlements must be reported on a gross basis. Further, additional disclosures are required by class of assets or liabilities, as well as inputs used to measure fair value and valuation techniques. ASU No. 2010-06 is effective for interim and annual reporting periods beginning after December 15, 2009 (our second quarter of fiscal year 2010), except for the disclosures about purchases, sales, issuances and settlements on a gross basis, which is effective for fiscal years beginning after December 15, 2010 (our fiscal year 2012). The adoption of the effective portions of this ASU did not result in a material impact on our consolidated financial position, results of operations or cash flows. We do not anticipate that the adoption of the remaining portions of this ASU will result in a material impact on our consolidated financial position, results of operations or cash flows.
In December 2010, the FASB issued ASU No. 2010-29, that updates requirements on the disclosure of pro forma revenue and earnings following a business combination or series of business combinations that are material on an individual or aggregate basis. This ASU specifies that if a public entity presents comparative financial statements, the entity should disclose revenue and earnings of the combined entity as though the business combination(s) that occurred during the current year had occurred as of the beginning of the comparable prior annual reporting period only. The amendments in this ASU also expand the supplemental pro forma disclosures under ASC 805 to include a description of the nature and amount of material, nonrecurring pro forma adjustments directly attributable to the business combination included in the reported pro forma revenue and earnings. ASU No. 2010-29 is effective prospectively for business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2010 (our fiscal year 2012). Early adoption is permitted and we have elected to adopt the provisions of this ASU. The adoption of this standard did not result in a material impact on our consolidated financial position, results of operations or cash flows.
In June 2011, the FASB issued ASU No. 2011-05, that updates the presentation of comprehensive income such that an entity has the option to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. ASU No. 2011-05 is effective for public entities for fiscal years, and interim periods within those years, beginning after December 15, 2011 (the second quarter of our fiscal year 2012). The provisions of this standard only affect the presentation of comprehensive income and will not materially impact our consolidated financial position, results of operations or cash flows.
In September 2011, the FASB issued ASU No. 2011-08, that will allow an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. Under these amendments, an entity would not be required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. ASU No. 2011-08 is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011 (our fiscal year 2013). Early adoption is permitted and we have elected to adopt the provisions of this ASU. The adoption of this standard did not result in a material impact on our consolidated financial position, results of operations or cash flows.
ITEM 7A. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK |
Market risk is the potential loss arising from adverse changes in credit risk, foreign currency exchange rates, interest rates or the stock market. We are exposed to various market risks, which are related to credit risks, changes in certain foreign currency exchange rates and changes in certain interest rates.
We conduct a relatively small portion of our business in a number of foreign currencies, principally the European Union Euro, British Pound, Israeli Shekel and Chinese RMB. We may receive some revenues in foreign currencies and purchase some inventory and services in foreign currencies. Accordingly, we are exposed
47
to transaction gains and losses that could result from changes in exchange rates of foreign currencies relative to the U.S. dollar. Transactions in foreign currencies have represented a relatively small portion of our business. As a result, foreign currency fluctuations have not had a material impact historically on our revenues or results of operations. However, there can be no assurance that future fluctuations in the value of foreign currencies will not have material adverse effects on our results of operations, cash flows or financial condition. Specific to the acquisition of Zarlink, as further discussed in Note 15 of our consolidated financial statements, we entered into foreign currency forward agreement in the fourth quarter of 2011 to minimize our foreign currency risk associated with the transaction that we funded in Canadian Dollars. We agreed to purchase CAD 623.0 million for $608.2 million for settlement in October 2011. Other than the foregoing, we have not conducted a foreign currency hedging program thus far. We have considered and may continue to consider the adoption of a foreign currency hedging program.
We are potentially subject to concentrations of credit risk consisting principally of trade accounts receivable. Concentrations of credit risk exist because we rely on a significant portion of customers whose principal sales are to the U.S. Government. Approximately 36% of total net sales in 2011 were in the Defense & Security end market, with a very significant amount to customers whose principal sales are to the U.S. Government or to subcontractors whose material sales are to the U.S. Government. We, as a subcontractor, sell our products to higher-tier subcontractors or to prime contractors based upon purchase orders that usually do not contain all of the conditions included in the prime contract with the U.S. Government. However these sales are usually subject to termination and/or price renegotiations by virtue of their reference to a U.S. Government prime contract. Therefore, we believe that all of our product sales that ultimately are sold to the U.S. Government may be subject to termination, at the convenience of the U.S. Government or to price renegotiations under the Renegotiation Act. We have never experienced a material loss due to termination of a U.S Government contract. We have never had to renegotiate our price under any government contract.
At the end of fiscal year 2011, interest under the Facilities is, at our option, Base Rate or LIBOR, plus a margin ranging from 2.00% to 2.50% for Base Rate-based loans that are either term loans or revolving loans and ranging from 3.00% to 3.50% for LIBOR-based loans that are either term loans or revolving loans, depending on our consolidated leverage ratio. The Base Rate for term loans is equal to 2.0% per annum and for revolving loans is a fluctuating interest rate per annum equal to the highest of (a) the prime rate, (b) 1/2 of 1% per annum above the federal funds effective rate and (c) one-month LIBOR plus 1%. Interest for Base Rate-based loans is calculated on the basis of a 365-day year and interest for LIBOR-based loans is calculated on the basis of a 360-day year. The current principal amount outstanding under our term loan facility is a LIBOR-based loan and is subject to an interest rate of 4.00%. A one percent increase in the variable rate of interest on the term loan facility would increase interest expense by approximately $3.7 million annually. Subsequent to the end of fiscal year 2011, we amended our credit agreement and increased the term loan balance to $800.0 million which was subject to an interest rate of 5.75%. We also borrowed $50.0 million under the Revolving Facility. A one percent increase in the variable rate of interest on the term loan facility and Revolving Facility would increase interest expense by approximately $8.5 million annually.
In connection with the Credit Agreement, we entered into interest rate swap agreements for the purpose of minimizing the variability of cash flows in the interest rate payments of our variable rate borrowings. The cash flows received under the interest rate swap agreements are expected to offset the change in cash flows associated with LIBOR rate borrowings between the effective and maturity dates of the swaps. Our three swap agreements have notional amounts, fixed rates and terms as follows: $24.0 million at 1.49% for two years, $121.0 million at 1.83% for three years and $24.0 million at 2.21% for four years. We reflect the change in value of the swaps through other income or expense and at October 2, 2011, recorded a liability of $2.1 million. We recorded the related expense in other income (expense), net. We classify interest rate swap balances as Level 2 fair value measurements. We determined the fair value of our interest rate swap agreements based on mid-market valuations reported to us by RJ Capital Services, Inc., the counterparty to the swap agreements.
48
ITEM 8. | FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA |
MICROSEMI CORPORATION AND SUBSIDIARIES
Index to Consolidated Financial Statements
Page | ||||||
1. |
Consolidated Financial Statements | |||||
Report of Independent Registered Public Accounting Firm | 50 | |||||
Consolidated Balance Sheets at October 2, 2011 and October 3, 2010 | 51 | |||||
52 | ||||||
53 | ||||||
54 | ||||||
Notes to Consolidated Financial Statements | 55 | |||||
2. |
Financial Statement Schedule | |||||
Schedule for the fiscal years ended October 2, 2011, October 3, 2010 and September 27, 2009 | ||||||
II Valuation and Qualifying Accounts | 82 | |||||
Financial statement schedules not listed above are either omitted because they are not applicable or the required information is shown in the consolidated financial statements or in the notes thereto. |
49
Report of Independent Registered Public Accounting Firm
To the Board of Directors and
Stockholders of Microsemi Corporation:
In our opinion, the consolidated financial statements listed in the accompanying index appearing under Item 8(1) present fairly, in all material respects, the financial position of Microsemi Corporation and its subsidiaries at October 2, 2011 and October 3, 2010 and the results of their operations and their cash flows for each of the three years in the period ended October 2, 2011 in conformity with accounting principles generally accepted in the United States of America. In addition, in our opinion, the financial statement schedule listed in the accompanying index appearing under Item 8(2) presents fairly, in all material respects, the information set forth therein when read in conjunction with the related consolidated financial statements. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of October 2, 2011, based on criteria established in Internal Control Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). The Companys management is responsible for these financial statements and financial statement schedule, for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in Managements Report to Stockholders on Internal Control over Financial Reporting. Our responsibility is to express opinions on these financial statements, on the financial statement schedule, and on the Companys internal control over financial reporting based on our integrated audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects. Our audits of the financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
A companys internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A companys internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the companys assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
/s/ PricewaterhouseCoopers LLP
Irvine, California
November 23, 2011
50
MICROSEMI CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(amounts in thousands, except per share data)
October 2, 2011 |
October 3, 2010 |
|||||||
ASSETS | ||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 266,631 | $ | 199,950 | ||||
Accounts receivable, net of allowance for doubtful accounts of $2,149 at October 2, 2011 and $1,978 at October 3, 2010 |
110,908 | 78,722 | ||||||
Inventories |
140,827 | 126,151 | ||||||
Deferred income taxes |
43,424 | 12,620 | ||||||
Other current assets |
16,100 | 14,726 | ||||||
|
|
|
|
|||||
Total current assets |
577,890 | 432,169 | ||||||
Property and equipment, net |
89,922 | 75,913 | ||||||
Goodwill |
491,079 | 270,832 | ||||||
Intangible assets, net |
281,689 | 92,343 | ||||||
Other assets |
29,893 | 8,629 | ||||||
|
|
|
|
|||||
TOTAL ASSETS |
$ | 1,470,473 | $ | 879,886 | ||||
|
|
|
|
|||||
LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 48,561 | $ | 33,827 | ||||
Accrued liabilities |
101,078 | 37,052 | ||||||
Current maturity of long-term liabilities |
4,050 | 444 | ||||||
|
|
|
|
|||||
Total current liabilities |
153,689 | 71,323 | ||||||
|
|
|
|
|||||
Credit facility |
357,384 | | ||||||
Deferred income taxes |
35,568 | 19,513 | ||||||
Other long-term liabilities |
33,008 | 22,607 | ||||||
Commitments and contingencies (Note 10) |
||||||||
Stockholders equity: |
||||||||
Preferred stock, $1.00 par value; authorized 1,000 shares; none issued |
| | ||||||
Common stock, $0.20 par value; 250,000 authorized, 86,806 issued and outstanding at October 2, 2011 and 83,240 issued and outstanding at October 3, 2010 |
17,361 | 16,648 | ||||||
Capital in excess of par value of common stock |
612,517 | 543,628 | ||||||
Retained earnings |
260,160 | 205,713 | ||||||
Accumulated other comprehensive income |
786 | 454 | ||||||
|
|
|
|
|||||
Total stockholders equity |
890,824 | 766,443 | ||||||
|
|
|
|
|||||
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY |
$ | 1,470,473 | $ | 879,886 | ||||
|
|
|
|
The accompanying notes are an integral part of these statements.
51
MICROSEMI CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
For each of the three fiscal years in the period ended October 2, 2011
(amounts in thousands, except earnings per share)
2011 | 2010 | 2009 | ||||||||||
Net sales |
$ | 835,854 | $ | 518,268 | $ | 452,972 | ||||||
Cost of sales |
394,683 | 270,057 | 272,565 | |||||||||
|
|
|
|
|
|
|||||||
Gross profit |
441,171 | 248,211 | 180,407 | |||||||||
|
|
|
|
|
|
|||||||
Operating expenses: |
||||||||||||
Selling, general and administrative |
187,529 | 114,663 | 113,080 | |||||||||
Research and development costs |
114,155 | 55,395 | 41,435 | |||||||||
In-process research & development |
| | 1,310 | |||||||||
Amortization of intangible assets |
62,425 | 20,165 | 15,203 | |||||||||
Restructuring and severance charges |
22,081 | 2,107 | 13,264 | |||||||||
Impairment charges related to facility closures |
| | 6,185 | |||||||||
|
|
|
|
|
|
|||||||
Total operating expenses |
386,190 | 192,330 | 190,477 | |||||||||
|
|
|
|
|
|
|||||||
Operating income (loss) |
54,981 | 55,881 | (10,070 | ) | ||||||||
|
|
|
|
|
|
|||||||
Other income (expenses): |
||||||||||||
Interest expense |
(16,654 | ) | (756 | ) | (352 | ) | ||||||
Interest income |
383 | 432 | 1,221 | |||||||||
Other, net |
(16,661 | ) | (526 | ) | 327 | |||||||
|
|
|
|
|
|
|||||||
Total other income (loss) |
(32,932 | ) | (850 | ) | 1,196 | |||||||
|
|
|
|
|
|
|||||||
Income (loss) before income taxes |
22,049 | 55,031 | (8,874 | ) | ||||||||
Provision (benefit) for income taxes |
(32,398 | ) | (4,007 | ) | 17,949 | |||||||
|
|
|
|
|
|
|||||||
Net income (loss) |
$ | 54,447 | $ | 59,038 | $ | (26,823 | ) | |||||
|
|
|
|
|
|
|||||||
Earnings (loss) per share: |
||||||||||||
Basic |
$ | 0.65 | $ | 0.73 | $ | (0.33 | ) | |||||
|
|
|
|
|
|
|||||||
Diluted |
$ | 0.63 | $ | 0.72 | $ | (0.33 | ) | |||||
|
|
|
|
|
|
|||||||
Weighted-average common shares outstanding: |
||||||||||||
Basic |
83,916 | 80,797 | 80,943 | |||||||||
|
|
|
|
|
|
|||||||
Diluted |
85,747 | 81,541 | 80,943 | |||||||||
|
|
|
|
|
|
The accompanying notes are an integral part of these statements.
52
MICROSEMI CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY
For each of the three fiscal years in the period ended October 2, 2011
(amounts in thousands)
Common Stock | Capital in Excess of Par value of Common Stock |
Retained Earnings |
Accumulated Other Comprehensive Income |
Total | ||||||||||||||||||||
Shares | Amount | |||||||||||||||||||||||
Balance at September 28, 2008 |
79,797 | $ | 15,959 | $ | 483,233 | $ | 173,498 | $ | 480 | $ | 673,170 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Proceeds from exercise of stock options |
277 | 55 | 2,805 | | | 2,860 | ||||||||||||||||||
Grants and cancellations of restricted share awards |
1,339 | 268 | (268 | ) | | | | |||||||||||||||||
Tax benefit stock-based compensation |
| | 41 | | | 41 | ||||||||||||||||||
Stock-based compensation |
| | 27,051 | | | 27,051 | ||||||||||||||||||
Other Comprehensive income |
| | | | 52 | 52 | ||||||||||||||||||
Net loss |
| | | (26,823 | ) | | (26,823 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Balance at September 27, 2009 |
81,413 | $ | 16,282 | $ | 512,862 | $ | 146,675 | $ | 532 | $ | 676,351 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Proceeds from exercise of stock options |
464 | 93 | 4,714 | | | 4,807 | ||||||||||||||||||
Grants and cancellations of restricted share awards |
1,363 | 273 | (273 | ) | | | | |||||||||||||||||
Issuance of stock awards related to acquisition |
| | 161 | | | 161 | ||||||||||||||||||
Tax benefit stock-based compensation |
| | 730 | | | 730 | ||||||||||||||||||
Stock-based compensation |
| | 25,434 | | | 25,434 | ||||||||||||||||||
Other Comprehensive loss |
| | | | (78 | ) | (78 | ) | ||||||||||||||||
Net income |
| | | 59,038 | | 59,038 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Balance at October 3, 2010 |
83,240 | $ | 16,648 | $ | 543,628 | $ | 205,713 | $ | 454 | $ | 766,443 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Proceeds from exercise of stock options |
2,089 | 418 | 26,790 | | | 27,208 | ||||||||||||||||||
Tax withholding on restricted stock units |
| | (1,538 | ) | | | (1,538 | ) | ||||||||||||||||
Grants and cancellations of restricted share awards |
1,477 | 295 | (295 | ) | | | | |||||||||||||||||
Issuance of stock awards related to acquisition |
| | 15,293 | | | 15,293 | ||||||||||||||||||
Tax benefit stock-based compensation |
| | | | | | ||||||||||||||||||
Stock-based compensation |
| | 28,639 | | | 28,639 | ||||||||||||||||||
Other Comprehensive income |
| | | | 332 | 332 | ||||||||||||||||||
Net income |
| | | 54,447 | | 54,447 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Balance at October 2, 2011 |
86,806 | $ | 17,361 | $ | 612,517 | $ | 260,160 | $ | 786 | $ | 890,824 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these statements.
53
MICROSEMI CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
For each of the three fiscal years in the period ended October 2, 2011
(amounts in thousands)
2011 | 2010 | 2009 | ||||||||||
Cash flows from operating activities: |
||||||||||||
Net income (loss) |
$ | 54,447 | $ | 59,038 | $ | (26,823 | ) | |||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||||||
Depreciation and amortization |
91,482 | 39,436 | 33,145 | |||||||||
Provision for doubtful accounts |
171 | (324 | ) | 571 | ||||||||
Impairment charges related to facility closures |
| | 6,185 | |||||||||
In process research and development |
| | 1,310 | |||||||||
Deferred income taxes |
(19,442 | ) | 21,561 | (18,610 | ) | |||||||
Valuation allowance on deferred income taxes |
(21,604 | ) | (15,616 | ) | 39,389 | |||||||
Charge for stock based compensation |
28,465 | 25,277 | 26,933 | |||||||||
Excess tax benefits-stock awards |
(7,327 | ) | (605 | ) | (89 | ) | ||||||
Effect of fair value option on credit facility issuance and refinancing costs |
14,218 | | | |||||||||
Change in assets and liabilities (net of acquisitions and disposition): |
||||||||||||
Accounts receivable |
9,692 | (8,068 | ) | 46,450 | ||||||||
Inventories |
14,968 | (20,295 | ) | 30,188 | ||||||||
Other current assets |
3,697 | (1,669 | ) | (6,229 | ) | |||||||
Other assets |
6,201 | 1,320 | (1,809 | ) | ||||||||
Accounts payable |
2,354 | 15,153 | (17,048 | ) | ||||||||
Accrued liabilities |
(16,603 | ) | (6,053 | ) | (4,512 | ) | ||||||
Other long-term liabilities |
(21,485 | ) | (1,544 | ) | (1,851 | ) | ||||||
|
|
|
|
|
|
|||||||
Net cash provided by operating activities |
139,234 | 107,611 | 107,200 | |||||||||
|
|
|
|
|
|
|||||||
Cash flows from investing activities: |
||||||||||||
Purchases of property and equipment |
(25,826 | ) | (16,224 | ) | (12,625 | ) | ||||||
Proceeds from sale of available for sale securities |
| 46,550 | 15,450 | |||||||||
Proceeds from the divestiture or sale of assets |
2,157 | | 5,877 | |||||||||
Payments for acquisitions, net of cash acquired |
(436,849 | ) | (112,370 | ) | (55,856 | ) | ||||||
|
|
|
|
|
|
|||||||
Net cash used in investing activities |
(460,518 | ) | (82,044 | ) | (47,154 | ) | ||||||
|
|
|
|
|
|
|||||||
Cash flows from financing activities: |
||||||||||||
Proceeds from (repayments of) auction rate securities credit facility |
| (46,550 | ) | 46,550 | ||||||||
Repayments of credit facility |
(52,814 | ) | | | ||||||||
Credit facility issuance costs |
(17,218 | ) | | | ||||||||
Proceeds from credit facility |
425,000 | | | |||||||||
Repayment of note payable |
| (981 | ) | | ||||||||
Excess tax benefit from stock awards |
7,327 | 365 | 89 | |||||||||
Stock settled tax withholdings |
(1,538 | ) | | | ||||||||
Exercise proceeds from stock awards |
27,208 | 4,807 | 2,860 | |||||||||
|
|
|
|
|
|
|||||||
Net cash (used in) provided by financing activities |
387,965 | (42,359 | ) | 49,499 | ||||||||
|
|
|
|
|
|
|||||||
Net increase (decrease) in cash and cash equivalents |
66,681 | (16,792 | ) | 109,545 | ||||||||
Cash and cash equivalents at beginning of year |
199,950 | 216,742 | 107,197 | |||||||||
|
|
|
|
|
|
|||||||
Cash and cash equivalents at end of year |
$ | 266,631 | $ | 199,950 | $ | 216,742 | ||||||
|
|
|
|
|
|
|||||||
Supplemental disclosure of cash flow information |
||||||||||||
Cash paid during the year for: |
||||||||||||
Interest |
$ | 12,625 | $ | 790 | $ | 340 | ||||||
Income taxes |
$ | 6,553 | $ | 8,398 | $ | 4,705 |
The accompanying notes are an integral part of these statements.
54
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. | DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Description of Business
We are a leading designer, manufacturer and marketer of high performance analog and mixed-signal integrated circuits and high-reliability semiconductors. Our semiconductors manage and control or regulate power, protect against transient voltage spikes and transmit, receive and amplify signals.
Our products include individual components as well as integrated circuit solutions that enhance customer designs by reducing size, protecting circuits, improving performance, reliability, and battery optimization. The principal markets we serve include Defense & Security, Aerospace, Enterprise & Communication and Industrial & Alternative Energy.
During 2009, we acquired Electro Module, Inc. and its wholly-owned subsidiary, Babcock, Inc. Babcock, Inc. is a leading manufacturer of high-reliability power supplies, relays and flat panel displays and supplies. We subsequently renamed Babcock, Inc., Microsemi Corp. Power Management Group (PMG). Also during 2009, we entered into an asset purchase agreement in which we acquired substantially all the assets of the Defense and Security business of Endwave Corporation. This business designs, manufactures and markets radio frequency modules that enable the transmission, reception and processing of high frequency signals. Markets for these products include defense electronics, homeland security systems and other applications that require high frequency radio frequency circuitry and subsystems. We subsequently renamed the Defense and Security business of Endwave Corporation, Microsemi Corp. RF Integrated Solutions. Our final acquisition of 2009 was the purchase of substantially all the assets of Nexsem, Inc., a designer and marketer of high-voltage DC to DC conversion devices for applications such as in LCD televisions, set top boxes, notebooks and netbooks. In the fourth quarter of 2009 and in connection with a settlement with the United States Department of Justice, we entered into an agreement which, in substance, resulted in the divestiture of the assets purchased from SEMICOA.
During 2010, we acquired White Electronic Designs Corporation (White Electronic), a defense electronics manufacturer and supplier that designs, develops and manufactures innovative electronic components and systems for inclusion in high technology products for the defense and aerospace markets. We also acquired substantially all the assets of VT Silicon, a designer and manufacturer of multi-band radio frequency integrated circuit (RFIC) solutions for the mobile wireless broadband market and all the shares of Arxan Defense Systems, Inc., a leading provider of anti-tamper solutions, providing full-service support to defense clients in securing systems against tampering, piracy and reverse engineering.
During 2011, we acquired Actel Corporation (Actel), a leading supplier of low-power FPGAs, mixed-signal FPGAs, and system-critical FPGAs. We sometimes refer to this division herein as Microsemi SoC. We also acquired AML Communications, Inc., a designer, manufacturer, and marketer of microelectronic assemblies for the defense industry, Asic Advantage, Inc. (Asic Advantage), a fabless semiconductor company that designs and manufactures a broad portfolio of high-performance, high-voltage and radiation-hardened mixed-signal integrated circuit solutions for the aerospace, automotive, communications, industrial and medical markets and substantially all the assets of Brijot Imaging Systems, Inc. (Brijot) and its passive millimeter wave imaging solutions technology.
Fiscal Year
We report results of operations on the basis of fifty-two and fifty-three week periods. The fiscal year ended on October 2, 2011 consisted of fifty-two week, the fiscal year ended on October 3, 2010 consisted of fifty-three weeks, and the fiscal year ended on September 27, 2009 consisted of fifty-two weeks. In referencing a year, we are referring to the fiscal year ended on the Sunday closest to September 30.
55
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
Principles of Consolidation and Presentation of Financial Information
The consolidated financial statements include the accounts of Microsemi and our subsidiaries. All intercompany transactions and balances have been eliminated.
Use of Estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the respective reporting periods. Actual results could differ from those estimates.
Cash and Cash Equivalents
We consider all short-term, highly liquid investments with maturities of three months or less at date of acquisition to be cash equivalents.
Accounts receivable and allowance for doubtful accounts
Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The accounts receivable amount shown in the balance sheet are trade accounts receivable balances at the respective dates, net of allowance for doubtful accounts. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance based in part on our historical write-off experience and specific review of account balances due. Past due balances over 90 days and over a specified amount are reviewed individually for collectability. All other balances are reviewed on a pooled basis by type of receivable. Account balances are charged off against the allowance when we determine that it is probable the receivable will not be recovered. We review our allowance for doubtful accounts quarterly. We do not have any off-balance-sheet credit exposure related to our customers. To date, our allowance for doubtful accounts has generally been within managements estimates.
Inventories
Inventories are stated at the lower of cost, as determined using the first-in, first-out (FIFO) method, or market. Costs include materials, labor and manufacturing overhead. We evaluate the carrying value of our inventories taking into account such factors as historical and anticipated future sales compared with quantities on hand and the price we expect to obtain for our products in their respective markets. We also evaluate the composition of our inventories to identify any slow-moving or obsolete products. Additionally, inventory write-downs are made based upon such judgments for any inventories that are identified as having a net realizable value less than their cost, which is further reduced by related selling expenses. To date, the net realizable value of our inventories has generally been within managements estimates.
Fair Value of Financial Assets and Liabilities
Accounting Standards Codification 825 (ASC 825) permits entities to elect the fair value option for certain financial assets and financial liabilities. For financial assets or financial liabilities for which an entity elects the fair value option, ASC 825 requires that the entity record the financial asset or financial liability at fair value rather than at historical cost with changes in fair value recorded in the income statement. ASC 825-25-3 requires that upfront costs and fees related to items for which the fair value option is elected shall be recognized in earnings as incurred and not deferred. We have elected the fair value option on our credit facility that we entered into in 2011.
56
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
Property and Equipment
Property and equipment are stated at lower of cost or realizable values. Depreciation is computed on the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the shorter of the lease terms or the estimated useful lives. Maintenance and repairs are charged to expense as incurred and the costs of additions and betterments that increase the useful lives of the assets are capitalized.
Long-Lived Assets
We assess the impairment of property, plant and equipment and amortizable intangible assets whenever events or changes in circumstances indicate that their carrying value may not be recoverable from the undiscounted estimated future cash flows expected to result from their use.
We are required to make judgments and assumptions in identifying those events or changes in circumstances that may trigger impairment. Some of the factors we consider include:
| Significant decrease in the market value of an asset. |
| Significant changes in the extent or manner for which the asset is being used or in its physical condition including manufacturing plant closures. |
| A significant change, delay or departure in our business strategy related to the asset. |
| Significant negative changes in the business climate, industry or economic conditions. |
| Current period operating losses or negative cash flow combined with a history of similar losses or a forecast that indicates continuing losses associated with the use of an asset. |
If events or circumstances indicate that the carrying amount of a long-lived asset or asset group may not be recoverable and the expected undiscounted future cash flows attributable to the asset group are less than the carrying value, an impairment loss equal to the excess of the carrying value of the assets within the asset group over their fair value is recorded. The appropriate asset group is determined based on the lowest level of largely independent cash inflows and outflows for the related assets. Depending on the nature of the primary assets in the asset group, fair value is estimated using one of several approaches including replacement cost, appraised values, market quotes or estimated expected future cash flows using a discount rate commensurate with the risk involved. During 2009, we recorded a held for sale impairment of $1.7 million related to the real estate and building for our closed manufacturing facility in Broomfield, Colorado and a held and used impairment of $4.5 million for the closure of our manufacturing facility in Scottsdale, Arizona to reflect our long-lived assets at their lower fair value.
Goodwill and Intangible Assets
We account for goodwill on an impairment-only approach and amortize intangible assets with definite useful lives over their respective useful lives. At least annually, and whenever events or changes in circumstances indicate that it is more likely than not that an impairment loss has been incurred, we are required to reassess goodwill. Whenever we determine that there has been an impairment of goodwill or other intangible assets with indefinite lives, we will record an impairment charge against earnings. We operate as one reporting unit and an impairment charge would equal the excess of the carrying value of goodwill in our one reporting unit over its then fair value. The identification of intangible assets and determination of the fair value and useful lives are subjective in nature and often involve the use of significant estimates and assumptions. The judgments made in determining the estimated useful lives assigned to each class of assets can significantly affect net income. We perform our annual review for goodwill impairment in the fourth quarter of each fiscal year.
57
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
Revenue Recognition, Sales Returns and Allowances
We primarily recognize revenue from customers, including distributors, when title and risk of loss have passed to the customer provided that: 1) evidence of an arrangement exists; 2) delivery has occurred; 3) the fee is fixed or determinable; and 4) collectability is reasonably assured. For substantially all sales, revenue is recognized at the time the product is shipped.
We enter into contracts with certain distributors, and these contracts may permit limited stock rotation returns. We provide an estimated allowance for such returns, and corresponding reductions in revenue are concurrently recorded, based on several factors including past history and notification from customers of pending returns. Actual returns have been within managements expectations. Estimated reductions to revenue are also recorded for customer incentive programs consisting of price protection and volume purchase rebates. Such programs are limited and actual reductions to revenue have been within managements expectations.
We also derive a portion of our revenue from fixed-price contracts. Revenue for these contracts are recorded under a percentage of completion method, which is based on the ratio of total costs incurred to date to estimated total costs at completion. Gross profit expected to be realized on fixed-price contracts are based on periodic estimates of total revenues and costs for each contract. Losses on contracts are accrued when estimated total costs exceed total revenues. Occasionally, we will enter into contracts on a cost plus fee basis. We recognize revenue based on reimbursements for actual expenses plus the contractually agreed upon fee with the customer.
Research and Development
We expense the cost of research and development as incurred. Research and development expenses principally comprise payroll and related costs, supplies, and the cost of prototypes.
Restructuring Charges
We recognize a liability for restructuring costs when the liability is incurred. The restructuring accruals are based upon management estimates at the time they are recorded and can change depending upon changes in facts and circumstances subsequent to the date the original liability is recorded. The main components of our restructuring charges are workforce reductions and elimination of excess facilities. Workforce-related charges are accrued when it is determined that a liability exists, which is generally when individuals have been notified of their expected termination dates and expected severance payments or when formal severance plans exist, when the severance payments are probable and reasonably estimable. The elimination of excess facilities results in charges for lease termination fees, future contractual commitments to pay lease charges net of estimated sublease income, facility remediation costs and moving costs to remove property and equipment from the facilities. We recognize charges for elimination of excess facilities when we have vacated the premises or ceased use of the facility.
Stock-Based Compensation
Compensation expense for stock options was calculated based on the date of grant or conversion using the Black-Scholes option pricing model with exercise prices equal to the closing price of our common stock on the date of grant. Restricted stock awards were granted to employees with compensation expense determined based on the closing price of our common stock on the date of grant. Stock options and restricted stock awards are subject to forfeiture if length of service requirements are unmet. Expected life was estimated based on historical exercise data that was stratified between members of the Board of Directors, executive employees and all other recipients. Expected volatility was estimated based on historical volatility using equally weighted daily price
58
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
observations over a period approximately equal to the expected life of each option. The risk free interest rate is based on the implied yield currently available on U.S. Treasury securities with an equivalent remaining term. No dividends are expected to be paid.
Accounting For Income Taxes
We account for income taxes under the asset and liability method, whereby deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. We evaluate the need to establish a valuation allowance for deferred tax assets based upon the amount of existing temporary differences, the period in which they are expected to be recovered and expected levels of taxable income. A valuation allowance to reduce deferred tax assets is established when it is more likely than not that some or all of the deferred tax assets will not be realized. We recognize uncertain tax positions when they meet a more-likely-than-not threshold. We recognize potential accrued interest and penalties related to unrecognized tax benefits within operations as income tax expense.
We file U.S. federal, state, and foreign income tax returns in jurisdictions with varying statutes of limitations. Fiscal years 2007 to 2011 generally remain subject examination by federal and most state tax authorities. In significant foreign jurisdictions, the 2008 to 2011 tax years generally remain subject to examination by tax authorities. We establish liabilities for possible assessments by tax authorities resulting from known tax exposures including, but not limited to, international tax issues and certain tax credits. We do not believe the results of any audits would have a material impact on our financial position, results of operations or cash flows.
Segment Information
We use the management approach for segment disclosure, which designates the internal organization that is used by management for making operating decisions and assessing performance as the source of our reportable segments. We manage our business on the basis of one reportable segment, as a manufacturer of semiconductors in different geographic areas, including the United States, Europe and Asia.
Foreign Currency
Our subsidiaries in Ireland and Israel use the United States Dollar (USD) as their functional currency. Our subsidiary in China uses the Chinese RMB as its functional currency. Our subsidiary in France uses the European Union Euro as its functional currency. For subsidiaries that use the US dollar as the function currency, assets and liabilities are remeasured to USD at the exchange rate in effect at the balance sheet date except for non-monetary assets and capital accounts which are measured at historical rates; revenues, expenses, gains and losses are remeasured at rates of exchange that approximate the rates in effect at the transaction date. For subsidiaries that use the local currency as the functional currency, all assets and liabilities are remeasured to USD using exchange rates in effect at the end of the period. Resulting translation gains or losses are recognized as a component of other comprehensive income. We also conduct a relatively small portion of our business in a number of foreign currencies, principally the European Union Euro, British Pound, Israeli Shekel and Chinese RMB.
59
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
Earnings Per Share
Basic earnings per share have been computed based upon the weighted-average number of common shares outstanding during the respective periods. Diluted earnings per share have been computed, when the result is dilutive, using the treasury stock method for stock awards outstanding during the respective periods. Earnings per share for the 2011, 2010 and 2009 were calculated as follows (amounts in thousands, except per share data):
Fiscal Years | ||||||||||||
2011 | 2010 | 2009 | ||||||||||
BASIC |
||||||||||||
Net income (loss) |
$ | 54,447 | $ | 59,038 | $ | (26,823 | ) | |||||
|
|
|
|
|
|
|||||||
Weighted-average common shares outstanding |
83,916 | 80,797 | 80,943 | |||||||||
|
|
|
|
|
|
|||||||
Basic earnings (loss) per share |
$ | 0.65 | $ | 0.73 | $ | (0.33 | ) | |||||
|
|
|
|
|
|
|||||||
DILUTED |
||||||||||||
Net income (loss) |
$ | 54,447 | $ | 59,038 | $ | (26,823 | ) | |||||
|
|
|
|
|
|
|||||||
Weighted-average common shares outstanding for basic |
83,916 | 80,797 | 80,943 | |||||||||
Dilutive effect of stock awards |
1,831 | 744 | | |||||||||
|
|
|
|
|
|
|||||||
Weighted-average common shares outstanding on a diluted basis |
85,747 | 81,541 | 80,943 | |||||||||
|
|
|
|
|
|
|||||||
Diluted earnings (loss) per share |
$ | 0.63 | $ | 0.72 | $ | (0.33 | ) | |||||
|
|
|
|
|
|
For the 2011 and 2010, approximately 7.3 million and 7.4 million awards, respectively, were excluded in the computation of diluted EPS as these stock awards would have been anti-dilutive. All stock awards in 2009 were excluded from the computation of diluted earnings per shares as we incurred a net loss.
Concentration of Credit Risk and Foreign Sales
We are potentially subject to concentrations of credit risk consisting principally of trade accounts receivable. Concentrations of credit risk exist because we rely on a significant portion of customers whose principal sales are to the U.S. Government. Approximately 36% of total net sales in 2011 were in the defense & security end market, with a very significant amount to customers whose principal sales are to the U.S. Government or to subcontractors whose material sales are to the U.S. Government. We, as a subcontractor, sell our products to higher-tier subcontractors or to prime contractors based upon purchase orders that usually do not contain all of the conditions included in the prime contract with the U.S. Government. However, these sales are usually subject to termination and/or price renegotiations by virtue of their reference to a U.S. Government prime contract. Therefore, we believe that all of our product sales that ultimately are sold to the U.S. Government may be subject to termination, at the convenience of the U.S. Government or to price renegotiations under the Renegotiation Act. We have never experienced a material loss due to termination of a U.S Government contract. We have never had to renegotiate our price under any government contract.
In addition, net sales from international markets represent a significant portion of total net sales. Our net sales to international customers represented approximately 46% for 2011, 40% for 2010 and 30% for 2009. These sales were principally to customers in Europe and Asia. We maintain reserves for potential credit losses and such losses have been within managements expectations.
60
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
RECENTLY ISSUED ACCOUNTING STANDARDS
In September 2009, the FASB issued ASU No. 2009-13, that eliminates the criterion for objective and reliable evidence of fair value for undelivered products or services. Instead, revenue arrangements with multiple deliverables should be divided into separate units of accounting provided the deliverables meet certain criteria. ASU No. 2009-13 provides a hierarchy for estimating the selling price for each of the deliverables. ASU No. 2009-13 eliminates the use of the residual method of allocation and requires that arrangement consideration be allocated at the inception of the arrangement to all deliverables based on their relative selling price. ASU No. 2009-13 is effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010 (our fiscal year 2011). The adoption of this standard did not result in a material impact on our consolidated financial position, results of operations or cash flows but may do so in the future depending on the terms included in revenue arrangements we enter into prospectively.
In January 2010, the FASB issued ASU No. 2010-06, that requires new fair value disclosures pertaining to significant transfers in and out of Level 1 and Level 2 fair value measurements and the reasons for the transfers and activity. For Level 3 fair value measurements, purchases, sales, issuances and settlements must be reported on a gross basis. Further, additional disclosures are required by class of assets or liabilities, as well as inputs used to measure fair value and valuation techniques. ASU No. 2010-06 is effective for interim and annual reporting periods beginning after December 15, 2009 (our second quarter of fiscal year 2010), except for the disclosures about purchases, sales, issuances and settlements on a gross basis, which is effective for fiscal years beginning after December 15, 2010 (our fiscal year 2012). The adoption of the effective portions of this ASU did not result in a material impact on our consolidated financial position, results of operations or cash flows. We do not anticipate that the adoption of the remaining portions of this ASU will result in a material impact on our consolidated financial position, results of operations or cash flows.
In December 2010, the FASB issued ASU No. 2010-29, that updates requirements on the disclosure of pro forma revenue and earnings following a business combination or series of business combinations that are material on an individual or aggregate basis. This ASU specifies that if a public entity presents comparative financial statements, the entity should disclose revenue and earnings of the combined entity as though the business combination(s) that occurred during the current year had occurred as of the beginning of the comparable prior annual reporting period only. The amendments in this ASU also expand the supplemental pro forma disclosures under ASC 805 to include a description of the nature and amount of material, nonrecurring pro forma adjustments directly attributable to the business combination included in the reported pro forma revenue and earnings. ASU No. 2010-29 is effective prospectively for business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2010 (our fiscal year 2012). Early adoption is permitted and we have elected to adopt the provisions of this ASU. The adoption of this standard did not result in a material impact on our consolidated financial position, results of operations or cash flows.
In June 2011, the FASB issued ASU No. 2011-05, that updates the presentation of comprehensive income such that an entity has the option to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. ASU No. 2011-05 is effective for public entities for fiscal years, and interim periods within those years, beginning after December 15, 2011 (the second quarter of our fiscal year 2012). The provisions of this standard only affect the presentation of comprehensive income and will not materially impact our consolidated financial position, results of operations or cash flows.
In September 2011, the FASB issued ASU No. 2011-08, that will allow an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. Under
61
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
these amendments, an entity would not be required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. ASU No. 2011-08 is effective for annual and interim goodwill impairment test performed for fiscal years beginning after December 15, 2011 (our fiscal year 2013). Early adoption is permitted and we have elected to adopt the provisions of this ASU. The adoption of this standard did not result in a material impact on our consolidated financial position, results of operations or cash flows.
2. | ACQUISITIONS |
For the acquisitions we completed during the current fiscal year, the fair value of the identified intangible assets was estimated by performing a discounted cash flow analysis using the income approach. This method includes a forecast of direct revenues and costs associated with the respective intangible assets and charges for economic returns on tangible and intangible assets utilized in cash flow generation. Net cash flows attributable to the identified intangible assets were discounted to their present value at a rate commensurate with the perceived risk. The projected cash flow assumptions considered contractual relationships, customer attrition, eventual development of new technologies and market competition.
The useful lives of completed technology rights are based on the number of years in which net cash flows have been projected. The useful life of backlog is estimated based upon the fulfillment period. The useful lives of customer relationships are estimated based upon the length of the relationships currently in place, historical attrition patterns and natural growth and diversification of other potential customers. The useful life of a trade name was estimated based on the period in which a benefit could be ascribed to the identified trade names.
Assumptions used in forecasting cash flows for each of the identified intangible assets included consideration of the following:
| Historical performance including sales and profitability. |
| Business prospects and industry expectations. |
| Estimated economic life of asset. |
| Development of new technologies. |
| Acquisition of new customers. |
| Attrition of existing customers. |
| Obsolescence of technology over time. |
Generally, the allocation of purchase prices resulted in an allocation to goodwill. Depending on the tax treatment of a particular acquisition, goodwill and identifiable intangible assets may not be deductible for tax purposes. The factors that contributed to a purchase price resulting in the recognition of goodwill include:
| The premium paid over market capitalization immediately prior to the merger announcement. |
| Our belief that the merger will create a more diverse semiconductor company with expansive offerings which will enable us to expand our product offerings. |
| Our belief that both companies are committed to improving cost structures and that our combined efforts after the merger should result in a realization of cost savings and an improvement of overall efficiencies. |
The purchase price allocation for acquisitions completed in 2011 are preliminary, primarily with respect to certain tax matters and may be subject to adjustment. If such adjustment were to occur, it would result in corresponding adjustment to goodwill and income tax liabilities.
62
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
Actel Corporation
During the quarter ended January 2, 2011, we completed our acquisition of Actel Corporation (Actel) for $20.88 per share in cash. Actel is the leading supplier of low-power field-programmable gate arrays (FPGAs), mixed-signal FPGAs, and system-critical FPGAs. Delivering the lowest power consumption of any comparably sized FPGAs at both the chip and the system level, Actels flash- and antifuse-based FPGA solutions enable power-efficient design. We sometimes refer to this division herein as Microsemi SoC.
The total consideration as shown in the table below is allocated to Actels tangible and intangible assets and liabilities based on their preliminary estimated fair values as of the date of the completion of the transaction. The consideration is allocated as follows (in thousands):
Calculation of consideration: |
||||
Cash consideration to Actel shareholders |
$ | 548,759 | ||
Change in control obligations |
17,298 | |||
Fair value of vested stock awards assumed by Microsemi |
15,294 | |||
|
|
|||
Total consideration |
$ | 581,351 | ||
Allocation of consideration: |
||||
Book value of Actels net assets |
182,765 | |||
Adjustments to historical net book value: |
||||
Inventories |
5,494 | |||
Identifiable intangible assets |
232,600 | |||
Deferred tax liability |
(24,379 | ) | ||
|
|
|||
Adjustment to goodwill |
$ | 184,871 | ||
|
|
Identifiable intangible assets and their estimated useful lives are as follows (amounts in thousands):
Asset Amount |
Weighted Average Useful Life (Years) |
|||||||
Completed technology |
$ | 147,000 | 8 | |||||
Customer relationships |
68,000 | 7 | ||||||
Backlog |
13,600 | 1 | ||||||
Trade name |
4,000 | 3 | ||||||
|
|
|||||||
$ | 232,600 | |||||||
|
|
We utilized the straight line method of amortization for completed technology, customer relationships and trade name and the estimated fulfillment period for backlog. This allocation is preliminary with respect to certain tax matters and is based on our estimates. The amount ultimately allocated to identifiable intangible assets is not expected to change materially from this allocation.
AML Communications, Inc.
During the quarter ended July 3, 2011, we completed our acquisition of AML Communications, Inc. (AML), for $2.50 per share in cash. AML is a designer, manufacturer, and marketer of microelectronic assemblies for the defense industry. AML was integrated into Microsemi Corp. RF Integrated Solutions.
63
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
The total consideration as shown in the table below is allocated to AMLs tangible and intangible assets and liabilities based on their preliminary estimated fair values as of the date of the completion of the transaction. The consideration is allocated as follows (in thousands):
Calculation of consideration: |
||||
Cash consideration to AML share- and option-holders |
$ | 31,264 | ||
Change in control obligations |
1,956 | |||
|
|
|||
Total consideration |
$ | 33,220 | ||
Allocation of consideration: |
||||
Book value of AMLs net assets |
$ | 11,397 | ||
Adjustments to historical net book value: |
||||
Inventories |
304 | |||
Identifiable intangible assets |
10,000 | |||
Deferred tax liability |
(4,675 | ) | ||
|
|
|||
Adjustment to goodwill |
$ | 16,194 | ||
|
|
Identifiable intangible assets and their estimated useful lives are as follows (amounts in thousands):
Asset Amount |
Weighted Average Useful Life (Years) |
|||||||
Completed technology |
$ | 4,200 | 6 | |||||
Customer relationships |
4,600 | 5 | ||||||
Backlog |
1,100 | 2 | ||||||
Trade name |
100 | 2 | ||||||
|
|
|||||||
$ | 10,000 | |||||||
|
|
We utilized the straight line method of amortization for completed technology, customer relationships and trade name and the estimated fulfillment period for backlog. This allocation is preliminary and is based on our estimates. The amount ultimately allocated to goodwill and identifiable intangible assets is not expected to change materially from this allocation.
Brijot Imaging Systems, Inc.
During the quarter ended July 3, 2011, we acquired substantially all the assets of Brijot Imaging Systems, Inc. (Brijot) and its passive millimeter wave imaging solutions technology. Total consideration, including cash and assumed liabilities, was approximately $3.1 million. Brijot was integrated into Microsemi Corp. RF Integrated Solutions.
Asic Advantage, Inc.
During the quarter ended October 2, 2011, we completed our acquisition of Asic Advantage, Inc. (Asic Advantage). Asic Advantage is a fabless semiconductor company that designs and manufactures a broad portfolio of high-performance, high-voltage and radiation-hardened mixed-signal integrated circuit solutions for the aerospace, automotive, communications, industrial and medical markets. Asic Advantage was integrated into Microsemi Corp. Analog Mixed Signal Group.
64
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
The total consideration as shown in the table below is allocated to Asic Advantages tangible and intangible assets and liabilities based on their preliminary estimated fair values as of the date of the completion of the transaction. The consideration is allocated as follows (in thousands):
Calculation of consideration: |
||||
Cash consideration to Asic Advantage share- and option-holders |
$ | 30,064 | ||
Allocation of consideration: |
||||
Book value of Asic Advantages net assets |
$ | 6,253 | ||
Adjustments to historical net book value: |
||||
Inventories |
195 | |||
Identifiable intangible assets |
9,170 | |||
Deferred tax liability |
(3,339 | ) | ||
|
|
|||
Adjustment to goodwill |
$ | 17,785 | ||
|
|
Identifiable intangible assets and their estimated useful lives are as follows (amounts in thousands):
Asset Amount |
Weighted Average Useful Life (Years) |
|||||||
Completed technology |
$ | 2,890 | 6 | |||||
Customer relationships |
3,940 | 5 | ||||||
Backlog |
2,230 | 1 | ||||||
Trade name |
110 | 2 | ||||||
|
|
|||||||
$ | 9,170 | |||||||
|
|
We utilized the straight line method of amortization for completed technology, customer relationships and trade name and the estimated fulfillment period for backlog. This allocation is preliminary and is based on our estimates. The amount ultimately allocated to goodwill and identifiable intangible assets is not expected to change materially from this allocation.
Supplemental pro forma data
The following supplemental pro forma data summarizes the results of operations for the 2011 and 2010, as if the three acquisitions noted above and three acquisitions we completed in 2010 (White Electronic Designs Corporation, VT Silicon and Arxan Defense Systems, Inc.) had occurred on September 27, 2009. The supplemental pro forma information presented is for illustrative purposes only and is not necessarily indicative of the financial position or results of operations that would have been realized if the transactions had been completed on the dates indicated, nor is it indicative of future operating results or financial position. Net sales and earnings for the acquisitions on a standalone basis since their acquisition dates are impracticable to determine as on the acquisition date, we began to immediately integrate these acquisitions into existing operations, engineering groups, sales distribution networks and management structure. The pro forma adjustments are based upon currently available information and certain assumptions that we believe are reasonable under the circumstances.
The supplemental pro forma data reports actual operating results, adjusted to include the pro forma effect of, among others, the impact in cost of goods sold from manufacturing profit in acquired inventory, amortization expense of identified intangible assets, timing of the impact of restructuring expenses, timing of credit facility
65
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
issuance costs, foregone interest income, incremental interest expense and the related tax effect of these items. Supplemental pro forma earnings for 2011 were adjusted to exclude $5.9 million in cost of goods sold from manufacturing profit in acquired inventory, $8.6 million in acquisition costs, $14.2 million in credit facility issuance costs, and $5.0 million in non-cash benefits of valuation allowance releases and supplemental pro forma earnings and earnings for 2010 were adjusted to include these items.
Supplemental pro forma data is as follows (amounts in thousands, except per share data):
Fiscal Year Ended | ||||||||
October 2, 2011 |
October 3, 2010 |
|||||||
Net sales |
$ | 875,759 | $ | 806,331 | ||||
Net income (loss) |
$ | 106,317 | $ | (89,868 | ) | |||
Net income (loss) per share |
||||||||
Basic |
$ | 1.27 | $ | (1.11 | ) | |||
Diluted |
$ | 1.24 | $ | (1.11 | ) |
3. | INVENTORIES |
Inventories are summarized as follows (amounts in thousands):
October 2, 2011 |
October 3, 2010 |
|||||||
Raw materials |
$ | 40,454 | $ | 38,135 | ||||
Work in progress |
65,190 | 55,375 | ||||||
Finished goods |
35,183 | 32,641 | ||||||
|
|
|
|
|||||
$ | 140,827 | $ | 126,151 | |||||
|
|
|
|
4. | PROPERTY AND EQUIPMENT |
Property and equipment consisted of the following components (amounts in thousands):
Asset Life | October 2, 2011 |
October 3, 2010 |
||||||||||
Buildings |
20-40 years | $ | 38,571 | $ | 37,327 | |||||||
Machinery and equipment |
3-10 years | 163,566 | 147,041 | |||||||||
Furniture and fixtures |
5-10 years | 5,902 | 5,904 | |||||||||
Leasehold improvements |
|
Shorter of asset life or life of lease |
|
21,221 | 21,470 | |||||||
|
|
|
|
|||||||||
229,260 | 211,742 | |||||||||||
Accumulated depreciation |
(148,090 | ) | (142,897 | ) | ||||||||
Land |
1,725 | 1,484 | ||||||||||
Construction in progress |
7,027 | 5,584 | ||||||||||
|
|
|
|
|||||||||
$ | 89,922 | $ | 75,913 | |||||||||
|
|
|
|
Depreciation expense was $29.1 million, $19.3 million and $17.9 million in 2011, 2010 and 2009, respectively.
66
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
5. | GOODWILL AND INTANGIBLE ASSETS, NET |
Goodwill and intangible assets, net consisted of the following components (amounts in thousands):
October 2, 2011 | October 3, 2010 | Life (in years) |
||||||||||||||||||
Gross Carrying Value |
Accumulated Amortization |
Gross Carrying Value |
Accumulated Amortization |
|||||||||||||||||
Amortizable intangible assets |
||||||||||||||||||||
Completed technology |
$ | 253,838 | $ | (76,010 | ) | $ | 99,747 | $ | (46,637 | ) | 2 to 15 | |||||||||
Customer relationships |
116,760 | (21,464 | ) | 40,220 | (6,436 | ) | 4 to 15 | |||||||||||||
Backlog |
26,900 | (22,242 | ) | 9,880 | (6,029 | ) | 1 to 2 | |||||||||||||
Other |
7,394 | (3,485 | ) | 3,183 | (1,585 | ) | 5 | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
$ | 404,892 | $ | (123,201 | ) | $ | 153,030 | $ | (60,687 | ) | |||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Non-amortizing intangible assets |
||||||||||||||||||||
Goodwill |
$ | 491,079 | $ | 270,832 | ||||||||||||||||
|
|
|
|
A reconciliation of our goodwill for the years ended October 2, 2011 and October 3, 2010 is as follows (in thousands):
October 2, 2011 | October 3, 2010 | |||||||
Beginning balance |
$ | 270,832 | $ | 222,731 | ||||
Additions from acquisitions |
220,291 | 48,101 | ||||||
Post-acquisition adjustments |
(44 | ) | | |||||
|
|
|
|
|||||
Ending balance |
$ | 491,079 | $ | 270,832 | ||||
|
|
|
|
Amortization expense for intangible assets in 2011, 2010 and 2009 was $62.4 million, $20.2 million and $15.2 million, respectively. Estimated amortization in each of the five succeeding years and thereafter is as follows (amounts in thousands):
Fiscal Year | ||||||||||||||||||||||||
2012 | 2013 | 2014 | 2015 | 2016 | Thereafter | |||||||||||||||||||
Amortization expense |
$ | 53,087 | $ | 48,511 | $ | 44,444 | $ | 38,569 | $ | 35,634 | $ | 61,444 |
67
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
6. | ACCRUED LIABILITIES |
Accrued liabilities consisted of the following components (amounts in thousands):
October 2, 2011 |
October 3, 2010 |
|||||||
Payroll, bonus, accrued time off and other employee benefits |
$ | 41,264 | $ | 18,021 | ||||
Fair value of foreign currency forward |
11,675 | | ||||||
Restructuring and severance |
9,562 | 5,832 | ||||||
Licenses |
9,636 | 27 | ||||||
Outside services |
7,815 | 6,173 | ||||||
Interest |
4,037 | 8 | ||||||
Warranties |
2,945 | 1,094 | ||||||
Commissions |
2,692 | 2,106 | ||||||
Other |
11,452 | 3,791 | ||||||
|
|
|
|
|||||
$ | 101,078 | $ | 37,052 | |||||
|
|
|
|
7. | INCOME TAXES |
Pretax income (loss) was generated from the following sources (amounts in thousands):
For each of the three fiscal years in the period ended on or about October 2, 2011 |
||||||||||||
2011 | 2010 | 2009 | ||||||||||
Domestic |
$ | (40,359 | ) | $ | (19,878 | ) | $ | (61,840 | ) | |||
Foreign |
62,408 | 74,909 | 52,966 | |||||||||
|
|
|
|
|
|
|||||||
Total |
$ | 22,049 | $ | 55,031 | $ | (8,874 | ) | |||||
|
|
|
|
|
|
The provision (benefit) for income taxes consisted of the following components (amounts in thousands):
For each of the three fiscal years in the period ended on or about October 2, 2011 |
||||||||||||
2011 | 2010 | 2009 | ||||||||||
Current: |
||||||||||||
Federal |
$ | 314 | $ | (17,830 | ) | $ | (10,791 | ) | ||||
State |
10 | 533 | 1,227 | |||||||||
Foreign |
8,324 | 7,345 | 6,733 | |||||||||
Deferred |
||||||||||||
Federal |
(24,679 | ) | 5,352 | 13,708 | ||||||||
State |
(1,609 | ) | 373 | 7,293 | ||||||||
Foreign |
(14,758 | ) | 220 | (221 | ) | |||||||
|
|
|
|
|
|
|||||||
$ | (32,398 | ) | $ | (4,007 | ) | $ | 17,949 | |||||
|
|
|
|
|
|
We recorded a benefit for income taxes of $32.4 million on pretax income of $22.0 million in 2011 compared to a benefit for income taxes of $4.0 million on pre-tax income of $55.0 million in 2010. The benefit
68
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
for income taxes of $32.4 million included the release of $16.4 million of the remaining valuation allowance related to our Israel operations deferred tax assets, release of $5.2 million of our U.S. valuation allowance and recognition of $20.8 million in current year tax benefits from net operating losses and tax credits as a result of the excess deferred tax liabilities resulting from our acquisitions of Actel Corporation, AML Corporation, and ASIC Advantage, Inc. These benefits were partially offset by foreign tax expense of $10.0 million. We had cumulative operating losses for our U.S. operations. During the fourth quarter of 2009, we determined that it was more likely than not that the benefits of certain U.S. deferred tax assets would not be realized. Key positive and negative evidence we considered in making this determination included recent history of cumulative operating losses for our U.S. operations; future estimates of operating results for our U.S. operations; and our ability to carry back our U.S. operating losses, tax credits and reversing temporary differences due to lower availability of previously paid taxes. Based on this assessment, we determined that a valuation allowance was required for the deferred tax assets related to our U.S. operations that could not be carried back to recover previously paid taxes. Accordingly, we recorded a $28.4 million valuation allowance on a substantial portion of our U.S. deferred tax assets, which was included in the total tax provision of $17.9 million for fiscal year 2009.
During fiscal year 2011 we released the remaining valuation allowance related to our Israel operation, based on evaluation of key positive negative evidence including the history of substantial losses in past years but cumulative income for the past three year period, and the indefinite carryforward period for the Israeli net operating loss carryforwards which are the principal component of our deferred tax assets in Israel.
We have federal and state net operating losses (NOLs) of approximately $64.9 million and $87.3 million that begin expiring in 2021 and 2014 respectively. Of the total NOL carryforward, $8.8 million related to the excess tax benefit from employee stock compensation. Equity will be increased by $8.8 million if and when such excess tax benefits are ultimately realized. Foreign NOLs of approximately $55.5 million carry forward indefinitely. We have federal and state research and experimentation credits of approximately $15.8 million and $34.7 million, respectively. We have federal foreign tax credits of approximately $2.6 million. We have federal and state enterprise zone credits, state investment tax credits, and alternative minimum tax credits of approximately $0.9 million, $0.8 million, and $0.3 million, respectively, that have an indefinite carry forward.
The utilization of the NOLs and credits acquired with the Advance Power Technology, Inc. which we acquired in fiscal year 2006, and renamed Microsemi Corp. Power Products Group (PPG), the NOLs and credits acquired with White Electronic which we acquired in fiscal year 2010, and the NOLs and credits acquired with Actel Corporation, AML Corporation, and ASIC Advantage, Inc. which we acquired in fiscal year 2011 may be subject to limitations due to change in control.
No provision has been made for future U.S. income taxes on certain undistributed earnings of foreign operations since they have been indefinitely reinvested in these operations. Determination of the amount of unrecognized deferred tax liability for temporary differences related to these undistributed earnings is not practicable. At the end of fiscal years 2011 and 2010, these undistributed earnings aggregated approximately $253.8 million and $191.4 million, respectively.
69
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
The following is a reconciliation of income tax computed at the federal statutory rate to our actual tax expense (amounts in thousands):
For each of the three fiscal years in the period ended October 2, 2011 |
||||||||||||
2011 | 2010 | 2009 | ||||||||||
Tax computed at federal statutory rate |
$ | 7,717 | $ | 19,261 | $ | (3,107 | ) | |||||
State taxes, net of federal impact |
(7,023 | ) | 2,147 | (2,495 | ) | |||||||
Foreign income taxed at different rates |
(9,830 | ) | (14,621 | ) | (22,969 | ) | ||||||
Tax credits |
(4,234 | ) | (3,025 | ) | (1,899 | ) | ||||||
Stock award compensation |
347 | 3,288 | 3,225 | |||||||||
Unrecognized tax benefits |
1,541 | 2,325 | 3,298 | |||||||||
Imputed interest |
47 | 61 | 335 | |||||||||
Executive compensation |
444 | 1,312 | 1,558 | |||||||||
Non-deductible permanent items |
2,803 | 727 | | |||||||||
Pre-acquisition loss carryforwards |
(2,298 | ) | | | ||||||||
Other differences, net |
(308 | ) | 134 | 614 | ||||||||
Valuation allowance |
(21,604 | ) | (15,616 | ) | 39,389 | |||||||
|
|
|
|
|
|
|||||||
$ | (32,398 | ) | $ | (4,007 | ) | $ | 17,949 | |||||
|
|
|
|
|
|
The tax affected deferred tax assets (liabilities) are comprised of the following components (amounts in thousands):
October 2, 2011 |
October 3, 2010 |
|||||||
Accounts receivable, net |
$ | 1,159 | $ | 1,161 | ||||
Inventories |
22,041 | 10,313 | ||||||
Accrued employee benefit expenses |
6,209 | 2,603 | ||||||
Net operating losses |
32,095 | 16,840 | ||||||
Tax credits |
32,334 | 12,319 | ||||||
Accrued other expenses |
9,296 | 4,343 | ||||||
Deferred equity compensation |
12,075 | 8,683 | ||||||
Property and equipment, net |
(465 | ) | 1,403 | |||||
Other assets |
7,822 | 3,826 | ||||||
|
|
|
|
|||||
Total deferred tax assets |
122,566 | 61,491 | ||||||
|
|
|
|
|||||
Intangible assets |
(96,624 | ) | (30,781 | ) | ||||
|
|
|
|
|||||
Total deferred tax liabilities |
(96,624 | ) | (30,781 | ) | ||||
|
|
|
|
|||||
Less valuation allowance |
(18,086 | ) | (37,604 | ) | ||||
|
|
|
|
|||||
$ | 7,856 | $ | (6,893 | ) | ||||
|
|
|
|
70
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (amounts in thousands):
October 2, 2011 |
October 3, 2010 |
September 27, 2009 |
||||||||||
Beginning gross unrecognized tax benefits |
$ | 21,719 | $ | 16,431 | $ | 12,819 | ||||||
Additions based on tax positions related to the current year |
2,665 | 4,757 | 2,411 | |||||||||
Additions based on current year acquisitions |
8,164 | 349 | | |||||||||
Additions based on tax positions of prior years |
382 | 2,408 | 2,236 | |||||||||
Reductions for lapses and settlements |
(560 | ) | (2,226 | ) | (1,035 | ) | ||||||
|
|
|
|
|
|
|||||||
Ending gross unrecognized tax benefit |
$ | 32,370 | $ | 21,719 | $ | 16,431 | ||||||
|
|
|
|
|
|
We recognize interest and penalties accrued related to unrecognized tax benefits in tax expense. During the years ended October 2, 2011, October 3, 2010, and September 27, 2009, we recognized approximately $0.7 million, $0.2 million, and $0.8 million, respectively, in interest and penalties. The cumulative interest and penalties at October 2, 2011, October 3, 2010, and September 27, 2009 were $4.2 million, $3.5 million, and $3.3 million, respectively.
Unrecognized tax benefits of $34.0 million (including interest) at October 2, 2011 would impact the effective tax rate if recognized after the valuation allowance has been released. We anticipate a decrease in gross unrecognized tax benefits of approximately $11.5 million within the next twelve months based on federal, state, and foreign expirations in various jurisdictions.
We file U.S. state, and foreign income tax returns in jurisdictions with varying statutes of limitations. Fiscal years 2007 to 2011 generally remain subject examination by federal and most state tax authorities. In significant foreign jurisdictions, the 2008 to 2011 tax years generally remain subject to examination by tax authorities. We establish liabilities for possible assessments by tax authorities resulting from known tax exposures including, but not limited to, international tax issues and certain tax credits. We are currently undergoing an Internal Revenue Service examination as well as certain state examinations. There have been no significant proposed adjustments to date. We do not believe the results of any audits would have a material impact on our financial position, results of operations or cash flows. We will continue to monitor the status of these audits.
71
8. | LONG-TERM LIABILITIES |
Long-term liabilities consisted of (amounts in thousands):
October 2, 2011 |
October 3, 2010 |
|||||||
Credit facility |
$ | 361,022 | $ | | ||||
Deferred tax liabilities |
35,568 | 19,513 | ||||||
Other long-term liabilities: |
||||||||
Unrecognized tax benefits |
14,466 | 14,110 | ||||||
Accrued retirement |
4,109 | 3,813 | ||||||
Capital leases |
3,371 | 3,244 | ||||||
Interest rate swaps |
2,808 | | ||||||
Environmental |
314 | 314 | ||||||
Other |
8,352 | 1,570 | ||||||
|
|
|
|
|||||
Total long-term liabilities |
430,010 | 42,564 | ||||||
Current portion |
(4,050 | ) | (444 | ) | ||||
|
|
|
|
|||||
Long-term portion |
$ | 425,960 | $ | 42,120 |
We lease a building in Santa Ana, California, under a long-term capital lease obligation. We also lease certain equipment under a capital lease with terms ranging from one to three years. Building and equipment under capital lease obligations are reflected in property and equipment, net, in the accompanying consolidated balance sheets. Other long-term liabilities include environmental reserves and statutory and supplemental retirement benefits.
The contractual obligations under our capital lease obligations and credit facility at October 2, 2011 were (amounts in thousands):
Fiscal Year | ||||||||||||||||||||||||
2012 | 2013 | 2014 | 2015 | 2016 | Thereafter | |||||||||||||||||||
Capital leases |
$ | 351 | $ | 439 | $ | 293 | $ | 293 | $ | 293 | $ | 5,266 | ||||||||||||
Credit facility |
3,750 | 3,750 | 3,750 | 3,750 | 3,750 | 353,438 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total |
$ | 4,101 | $ | 4,189 | $ | 4,043 | $ | 4,043 | $ | 4,043 | $ | 358,704 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Subsequent to October 2, 2011, we amended or credit facility in connection with the Zarlink acquisition and increased the term loan facility to $800.0 million. See Note 15 for further discussion.
9. | STOCK-BASED COMPENSATION AND EMPLOYEE BENEFIT PLANS |
Stock Based Compensation
In February 2008, our stockholders approved the Microsemi Corporation 2008 Performance Incentive Plan (the 2008 Plan). The 2008 Plan replaced the 1987 Stock Plan, as amended, previously approved by our stockholders. The 2008 Plan includes a share limit of approximately 4.1 million shares of the Companys common stock for delivery under awards that have been and may be granted under the 2008 Plan. Awards authorized by the 2008 Plan include options, stock appreciation rights, restricted stock, stock bonuses, stock units, performance share awards, and other cash or share-based awards (each an Award). The shares of common stock delivered under the 2008 Plan may be newly-issued shares or shares held by the Company as treasury stock.
72
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
The share limit under the 2008 Plan increases on the first day of each October for the first five consecutive years by an amount equal to the lowest of (i) three percent of the total number of shares of common stock issued and outstanding on the last day of the immediately preceding fiscal year, (ii) 7.5 million shares of common stock or (iii) such number of shares of common stock as may be established by the Board of Directors. Shares issued in respect of any Full-Value Award granted under the 2008 Plan shall be counted against the share limit as 2.25 shares for every one share actually issued in connection with such award. Full-Value Award means any award under the 2008 Plan that is not a stock option grant or a stock appreciation right grant. The maximum term of a stock option grant or a stock appreciation right grant is six years.
Awards granted or assumed, weighted-average exercise price, weighted-average fair value and weighted-average assumptions used in the calculation of compensation expense are as follows:
# of Awards |
Per Award | Risk Free Rate |
Expected Dividend Yield |
Expected Life (Years) |
Expected Volatility |
|||||||||||||||||||||||
Fiscal Year Ended |
Exercise Price |
Fair Value |
||||||||||||||||||||||||||
October 2, 2011 |
||||||||||||||||||||||||||||
Stock options and stock appreciation rights |
3,132,241 | $ | 13.60 | $ | 7.42 | 0.2 | % | 0.0 | % | 1.1 | 41.6 | % | ||||||||||||||||
Restricted stock awards and units |
1,876,113 | $ | 20.75 | |||||||||||||||||||||||||
October 3, 2010 |
||||||||||||||||||||||||||||
Stock options |
27,601 | $ | 13.87 | $ | 5.25 | 0.2 | % | 0.0 | % | 0.5 | 34.3 | % | ||||||||||||||||
Restricted stock awards |
1,399,589 | $ | 14.99 | |||||||||||||||||||||||||
September 27, 2009 |
||||||||||||||||||||||||||||
Stock options |
8,800 | $ | 21.32 | $ | 6.35 | 1.9 | % | 0.0 | % | 3.0 | 41.3 | % | ||||||||||||||||
Restricted stock awards |
1,370,667 | $ | 20.70 |
In connection with the acquisitions of Actel and Asic Advantage in 2011 and White Electronic Designs Corporation in 2010, we assumed stock options, stock appreciation rights and restricted stock units and converted them to Microsemi awards in accordance with the respective merger agreement. For 2011, 2010 and 2009, total compensation expense for stock awards amounted to $28.5 million, $25.3 million and $26.9 million, respectively.
Compensation expense for stock options and stock appreciation rights was calculated based on the grant or assumption date using the Black-Scholes pricing model. All stock appreciation rights we have granted or assumed are stock-settled. Stock options and stock appreciation rights are granted at exercise prices equal to the closing price of our common stock on the date of grant. Assumed stock options and stock appreciation rights are granted at exercise prices determined in accordance with the acquisition agreement. Expected life was estimated based on historical exercise data that was stratified between members of the Board of Directors, executive employees and all other recipients. Expected volatility was estimated based on historical volatility using equally weighted daily price observations over a period approximately equal to the expected life of each option. The risk free interest rate is based on the implied yield currently available on U.S. Treasury securities with an equivalent remaining term. No dividends are expected to be paid. Restricted stock awards and units are granted to employees with compensation expense determined based on the closing price of our common stock on the date of grant. Stock awards are subject to forfeiture if a participant does not meet length of service requirements.
73
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
Activity and price information related to stock options and stock appreciation rights are as follows:
Stock Options |
Weighted- Average Exercise Price |
|||||||
Outstanding September 28, 2008 |
11,772,050 | $ | 20.39 | |||||
Granted |
8,800 | 21.32 | ||||||
Exercised |
(276,487 | ) | 10.34 | |||||
Forfeited |
(841,377 | ) | 22.60 | |||||
|
|
|
|
|||||
Outstanding September 27, 2009 |
10,662,986 | $ | 20.48 | |||||
Assumed from acquisition |
27,601 | 13.87 | ||||||
Exercised |
(464,458 | ) | 10.35 | |||||
Forfeited |
(999,971 | ) | 23.43 | |||||
|
|
|
|
|||||
Outstanding October 3, 2010 |
9,226,158 | $ | 20.65 | |||||
Granted |
12,235 | 23.69 | ||||||
Assumed from acquisition |
3,120,006 | 13.56 | ||||||
Exercised |
(2,154,508 | ) | 13.90 | |||||
Forfeited |
(729,806 | ) | 20.88 | |||||
|
|
|
|
|||||
Outstanding October 2, 2011 |
9,474,085 | $ | 19.84 |
Stock options and stock appreciation exercisable under the Plan were 8.8 million, 8.9 million and 8.4 million at October 2, 2011, October 3, 2010 and September 27, 2009, respectively, at weighted-average exercise prices of $20.39, $20.58 and $19.66, respectively. The total intrinsic value of stock options and stock appreciation rights exercised during the 2011, 2010 and 2009 was $18.6 million, $2.7 million and $1.0 million, respectively.
Intrinsic value and weighted-average remaining life related to outstanding and unvested stock options and stock appreciation rights are as follows (intrinsic value in thousands):
Intrinsic Value |
Weighted- Average Remaining Life |
|||||||
September 27, 2009 |
||||||||
Outstanding |
$ | 11,356 | 4.3 | |||||
Unvested |
$ | 180 | 3.9 | |||||
October 3, 2010 |
||||||||
Outstanding |
$ | 13,156 | 3.4 | |||||
Unvested |
$ | | 3.4 | |||||
October 2, 2011 |
||||||||
Outstanding |
$ | 12,684 | 3.1 | |||||
Unvested |
$ | 2,414 | 7.8 |
During 2009, we granted 49,000 shares to non-employee directors with restrictions that lapsed immediately at grant. Grants to employees included 100,000 shares with restrictions that lapse in the amounts of 25,000 after one year and 75,000 after two years with remaining grants issued with restrictions that lapse annually over three years. During 2010, we granted 49,000 shares to non-employee directors with restrictions that lapsed immediately at grant. Grants to employees included 100,000 shares with restrictions that lapse in the amounts of 40,000 after one year and 60,000 after two years with remaining grants issued with restrictions that lapse annually over three years. During 2011, we granted 48,766 shares to non-employee directors with restrictions that lapsed immediately at grant and assumed 252,399 restricted share units whose vesting terms were assumed and not modified. Remaining grants were to employees with restrictions that lapse annually over three years. During the restriction period, the shares have the same voting rights as common stock but are non-transferable.
74
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
Activity and price information related to restricted stock awards are as follows:
Restricted Stock Awards |
Weighted- Average Grant Price |
|||||||
Outstanding and Unvested September 28, 2008 |
593,529 | $ | 26.75 | |||||
Granted |
1,370,667 | 20.70 | ||||||
Vested |
(313,136 | ) | 24.58 | |||||
Canceled |
(31,364 | ) | 18.49 | |||||
|
|
|
|
|||||
Outstanding and Unvested September 27, 2009 |
1,619,696 | $ | 22.21 | |||||
Granted |
1,397,550 | 14.99 | ||||||
Vested |
(1,059,469 | ) | 22.09 | |||||
Assumed from acquisition |
2,039 | 16.95 | ||||||
Canceled |
(43,539 | ) | 16.37 | |||||
|
|
|
|
|||||
Outstanding and Unvested October 3, 2010 |
1,916,277 | $ | 17.14 | |||||
Granted |
1,623,714 | 20.88 | ||||||
Assumed from acquisition |
252,399 | 19.90 | ||||||
Vested |
(1,265,241 | ) | 17.98 | |||||
Canceled |
(176,763 | ) | 18.82 | |||||
|
|
|
|
|||||
Outstanding and Unvested October 2, 2011 |
2,350,386 | $ | 19.44 |
At October 2, 2011, unamortized compensation expense related to unvested stock awards, net of estimated forfeitures, was $34.3 million. The weighted average period over which compensation expense related to these grants will be recognized is 1.4 years.
Remaining shares available for grant at October 2, 2011, October 3, 2010 and September 27, 2009 under the Plan were 6.4 million, 6.9 million and 4.0 million, respectively.
Annual Incentive Bonus and Profit Sharing Plan
Our annual incentive bonus and profit sharing plan covers employees who meet certain minimum employment requirements and provides terms and conditions for current bonuses based upon our earnings. The Compensation Committee of the Board of Directors determines annual contributions to the plan. Total charges to income were $16.0 million, $7.3 million and $2.6 million in 2011, 2010 and 2009, respectively.
401(k) Savings Plan
We sponsor a 401(k) Savings Plan whereby participating employees may elect to contribute up to 50% of their eligible wages up to the statutory contribution limit. During the third quarter of 2009, we suspended the employer match to this plan. Employees 50 years of age and older may contribute a further 75% of their eligible wages up to the statutory contribution limit. We do not match this supplemental contribution. We contributed $2.2 million to this plan during 2009 and made no contributions in subsequent years.
10. | COMMITMENTS AND CONTINGENCIES |
Operating Leases
We occupy premises and lease equipments under operating lease agreements expiring through 2029. The aggregate undiscounted future minimum rental payments under these leases are as follows (amounts in thousands):
Payments due by period | ||||||||||||
Total |
2012 |
2013 | 2014 | 2015 | 2016 | Thereafter | ||||||
$64,538 |
$11,340 | $11,253 | $9,477 | $7,677 | $5,523 | $19,268 |
75
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
Lease expense charged to income was $13.6 million, $7.8 million and $7.7 million in 2011, 2010 and 2009, respectively.
Purchase Obligations
We have entered into agreements to buy material with certain vendors. The minimum annual payments are as follows (amounts in thousands):
Payments due by period | ||||||||||||
Total |
2011 |
2012 | 2013 | 2014 | 2015 | Thereafter | ||||||
$32,266 |
$27,397 | $4,869 | $ | $ | $ | $ |
Contingencies
In Broomfield, Colorado, the owner of a property located adjacent to a manufacturing facility owned by one of our subsidiaries, Microsemi Corp. Colorado had notified the subsidiary and other parties of a claim that contaminants migrated to his property, thereby diminishing its value. In August 1995, the subsidiary, together with Coors Porcelain Company, FMC Corporation and Siemens Microelectronics, Inc. (former owners of the manufacturing facility), agreed to settle the claim and to indemnify the owner of the adjacent property for remediation costs. Although tricholorethylene and other contaminants previously used by former owners at the facility are present in soil and groundwater on the subsidiarys property, we vigorously contest any assertion that the subsidiary caused the contamination. In November 1998, we signed an agreement with the three former owners of this facility whereby they have 1) reimbursed us for $0.5 million of past costs, 2) assumed responsibility for 90% of all future clean-up costs, and 3) promised to indemnify and protect us against any and all third-party claims relating to the contamination of the facility. An Integrated Corrective Action Plan was submitted to the State of Colorado. Sampling and management plans were prepared for the Colorado Department of Public Health & Environment. State and local agencies in Colorado are reviewing current data and considering study and cleanup options. The most recent forecast estimated that the total project cost, up to the year 2020, would be approximately $5.3 million; accordingly, we recorded a one-time charge of $0.5 million for this project in 2003. There has not been any significant development since September 28, 2003.
We are generally self-insured for losses and liabilities related to workers compensation and employers liability insurance. Accrued workers compensation liability was $1.5 million and $1.2 million at October 2, 2011 and October 3, 2010, respectively. Our self-insurance accruals are based on estimates and, while we believe that the amounts accrued are adequate, the ultimate claims may be in excess of the amounts provided.
On December 8, 2010, Intellectual Ventures I LLC and Intellectual Ventures II LLC filed a complaint in the United States District Court for the District of Delaware (the Complaint) against Altera Corporation, Microsemi, and Lattice Semiconductor Corporation. On February 15, 2011, the plaintiffs filed an amended complaint adding Xilinx, Inc. as a defendant. The complaint alleges, inter alia, that programmable logic devices manufactured and sold by our subsidiary Microsemi SoC infringe United States Patent Numbers 5,687,325, 6,260,087 and 6,272,646 assigned to Intellectual Ventures II LLC, and seeks damages and other relief at law or in equity as the court deems appropriate. We have responded to the complaint. On April 26, 2011, the defendants filed a motion to transfer the case to the United States District Court for the Northern District of California. On August 8, 2011, the defendants filed a motion to stay the litigation pending conclusion of reexamination of the patents-in-suit by the United States Patent & Trademark Office. The Court has not yet decided the motion to transfer or motion to stay. Discovery has not yet commenced and no trial date has been set. While material losses are reasonably possible, given the early stages of this matter, we cannot reasonably estimate the amount of any loss in the event of an unfavorable outcome.
76
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
We are also involved in other pending litigation matters arising out of the normal conduct of our business, including litigation relating to acquisitions, employment matters, commercial transactions, contracts, environmental matters and matters related to compliance with governmental regulations. The ultimate aggregate amount of monetary liability or financial impact with respect to these matters is subject to many uncertainties and is therefore not predictable with assurance. In the opinion of management, the final outcome of these matters, if they are adverse, will not have a material adverse effect on our financial position, results of operations or cash flows. However, there can be no assurance with respect to such result, and monetary liability or financial impact on us from these litigation matters could differ materially from those projected.
11. | RESTRUCTURING CHARGES AND SEVERANCE CHARGES |
In 2009, we approved consolidation plans that resulted in the closure of our manufacturing facility in Scottsdale, Arizona (Scottsdale), which ceased production during the quarter ended April 3, 2011. The Scottsdale facility occupied a 135,000 square foot leased facility. Employee severance is expected to be paid through 2013. Facility termination costs relate primarily to remaining obligations under facility and equipment leases and are expected to be paid through 2016. The following table reflects the restructuring activities for the Scottsdale facility and the accrued liabilities in the consolidated balance sheets at the dates below (amounts in thousands):
Employee Severance |
Facility Termination Costs |
Total | ||||||||||
Balance at October 3, 2010 |
$ | 4,124 | $ | | $ | 4,124 | ||||||
Provisions |
(1,903 | ) | 8,200 | 6,297 | ||||||||
Cash expenditures |
(1,866 | ) | (1,718 | ) | (3,584 | ) | ||||||
|
|
|
|
|
|
|||||||
Balance at October 2, 2011 |
$ | 355 | $ | 6,482 | $ | 6,837 | ||||||
|
|
|
|
|
|
At October 3, 2010, we had recorded severance accruals of $1.6 million from reductions in force at our various facilities other than Scottsdale. We recorded additional provisions, primarily related to activities at Microsemi SoC, for severance and retention payments totaling $15.8 million in 2011. Severance covered approximately 200 individuals in manufacturing, engineering and sales. Substantially all accrued amounts are expected to be paid within twelve months. The following table reflects the restructuring activities and the accrued liabilities in the consolidated balance sheets at the dates below (amounts in thousands):
Employee Severance |
||||
Balance at October 3, 2010 |
$ | 1,642 | ||
Provisions |
15,784 | |||
Cash expenditures |
(14,586 | ) | ||
Other non-cash settlement |
(116 | ) | ||
|
|
|||
Balance at October 2, 2011 |
$ | 2,724 | ||
|
|
12. | SEGMENT INFORMATION |
We manage our business on the basis of one reportable segment, as a manufacturer of semiconductors in different geographic areas, including the United States, Europe and Asia. We derive revenue from sales of our high-performance analog/mixed-signal integrated circuits and power and high-reliability individual component semiconductors. These products include individual components as well as integrated circuit solutions that
77
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
enhance customer designs by improving performance, reliability and battery optimization, reducing size or protecting circuits. The principal markets that we serve include Defense & Security, Aerospace, Enterprise & Communications and Industrial & Alternative Energy. We evaluate sales by end-market based on our understanding of end market uses of our products.
Net sales by the originating geographic area, end market and long lived assets by geographic area are as follows (amounts in thousands):
2011 | 2010 | 2009 | ||||||||||
Net Sales: |
||||||||||||
United States |
$ | 508,145 | $ | 243,822 | $ | 215,611 | ||||||
Europe |
132,145 | 125,209 | 135,844 | |||||||||
Asia |
195,564 | 149,237 | 101,517 | |||||||||
|
|
|
|
|
|
|||||||
Total |
$ | 835,854 | $ | 518,268 | $ | 452,972 | ||||||
|
|
|
|
|
|
|||||||
Defense & Security |
$ | 299,503 | $ | 208,098 | $ | 170,653 | ||||||
Aerospace |
212,127 | 107,587 | 112,847 | |||||||||
Enterprise & Communications |
148,792 | 116,369 | 70,102 | |||||||||
Industrial & Alternative Energy |
175,432 | 86,214 | 99,370 | |||||||||
|
|
|
|
|
|
|||||||
Total |
$ | 835,854 | $ | 518,268 | $ | 452,972 | ||||||
|
|
|
|
|
|
|||||||
Long lived assets: |
||||||||||||
United States |
$ | 69,647 | $ | 55,737 | $ | 51,874 | ||||||
Europe |
12,632 | 14,212 | 13,619 | |||||||||
Asia |
7,643 | 5,964 | 3,205 | |||||||||
|
|
|
|
|
|
|||||||
Total |
$ | 89,922 | $ | 75,913 | $ | 68,698 | ||||||
|
|
|
|
|
|
13. | CREDIT AGREEMENT AND DERIVATIVE INSTRUMENTS |
Credit Agreement
On November 2, 2010, we entered into a Credit Agreement with Morgan Stanley Senior Funding, Inc. (MSSF), Morgan Stanley & Co. Incorporated, East West Bank, Raymond James Bank, FSB and the lenders referred to therein (the Credit Agreement). Pursuant to the Credit Agreement, MSSF has provided $425.0 million senior secured first lien credit facilities (the Facilities), consisting of a term loan facility in an aggregate principal amount of $375.0 million and a revolving credit facility (the Revolving Facility) in an aggregate principal amount of $50.0 million. The Facilities financed the acquisition of Actel and fees and expenses related thereto. The Revolving Facility is also available for working capital requirements and other general corporate purposes. On March 2, 2011, we entered into Amendment No. 1 to the Credit Agreement that provided for new pricing terms, modified reporting requirements for permitted acquisitions and modified prepayment provisions related to the term loan facility. We had, as of October 2, 2011, $372.2 million borrowed under the term loan facility and no direct borrowings and $0.4 million in letters of credit outstanding under the Revolving Facility. We entered into Amendment No. 2 to the Credit Agreement on October 13, 2011 in connection with acquisition of Zarlink. See Note 15 for a description of the terms of the amended facility.
Fair Value Option
We elected the fair value option in accounting for the term loan balance currently outstanding under our Credit Agreement and changes in fair value of the loan balances are reflected as adjustments to the income
78
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
statement. We classified term loan balances currently outstanding under our Credit Agreement as Level 2 where valuations are based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. Our valuation was based on market quotes provided to us by MSSF. We determined the fair value of the currently outstanding term loan balance to be $361.0 million compared to a par value of $372.2 million. For 2011, we recorded income of $11.2 million in other income (expense), net, for the change in fair value of principal outstanding on our term loan. In addition, upon election of the fair value option, we were required to immediately expense up front debt issuance and refinancing costs and for 2011, we recorded expense of $14.2 million in other income (expense), net, for these costs.
Interest Rate Swap Agreements
In connection with the Credit Agreement, we entered into interest rate swap agreements for the purpose of minimizing the variability of cash flows in the interest rate payments of our variable rate borrowings. The cash flows received under the interest rate swap agreements are expected to offset the change in cash flows associated with LIBOR rate borrowings between the effective and maturity dates of the swaps. Our three swap agreements have notional amounts, fixed rates and terms as follows: $24.0 million at 1.49% for two years, $121.0 million at 1.83% for three years and $24.0 million at 2.21% for four years. We classified interest rate swap balances as Level 2 fair value measurements. We determined the fair value of our interest rate swap agreements based on mid-market valuations reported to us by RJ Capital Services, Inc., the counterparty to the swap agreements. We reflected the change in value of the swaps through other income or expense and at October 2, 2011, recorded a long-term liability of $2.8 million and a corresponding expense in other income (expense), net.
Foreign Currency Forward
In connection with the acquisition of Zarlink Semiconductor, Inc., as further discussed in Note 15 Subsequent Events, we entered into foreign currency forward agreement in the fourth quarter of 2011 to minimize our foreign currency risk associated with the transaction that we funded in Canadian Dollars (CAD). We agreed to purchase CAD 623.0 million for $608.2 million for settlement in October 2011. We classified interest rate forward balance as Level 1 fair value measurements where there are quoted prices in active markets for identical instruments. We determined the fair value of our foreign currency forward agreement based on corresponding quote from Morgan Stanley Capital Services LLC, the counterparty to the forward transaction. We reflected the change in value of the swap through other income or expense and at October 2, 2011, recorded a current liability of $11.7 million and a corresponding expense in other income (expense), net.
14. | UNAUDITED SELECTED QUARTERLY FINANCIAL DATA |
Selected quarterly financial data are as follows (amounts in thousands, except earnings per share):
Quarters ended in fiscal year 2011 | ||||||||||||||||
October 2, 2011 |
July 3, 2011 |
April 3, 2011 |
January 2, 2011 |
|||||||||||||
Net sales |
$ | 227,291 | $ | 216,722 | $ | 207,490 | $ | 184,351 | ||||||||
Gross profit |
$ | 129,875 | $ | 123,631 | $ | 92,636 | $ | 95,029 | ||||||||
Net income |
$ | 42,085 | $ | 30,602 | $ | (16,944 | ) | $ | (1,296 | ) | ||||||
Basic earnings per share |
$ | 0.50 | $ | 0.36 | $ | (0.20 | ) | $ | (0.02 | ) | ||||||
Diluted earnings per share |
$ | 0.49 | $ | 0.35 | $ | (0.20 | ) | $ | (0.02 | ) |
79
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
Quarters ended in fiscal year 2010 | ||||||||||||||||
October 3, 2010 |
June 27, 2010 |
March 28, 2010 |
December 27, 2009 |
|||||||||||||
Net sales |
$ | 151,201 | $ | 136,017 | $ | 118,218 | $ | 112,832 | ||||||||
Gross profit |
$ | 74,170 | $ | 65,772 | $ | 56,001 | $ | 52,268 | ||||||||
Net income |
$ | 6,560 | $ | 33,032 | $ | 11,486 | $ | 7,960 | ||||||||
Basic earnings per share |
$ | 0.08 | $ | 0.40 | $ | 0.14 | $ | 0.10 | ||||||||
Diluted earnings per share |
$ | 0.08 | $ | 0.40 | $ | 0.14 | $ | 0.10 |
15. | SUBSEQUENT EVENTS |
Acquisition
In October 2011, we acquired Zarlink Semiconductor Inc. pursuant to the previously announced Support Agreement dated September 21, 2011 for CAD $3.98 per share in cash. Microsemi, through its wholly-owned subsidiary purchased the issued and outstanding common shares of Zarlink and all the outstanding 6% unsecured, subordinated convertible debentures maturing September 30, 2012. The aggregate cash consideration for the Zarlink Securities acquired pursuant to the Offers and the Compulsory Acquisitions was approximately $630.2 million.
Credit Agreement
In connection with the acquisition of Zarlink, we entered into Amendment No. 2 to the Credit Agreement (as amended, the Amended and Restated Credit Agreement), which increased the term loan facility to $800.0 million. Following the acquisition of Zarlink, we also borrowed $49.6 million under the Revolving Facility. Based on current amounts outstanding and interest rates, we expect to record quarterly interest payments of approximately $12.6 million.
The Amended and Restated Credit Agreement also provided new pricing terms, which increased the current applicable margin on revolving loans and swingline loans determined at the Base Rate by 75 to 100 basis points to 3.00% to 3.75% and revolving loans and swingline loans determined at the Eurodollar Rate by 75 to 100 basis points to 4.00% to 4.75%, depending on Microsemis consolidated leverage ratio. For term loans, the new pricing terms increased the current applicable margin on term loans determined at the Base Rate by 150 basis points to 3.50% and term loans determined at the Eurodollar Rate by 150 basis points to 4.50%. The Base Rate is defined as a rate per annum equal to the greatest of (a) the prime rate, (b) 1/2 of 1% per annum above the federal funds effective rate, (c) the one-month Eurodollar Rate plus 1%, and (d) in the case of any term loans, 2.25%. The Eurodollar Rate is defined as (a) the rate per annum offered for deposits of dollars for the applicable interest period that appears on Reuters Screen LIBOR01 Page as of 11:00 A.M., London, England time, two (2) business days prior to the first day of such interest period or (b) if no such offered rate exists, such rate will be the rate of interest per annum as determined by the administrative agent (rounded upwards, if necessary, to the nearest 1/100 of 1%) at which deposits of dollars in immediately available funds are offered at 11:00 A.M., London, England time, two (2) business days prior to the first day in the applicable interest period by major financial institutions reasonably satisfactory to the administrative agent in the London interbank market for such interest period and for an amount equal or comparable to the principal amount of the loans to be borrowed, converted or continued as Eurodollar Rate loans on such date of determination. In the case of term loans, the Eurodollar Rate will not be lower than 1.25%.
Pursuant to the Amended and Restated Credit Agreement, Microsemi can request, at any time and from time to time, the establishment of one or more term loan and/or revolving credit facilities with commitments in an aggregate amount not to exceed $200,000,000 (increased from $100,000,000 pursuant to the Existing Agreement).
80
MICROSEMI CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
Microsemi paid upfront fees or original issue discount equal to 2.00% of the Term Loan Facility and an amendment fee on the Existing Revolving Facility of 0.25%. Additionally, Microsemi expects to pay an undrawn commitment fee ranging from 0.25% to 0.625% depending on Microsemis consolidated leverage ratio, on the unused portion of the Existing Revolving Facility. If any letters of credit are issued, then Microsemi expects to continue paying a fronting fee equal to 0.25% per annum of the aggregate face amount of each letter of credit and a participation fee on all outstanding letters of credit at a per annum rate equal to the margin then in effect with respect to Eurodollar Rate-based loans on the face amount of such letter of credit.
The Amended and Restated Credit Agreement includes financial covenants requiring a maximum leverage ratio and minimum fixed charge coverage ratio and also contains other customary affirmative and negative covenants and events of default.
Thailand Flooding
In the first quarter of fiscal year 2012, severe flooding in certain regions of Thailand forced a shutdown of our operations in two subcontracted facilities in Thailand. The two Thailand facilities together can account for as much as 5% of our total quarterly revenues. We currently expect to relocate our operations to other facilities outside the affected area. However, should circumstances change or we are not able to execute our relocation plans, we may experience disruptions for the affected products that could have an adverse effect on our ability to timely deliver certain products and have a material adverse impact on our results of operations. In addition, unforeseen impacts on our customers, suppliers or subcontractors as a result of the flooding in Thailand could further affect our revenue, consolidated financial position, results of operations and cash flows.
81
SCHEDULE IIVALUATION AND QUALIFYING ACCOUNTS
(amounts in thousands)
Column A |
Column B | Column C | Column D | Column E | Column F | |||||||||||||||
Classification |
Balance at beginning of period |
Charged to costs and expenses |
Charged to other accounts |
Deductions- recoveries and write-offs |
Balance at end of period |
|||||||||||||||
Allowance for doubtful accounts |
||||||||||||||||||||
September 27, 2009 |
$ | 1,731 | $ | 712 | $ | | $ | (141 | ) | $ | 2,302 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
October 3, 2010 |
$ | 2,302 | $ | 425 | $ | | $ | (749 | ) | $ | 1,978 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
October 2, 2011 |
$ | 1,978 | $ | 690 | $ | | $ | (519 | ) | $ | 2,149 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Tax valuation allowance |
||||||||||||||||||||
September 27, 2009 |
$ | 13,831 | $ | 39,389 | $ | | $ | | $ | 53,220 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
October 3, 2010 |
$ | 53,220 | $ | (15,616 | ) | $ | | $ | | $ | 37,604 | |||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
October 2, 2011 |
$ | 37,604 | $ | (21,604 | ) | $ | 2,086 | $ | | $ | 18,086 | |||||||||
|
|
|
|
|
|
|
|
|
|
ITEM 9. | CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE. |
None
ITEM 9A. | CONTROLS AND PROCEDURES. |
(a) Evaluation of disclosure controls and procedures.
As of October 2, 2011, under the supervision and with the participation of the Companys management, including the Companys Chief Executive Officer and Chief Financial Officer, the Company carried out an evaluation of the effectiveness of the design and operation of the Companys disclosure controls and procedures as defined in Exchange Act Rules 13a-15(e) and 15d-15(e). These disclosure controls and procedures are designed to ensure that the information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the SECs rules and forms, and that the information is accumulated and communicated to the Companys management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.
Based upon their evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Companys disclosure controls and procedures were effective as of October 2, 2011.
(b) Changes in internal control over financial reporting.
There have been no changes in the Companys internal control over financial reporting during the fiscal quarter ended October 2, 2011 that have materially affected, or are reasonably likely to materially affect, the Companys internal control over financial reporting.
(c) Managements Report on Internal Control over Financial Reporting
Management is responsible for establishing and maintaining adequate internal control over financial reporting. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.
82
Under the supervision and with the participation of management, including the Companys Chief Executive Officer and Chief Financial Officer, the Company conducted an evaluation of the effectiveness of its internal control over financial reporting as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) based on the framework in Internal Control Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on the Companys evaluation, management concluded that the Companys internal control over financial reporting was effective as of October 2, 2011.
PricewaterhouseCoopers LLP, the Companys independent registered public accounting firm that audited the consolidated financial statements included in this Form 10-K, has audited the effectiveness of the Companys internal control over financial reporting, as stated within their report which appears herein.
ITEM 9B. | OTHER INFORMATION |
None.
83
The Company intends to file a definitive proxy statement with the Securities and Exchange Commission pursuant to Regulation 14A within 120 days after the Companys fiscal year ended October 2, 2011. Except to the extent set forth below, the information required by Items 10, 11, 12, 13 and 14 will be set forth in that definitive proxy statement and such information is hereby incorporated by reference into such respective items in this Form 10-K.
ITEM 10. | DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE |
The information required by this item is incorporated by reference from the Companys Proxy Statement for the 2012 Annual Meeting of Stockholders under the headings Election of Directors, Executive Officers, Corporate Governance, Board Meetings and Committees, and Section 16(a) Beneficial Ownership Reporting Compliance.
ITEM 11. | EXECUTIVE COMPENSATION |
The information required by this item is incorporated by reference from the Companys Proxy Statement for the 2012 Annual Meeting of Stockholders under the headings Executive Compensation and Director Compensation, Compensation Committee Interlocks and Insider Participation, and Report of the Compensation Committee.
ITEM 12. | SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS. |
The information required by this item is incorporated by reference from the Companys Proxy Statement for the 2012 Annual Meeting of Stockholders under the heading Security Ownership of Certain Beneficial Owners and Management and Equity Compensation Plan Information.
ITEM 13. | CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE |
The information required by this item is incorporated by reference from the Companys Proxy Statement for the 2012 Annual Meeting of Stockholders under the heading Corporate Governance, Board Meetings and Committees and Transactions with Related Persons.
ITEM 14. | PRINCIPAL ACCOUNTANT FEES AND SERVICES. |
The information required by this item is incorporated by reference from the Companys Proxy Statement for the 2012 Annual Meeting of Stockholders under the heading Audit Matters.
84
ITEM 15. | EXHIBITS AND FINANCIAL STATEMENT SCHEDULES |
(a) | 1. Financial Statements. See Index under Item 8. |
2. | Financial Statement Schedule. See Index under Item 8. |
(b) | Exhibits |
The exhibits to this report are listed in the Exhibit Index
(c) | Financial statements of unconsolidated affiliates. |
None
85
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
MICROSEMI CORPORATION | ||
By |
/S/ JOHN W. HOHENER | |
John W. Hohener | ||
Executive Vice President, Chief Financial Officer, Secretary and Treasurer (Principal Financial and Accounting Officer and duly authorized to sign on behalf of the Registrant) |
Dated: November 23, 2011
86
POWER OF ATTORNEY
The undersigned hereby constitutes and appoints James J. Peterson and John W. Hohener, or either of them, his true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, to sign the report on Form 10-K and any or all amendments thereto and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof in any and all capacities.
Pursuant to the requirements of Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
Signature |
Title |
Date | ||
/s/ DENNIS R. LEIBEL Dennis R. Leibel |
Chairman of the Board |
November 23, 2011 | ||
/s/ JAMES J. PETERSON James J. Peterson |
President, Chief Executive Officer and Director (Principal Executive Officer) |
November 23, 2011 | ||
/s/ JOHN W. HOHENER John W. Hohener |
Executive Vice President, Chief Financial Officer, Secretary and Treasurer (Principal Financial and Accounting Officer) |
November 23, 2011 | ||
/s/ THOMAS R. ANDERSON Thomas R. Anderson |
Director |
November 23, 2011 | ||
/s/ WILLIAM E. BENDUSH William E. Bendush |
Director |
November 23, 2011 | ||
/s/ PAUL F. FOLINO Paul F. Folino |
Director |
November 23, 2011 | ||
/s/ WILLIAM L. HEALEY William L. Healey |
Director |
November 23, 2011 | ||
/s/ MATTHEW E. MASSENGILL Matthew E. Massengill |
Director |
November 23, 2011 |
87
EXHIBIT INDEX
Exhibit |
Description | |||
2.1 | Agreement and Plan of Merger, dated October 2, 2010, by and among Microsemi Corporation, Artful Acquisition Corp. and Actel Corporation(17) | |||
2.2 | Support Agreement, dated September 21, 2011, by and among 0916753 B.C. ULC, Microsemi Corporation and Zarlink Semiconductor Inc.(23) | |||
3.1 | Amended and Restated Certificate of Incorporation of Microsemi Corporation(20)* | |||
3.2 | Second Amended and Restated Bylaws of Microsemi Corporation* | |||
4.1 | Specimen certificate for the shares of common stock of Microsemi Corporation(7) | |||
10.1 | Microsemi Corporation 1987 Stock Plan, and amendments thereto(5)* | |||
10.1.1 | Form of Employee Stock Option Agreement prior to August 17, 2004(4)* | |||
10.1.2 | Form of Employee Stock Option Agreement from and after August 17, 2004(4)* | |||
10.1.3 | Form of Employee Stock Option Agreement from and after September 26, 2005(6)* | |||
10.1.4 | Form of Employee Stock Option Agreement from and after February 22, 2006(8)* | |||
10.1.5 | Form of Employee Stock Option Agreement from and after March 28, 2006(10)* | |||
10.1.6 | Form of Non-Employee Stock Option Agreement prior to February 22, 2006(4)* | |||
10.1.7 | Form of Non-Employee Stock Option Agreement from and after February 22, 2006(8)* | |||
10.1.8 | Form of Stock Option Exchange Grant and Replacement Option Agreement(2)* | |||
10.1.9 | Form of Amendment of Eligible Unvested Options(5)* | |||
10.1.10 | Form of Notice of Restricted Stock Award and Restricted Stock Agreement(11)* | |||
10.1.11 | Form of Notice of Restricted Stock Award and Employee Restricted Stock Agreement(12)* | |||
10.1.12 | Form of Notice of Restricted Stock Award and Non-Employee Restricted Stock Agreement(12)* | |||
10.1.13 | Summary of Automatic Annual Additions under 1987 Stock Plan(11)* | |||
10.2 | Microsemi Corporation 2008 Performance Incentive Plan(13)* | |||
10.2.1 | Form of Notice of Grant of Restricted Stock Award under Terms and Conditions of 2008 Performance Incentive Plan(14)* | |||
10.2.2 | Form of Notice of Grant of Stock Option under Terms and Conditions of 2008 Performance Incentive Plan(14)* | |||
10.3 | Microsemi Corporation Cash Bonus Plan(14)* | |||
10.4 | Microsemi Corporation 2007 Executive Cash Bonus Plan(11)* | |||
10.5 | Agreement dated November 10, 2008 between James J. Peterson and Microsemi Corporation(14)* | |||
10.5.1 | Letter Agreement, dated January 28, 2009, between James J. Peterson and Microsemi Corporation Relating to Amendment of Restricted Stock Award Agreement(15)* | |||
10.5.2 | Executive Retention Agreement dated March 31, 2009 between James J. Peterson and Microsemi Corporation(16)* | |||
10.6 | Executive Retention Agreement dated March 31, 2009 between John W. Hohener and Microsemi Corporation (16)* | |||
10.7 | Form of Executive Retention Agreement for Named Executive Officers other than James J. Peterson and John W. Hohener(16)* | |||
10.8 | Supplemental Executive Retirement Plan(1)* | |||
10.9 | Supplemental Medical Plan(4)* | |||
10.10 | Summary of Compensation Arrangements for Named Executive Officers(22) | |||
10.11 | Directors Compensation Policy(19) | |||
10.12 | Board Member Retirement Process(3)* |
88
10.13 | Form of Officers and Directors Indemnification Agreement(13)* | |||
10.14 | Motorola-Microsemi PowerMite ® Technology Agreement(8) | |||
10.15 | Settlement Agreement dated July 8, 1998 by and between Microsemi Corp. - Colorado, FMC Corporation, Siemens Microelectronics, Inc. and Coors Porcelain Company(9) | |||
10.16 | Credit Agreement, dated as of November 2, 2010, by and among Microsemi Corporation, Morgan Stanley Senior Funding, Inc., Morgan Stanley & Co. Incorporated, East West Bank, Raymond James Bank, FSB and the lenders referred to therein(18) | |||
10.16.1 | Amendment No. 1 to Credit Agreement, dated as of March 2, 2011, by and among Microsemi Corporation, Morgan Stanley Senior Funding, Inc. and the lenders referred to therein(21) | |||
10.16.2 | Amendment No. 2 to Credit Agreement, dated as of October 13, 2011, by and among Microsemi Corporation, Morgan Stanley Senior Funding, Inc., Morgan Stanley & Co. LLC and the lenders referred to therein(24) | |||
21 | List of Subsidiaries | |||
23 | Consent of Independent Registered Public Accounting Firm | |||
24 | Power of Attorney (see signature page) | |||
31.1 | Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated November 23, 2011 | |||
31.2 | Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated November 23, 2011 | |||
32 | Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, dated November 23, 2011 | |||
101 | The following financial statements are from Microsemi Corporations Annual Report on Form 10-K for the fiscal year ended October 2, 2011, formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheets; (ii) Consolidated Income Statements; (iii) Consolidated Statements of Stockholders Equity; (iv) Consolidated Statements of Cash Flows; and (v) Notes to Consolidated Financial Statements. |
| Filed with this report. | |||
* | Management contract or compensatory plan or arrangement required to be filed as an exhibit pursuant to applicable rules of the Securities and Exchange Commission. | |||
(1 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Quarterly Report on Form 10-Q (File No. 0-08866) as filed with the Commission on February 9, 1998. | ||
(2 | ) | Incorporated by reference to Exhibit 99(D)(2) to the Registrants Tender Offer Statement on Schedule TO (File No. 005-20930) as filed on November 1, 2002. | ||
(3 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Annual Report on Form 10-K (File No. 0-08866) as filed with the Commission on December 19, 2002. | ||
(4 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Current Report on Form 8-K (File No. 0-08866) as filed with the Commission on September 24, 2004. | ||
(5 | ) | Incorporated by reference to Exhibit 99(D)(1) to the Registrants Tender Offer Statement on Schedule TO (File No. 005-30432) as filed with the Commission on August 17, 2005. | ||
(6 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Current Report on Form 8-K (File No. 0-08866) as filed with the Commission on September 28, 2005. | ||
(7 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Annual Report on Form 10-K (File No. 0-08866) as filed with the Commission on December 16, 2005. | ||
(8 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Current Report on Form 8-K (File No. 0-08866) as filed with the Commission on February 28, 2006. | ||
(9 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Pre-Effective Amendment No. 2 to Form S-4 (Reg. No. 333-130655) as filed with the Commission on March 3, 2006. | ||
(10 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Current Report on Form 8-K (File No. 0-08866) as filed with the Commission on April 3, 2006. |
89
(11 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Current Report on Form 8-K (File No. 0-08866) as filed with the Commission on April 4, 2007. | ||
(12 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Current Report on Form 8-K (File No. 0-08866) as filed with the Commission on October 3, 2007. | ||
(13 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Current Report on Form 8-K (File No. 0-08866) as filed with the Commission on September 3, 2008. | ||
(14 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Annual Report on Form 10-K (File No. 0-08866) as filed with the Commission on November 21, 2008. | ||
(15 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Quarterly Report on Form 10-Q (File No. 0-08866) as filed with the Commission on April 30, 2009. | ||
(16 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Quarterly Report on Form 10-Q (File No. 0-08866) as filed with the Commission on July 30, 2009. | ||
(17 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Current Report on Form 8-K (File No. 0-08866) as filed with the Commission on October 4, 2010. | ||
(18 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Current Report on Form 8-K (File No. 0-08866) as filed with the Commission on November 5, 2010. | ||
(19 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Annual Report on Form 10-K (File No. 0-08866) as filed with the Commission on November 23, 2010. | ||
(20 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Quarterly Report on Form 10-Q (File No. 0-08866) as filed with the Commission on February 10, 2011. | ||
(21 | ) | Incorporated by reference to the Exhibit to the Registrants Current Report on Form 8-K (File No. 0-08866) as filed with the Commission on March 4, 2011. | ||
(22 | ) | Incorporated by reference to the indicated Exhibit to the Registrants Quarterly Report on Form 10-Q (File No. 0-08866) as filed with the Commission on May 6, 2011. | ||
(23 | ) | Incorporated by reference to the indicated Exhibit to Amendment No. 3 to the Schedule 14D-1F filed by Microsemi Corporation with the Commission on September 26, 2011. | ||
(24 | ) | Incorporated by reference to the Exhibit to the Registrants Current Report on Form 8-K (File No. 0-08866) as filed with the Commission on October 19, 2011. |
90
Exhibit 3.2
SECOND AMENDED AND RESTATED BYLAWS
OF
MICROSEMI CORPORATION
ARTICLE I
OFFICES
Section 1. Registered Office. The registered office within the State of Delaware shall be at 306 South State Street, Dover, Delaware 19901.
Section 2. Other Offices. The corporation may also have offices at such other places both within and without the State of Delaware as the board of directors may from time to time determine or the business of the corporation may require.
ARTICLE II
MEETINGS OF STOCKHOLDERS
Section 1. Time and Place. Meetings of stockholders for any purpose may be held at such time and place, within or without the State of Delaware, as shall be designated from time to time by the board of directors and stated in the notice of the meeting or in a duly executed waiver of notice thereof. The board of directors may, in its sole discretion, determine that a meeting of the stockholders shall not be held at any place, but may instead be held solely by means of remote communication in the manner authorized by the General Corporation Law of the State of Delaware (the DGCL).
Section 2. Annual Meetings. An annual meeting of stockholders shall be held each year on a date and at a time as shall be designated from time to time by the board of directors and stated in the notice of the meeting, and at such meeting the stockholders shall elect, by a plurality vote, a board of directors, and shall transact such other business as may properly be brought before the meeting.
Section 3. Special Meetings. Special meetings of the stockholders, for any purpose of purposes, unless otherwise prescribed by statute or by the Certificate of Incorporation, may be called by the president and shall be called by the president or secretary at the request in writing
of a majority of the board of directors. Business transacted at any special meeting of stockholders shall be limited to the purposes stated in the notice.
Section 4. Notice of Meetings. Except as otherwise provided by law, notice of each meeting of stockholders, whether annual or special, shall be given not less than ten (10) nor more than sixty (60) days before the date of the meeting to each stockholder entitled to vote at such meeting as of the record date for determining the stockholders entitled to notice of the meeting. Such notice shall state the place, if any (or the means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at the meeting), date and hour of the meeting, the record date for determining the stockholders entitled to vote at the meeting (if such date is different from the record date for determining the stockholders entitled to notice of the meeting) and, in the case of a special meeting, the purpose or purposes for which the meeting is called.
Section 5. List of Stockholders Entitled to Vote. The officer who has charge of the stock ledger of the corporation shall prepare and make, at least ten (10) days before every meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting, for a period of at least ten (10) days prior to the meeting, either (a) during ordinary business hours at the principal place of business of the corporation, or (b) on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of meeting. In the event that the corporation determines to make the list available on an electronic network, the corporation may take reasonable steps to ensure that such information is available only to stockholders of the corporation. If the meeting is to be held at a place, the list shall also be produced and kept at the time and place of the meeting during the whole time thereof, and may be inspected by any stockholder who is present. If the meeting is to be held solely by means of remote communication, then the list shall also be open to the examination of any stockholder during the whole time of the meeting on a reasonably accessible electronic network, and the information required to access such list shall be provided with the notice of the meeting.
2
Section 6. Notice of Stockholder Business and Nominations.
(A) Annual Meetings of Stockholders. (1) Nominations of persons for election to the board of directors and the proposal of other business to be considered by the stockholders may be made at an annual meeting of stockholders (a) pursuant to the corporations notice of meeting, (b) by or at the direction of the board of directors, or (c) by a stockholder of the corporation who (i) was a stockholder of record at the time of giving of notice provided for in these bylaws and at the time of the annual meeting, (ii) is entitled to vote at the meeting, and (iii) complies with the notice procedures set forth in these bylaws as to such business or nomination; clause (c) shall be the exclusive means for a stockholder to make nominations or submit other business (other than matters properly brought pursuant to Rule 14a-8 promulgated under the Securities Exchange Act of 1934, as amended (the Exchange Act) and included in the corporations notice of meeting) before an annual meeting of stockholders.
(2) Without qualification, for any nominations or any other business to be properly brought before an annual meeting by a stockholder pursuant to Section 6(A)(1) of Article II of these bylaws, the stockholder must have given timely notice thereof in writing to the secretary and such other business must otherwise be a proper matter for stockholder action. To be timely, a stockholders notice shall be delivered to the secretary at the principal executive offices of the corporation not earlier than the close of business on the 120th day and not later than the close of business on the 90th day prior to the first anniversary of the preceding years annual meeting; provided, however, that in the event that the date of the annual meeting is more than 30 days before or more than 60 days after such anniversary date, notice by the stockholder to be timely must be so delivered not earlier than the close of business on the 120th day prior to the date of such annual meeting and not later than the close of business on the later of the 90th day prior to the date of such annual meeting or, if the first public announcement of the date of such annual meeting is less than 100 days prior to the date of such annual meeting, the 10th day following the day on which public announcement of the date of such meeting is first made by the corporation. In no event shall any adjournment or postponement of an annual meeting or the announcement thereof commence a new time period for the giving of a stockholders notice as described above. To be in proper form, a stockholders notice (whether given pursuant to this Section 6(A)(2) or Section 6(B)) to the secretary must: (a) set forth, as to the stockholder giving
3
the notice and the beneficial owner, if any, on whose behalf the nomination or proposal is made (i) the name and address of such stockholder, as they appear on the corporations books, and of such beneficial owner, if any, (ii) the class or series and number of shares of the corporation which are, directly or indirectly, owned beneficially and of record by such stockholder and such beneficial owner, (iii) any material interest of the stockholder in such business, (iv) as to the stockholder giving the notice and any Stockholder Associated Person (as defined below) or any member of such stockholders immediate family sharing the same household, whether and the extent to which any hedging or other transaction or series of transactions has been entered into by or on behalf of, or any other agreement, arrangement or understanding (including, but not limited to, any short position or any borrowing or lending of shares of stock) has been made, the effect or intent of which is to mitigate loss or increase profit to or manage the risk or benefit of stock price changes for, or to increase or decrease the voting power of, such stockholder, such Stockholder Associated Person or immediate family member sharing the same household with respect to any share of stock of the corporation, and (v) as to the stockholder giving the notice and any Stockholder Associated Person or any member of such stockholders immediate family sharing the same household, to the extent not set forth pursuant to the immediately preceding clause: (A) whether and the extent to which such stockholder, Stockholder Associated Person or immediate family member sharing the same household has direct or indirect beneficial ownership of any option, warrant, convertible security, stock appreciation right, or similar right with an exercise or conversion privilege or a settlement payment or mechanism at a price related to any class or series of shares of the corporation or with a value derived in whole or in part from the value of any class or series of shares of the corporation, whether or not such instrument or right shall be subject to settlement in the underlying class or series of capital stock of the corporation or otherwise (a Derivative Instrument) and any other direct or indirect opportunity to profit or share in any profit derived from any increase or decrease in the value of shares of the corporation, (B) any proxy, contract, arrangement, understanding, or relationship pursuant to which such stockholder, Stockholder Associated Person or immediate family member has a right to vote any shares of any security of the corporation, (C) any contract, arrangement, understanding or relationship that has been entered into (including, but not limited to, any short position or any borrowing or lending of shares) by or on
4
behalf of such stockholder, Stockholder Associated Person or immediate family member with respect to a short interest in any security of the corporation (for purposes hereof, a person shall be deemed to have a short interest in a security if such person directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has the opportunity to profit or share in any profit derived from any decrease in the value of the subject security), (D) any rights to dividends on the shares of the corporation owned beneficially by such stockholder, Stockholder Associated Person or immediate family member sharing the same household that are separated or separable from the underlying shares of the corporation, (E) any proportionate interest in shares of the corporation or Derivative Instruments held, directly or indirectly, by a general or limited partnership in which such stockholder, Stockholder Associated Person or immediate family member sharing the same household is a general partner or, directly or indirectly, beneficially owns an interest in a general partner and (F) any performance-related fees (other than an asset-based fee) that such stockholder, Stockholder Associated Person or immediate family member sharing the same household is entitled to based on any increase or decrease in the value of shares of the corporation or Derivative Instruments, if any, as of the date of such notice, including without limitation any such interests held by members of such stockholders immediate family sharing the same household (which information shall be supplemented by such stockholder and beneficial owner, if any, not later than 10 days after the record date for the meeting to disclose such ownership as of the record date), and (iii) any other information relating to such stockholder or beneficial owner, if any, that would be required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for, as applicable, the proposal and/or for the election of directors in a contested election pursuant to Section 14 of the Exchange Act and the rules and regulations promulgated thereunder; (b) if the notice relates to any business other than a nomination of a director or directors that the stockholder proposed to bring before the meeting, set forth (i) a brief description of the business desired to be brought before the meeting, the reasons for conducting such business at the meeting and any material interest of such stockholder or beneficial owner, if any, in such business and (ii) a description of all agreements, arrangements and understandings between such stockholder or beneficial owner, if any, and any person or persons (including their names) in connection with the proposal of such business by such stockholder; and (c) set forth, as to each person, if any, whom the stockholder proposes to nominate for election or
5
reelection to the board of directors (i) all information relating to such person that would be required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors in a contested election pursuant to Section 14 of the Exchange Act and the rules and regulations promulgated thereunder (including such persons written consent to being named in the proxy statement as a nominee and to serving as a director if elected) and (ii) a description of all direct and indirect compensation and other material monetary agreements, arrangements and understandings during the past three years, and any other material relationships, between or among such stockholder and beneficial owner, if any, and their respective affiliates and associates, or others acting in concert therewith, on the one hand, and each proposed nominee, and his or her respective affiliates and associates, or others acting in concert therewith, on the other hand, including without limitation all information that would be required to be disclosed pursuant to Item 404 promulgated under Regulation S-K if the stockholder making the nomination and any beneficial owner on whose behalf the nomination is made, if any, or any affiliate or associate thereof or person acting in concert therewith, were the registrant for purposes of such rule and the nominee were a director or executive officer of such registrant. The corporation may require any proposed nominee to furnish such other information as may reasonably be required by the corporation to determine the eligibility of such proposed nominee to serve as an independent director of the corporation or that could be material to a reasonable stockholders understanding of the independence, or lack thereof, of such nominee. For purposes of this Section 6(A)(2), a Stockholder Associated Person of any stockholder shall mean: (i) any person controlling or controlled by, directly or indirectly, or acting in concert with, such stockholder; (ii) any beneficial owner of shares of stock of the corporation owned of record or beneficially by such stockholder; and (iii) any person controlling, controlled by or under common control with such Stockholder Associated Person.
(3) Notwithstanding anything in the second sentence of Section 6(A)(2) of Article II of these bylaws to the contrary, in the event that the number of directors to be elected to the board of directors is increased and there is no public announcement by the corporation naming all of the nominees for director or specifying the size of the increased board of directors at least 100 days prior to the first anniversary of the preceding years annual meeting, a stockholders notice required by these bylaws shall also be considered timely, but only with respect to nominees for any new positions created by such increase, if it shall be
6
delivered to the secretary at the principal executive offices of the corporation not later than the close of business on the 10th day following the day on which such public announcement is first made by the corporation.
(B) Special Meetings of Stockholders. Only such business shall be conducted at a special meeting of stockholders as shall have been brought before the meeting pursuant to the corporations notice of meeting. Nominations of persons for election to the board of directors may be made at a special meeting of stockholders at which directors are to be elected pursuant to the corporations notice of meeting (a) by or at the direction of the board of directors or (b) provided that the board of directors has determined that directors shall be elected at such meeting, by any stockholder of the corporation who (i) is a stockholder of record at the time of giving of notice provided for in this Section 6(B) and at the time of the special meeting, (ii) is entitled to vote at the meeting, and (iii) complies with the notice procedures set forth in this Section 6(B) as to such nomination. In the event the corporation calls a special meeting of stockholders for the purpose of electing one or more directors to the board of directors, any such stockholder may nominate a person or persons (as the case may be) for election to such position(s) as specified in the corporations notice of meeting, if the stockholders notice required by Section 6(A)(2) of Article II of these bylaws with respect to any nomination shall be delivered to the secretary at the principal executive offices of the corporation not earlier than the close of business on the 120th day prior to the date of such special meeting and not later than the close of business on the later of the 90th day prior to the date of the special meeting or, if the first public announcement of the date of such special meeting is less than 100 days prior to the date of such special meeting, the 10th day following the day on which public announcement is first made of the date of the special meeting and of the nominees proposed by the board of directors to be elected at such meeting. In no event shall any adjournment or postponement of a special meeting or the announcement thereof commence a new time period for the giving of a stockholders notice as described above.
(C) General. (1) Only such persons who are nominated in accordance with the procedures set forth in these bylaws shall be eligible to serve as directors and only such business shall be conducted at a meeting of stockholders as shall have been brought before the meeting in accordance with the procedures set forth in these bylaws. Except as otherwise provided by law,
7
the Certificate of Incorporation or these bylaws, the chairman of the meeting shall have the power and duty to determine whether a nomination or any business proposed to be brought before the meeting was made or proposed, as the case may be, in accordance with the procedures set forth in this Section 6 and, if any proposed nomination or business is not in compliance with this Section 6, to declare that such defective proposal or nomination shall be disregarded.
(2) For purposes of this Section 6, public announcement shall mean disclosure in a press release reported by a national news service or in a document publicly filed by the corporation with the Securities and Exchange Commission pursuant to Section 13, 14 or 15(d) of the Exchange Act and the rules and regulations promulgated thereunder.
(3) Notwithstanding the foregoing provisions of this Section 6, a stockholder shall also comply with all applicable requirements of the Exchange Act and the rules and regulations thereunder with respect to the matters set forth in this Section 6; provided, however, that any references in this Section 6 to the Exchange Act or the rules and regulations promulgated thereunder are not intended to and shall not limit the requirements applicable to nominations or proposals as to any other business to be considered pursuant to Section 6(A)(1)(c) or Section 6(B) of Article II of these bylaws. Nothing in these bylaws shall be deemed to affect any rights (i) of stockholders to request inclusion of proposals in the corporations proxy statement pursuant to Rule 14a-8 under the Exchange Act or (ii) of the holders of any series of preferred stock if and to the extent provided for under law, the Certificate of Incorporation or these bylaws.
Section 7. Quorum. The holders of a majority of the stock issued and outstanding and entitled to vote thereat, present in person or represented by proxy, shall constitute a quorum at all meetings of the stockholders for the transaction of business except as otherwise provided by statute or by the Certificate of Incorporation. If, however, such quorum shall not be present or represented at any meeting of the stockholders, then either (a) the chairman of the meeting or (b) the stockholders entitled to vote thereat, present in person or represented by proxy, shall have power to adjourn the meeting from time to time, as provided below in Section 8, until a quorum shall be present or represented.
8
Section 8. Adjournments. Any meeting of stockholders, annual or special, may be adjourned from time to time to reconvene at the same or other place by either (a) the chairman of the meeting or (b) the holders of a majority of the stock entitled to vote thereat, present in person or represented by proxy. When a meeting is adjourned to another time or place, if any, unless these bylaws otherwise require, notice need not be given of the adjourned meeting if the time and place, if any, thereof or means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at such adjourned meeting are announced at the meeting at which the adjournment is taken unless the adjournment is for more than thirty (30) days, or unless after the adjournment a new record date is fixed for the adjourned meeting, in which event a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting; provided, however, that the board of directors may fix a new record date for determination of stockholders entitled to vote at the adjourned meeting, and in such case shall also fix as the record date for stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote at the adjourned meeting. At such adjourned meeting at which a quorum shall be present or represented any business may be transacted which might have been transacted at the meeting as originally notified.
Section 9. Vote Required. When a quorum is present at any meeting, the vote of the holders of a majority of the stock present in person or represented by proxy at the meeting and entitled to vote on the subject matter shall decide any matter brought before such meeting, unless the matter is one upon which by express provision of the statutes, or of the Certificate of Incorporation, or of these bylaws, a different vote is required in which case such express provision shall govern and control the decision of such question. All directors shall be elected by a plurality of the votes of the stock present in person or represented by proxy at the meeting and entitled to vote on the election of directors.
Section 10. Voting; Proxies. The stockholders entitled to vote at any meeting of stockholders shall be determined in accordance with the provisions of Section 5 of Article VI of these bylaws, subject to the provisions of Section 217 and 218 of the DGCL (relating to voting rights of fiduciaries, pledgors and joint owners of stock and to voting trusts and other voting agreements). Unless otherwise provided in the Certificate of Incorporation, each stockholder
9
shall at every meeting of the stockholders be entitled to one vote in person or by proxy for each share of the capital stock having voting power held by such stockholder, but no proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period. The revocability of a proxy that states on its face that it is irrevocable shall be governed by the provisions of Section 212(e) of the DGCL.
Section 11. Conduct of Business. The board of directors of the corporation may adopt by resolution such rules and regulations for the conduct of any meeting of the stockholders as it shall deem appropriate. Except to the extent inconsistent with such rules and regulations as adopted by the board of directors, the chairman and secretary of any meeting of the stockholders shall have the right and authority to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such chairman or secretary, are appropriate for the proper conduct of the meeting. Such rules, regulations or procedures, whether adopted by the board of directors or prescribed by the chairman or secretary of the meeting, may include, without limitation, the following: (i) the establishment of an agenda or order of business for the meeting; (ii) the determination of when the polls shall open and close for any given matter or matters to be voted on at the meeting; (iii) rules and procedures for maintaining order at the meeting and the safety of those present; (iv) limitations on attendance at or participation in the meeting to stockholders of record of the corporation, their duly authorized and constituted proxies or such other persons as the chairman of the meeting shall determine; (v) restrictions on entry to the meeting after the time fixed for the commencement thereof; and (vi) limitations on the time allotted to questions or comments by participants.
Section 12. Inspectors of Election. In advance of any meeting of stockholders, the board of directors, by resolution, the chairman of the board, the chief executive officer or the president shall appoint one or more inspectors to act at the meeting and make a written report thereof. One or more other persons may be designated as alternate inspectors to replace any inspector who fails to act. If no inspector or alternate is able to act at a meeting of stockholders, the chairman of the meeting shall appoint one or more inspectors to act at the meeting. Unless otherwise required by applicable law, inspectors may be, among other things, officers, employees or agents of the corporation. Each inspector, before entering upon the discharge of the duties of inspector, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality and
10
according to the best of such inspectors ability. The inspector shall have the duties prescribed by law and shall take charge of the polls and, when the vote is completed, shall make a certificate of the result of the vote taken and of such other facts as may be required by applicable law.
ARTICLE III
DIRECTORS
Section 1. Number. The number of directors which shall constitute the whole board shall not be less than three (3) nor more than thirteen (13) as shall be determined from time to time by a resolution adopted by a majority of the entire board of directors, provided, however, that no decrease in the number of directors constituting the entire board of directors shall shorten the term of any incumbent director.
Section 2. Election. The directors shall be elected at the annual meeting of the stockholders, except as provided in Section 4 of this Article.
Section 3. Term of Office; Resignations; Removal. Each director elected shall hold office until his successor is elected and qualified. Any director may resign at any time upon written notice to the board of directors or to the secretary of the corporation. Any such resignation shall take effect at the time specified therein, or, if the time is not specified, it shall take effect immediately upon its receipt by the board of directors or the secretary; and unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it effective. Unless otherwise restricted by the Certificate of Incorporation or by law, any director may be removed for cause or without cause by the holders of a majority of shares entitled to vote at the election of directors. Directors need not be stockholders.
Section 4. Vacancies. Any vacancy occurring in the board of directors by reason of death, resignation, retirement, disqualification, removal from office, an increase in the number of directors or otherwise, may be filled by a majority of the directors then in office, though less than a quorum, or by a sole remaining director, or such vacancy may be filled by the stockholders of the corporation at a special meeting called for the purpose. The directors so chosen shall hold office until the next annual election and until their successors are duly elected and shall qualify, or until they shall resign or shall have been removed in the manner provided in these bylaws. If
11
there are no directors in office, then an election of directors may be held in the manner provided by the DGCL. If, at the time of filling any vacancy or any newly created directorship, the directors then in office shall constitute less than a majority of the whole board (as constituted immediately prior to any such increase), the Court of Chancery may, upon application of any stockholder or stockholders holding at least ten (10) percent of the total number of the shares at the time outstanding having the right to vote for such directors, summarily order an election to be held to fill any such vacancies or newly created directorships, or to replace the directors chosen by the directors then in office.
Section 5. Authority. The business of the corporation shall be managed by or under the direction of its board of directors which may exercise all such powers of the corporation and do all such lawful acts and things as are not by statute or by the Certificate of Incorporation or by these bylaws directed or required to be exercised or done by the stockholders.
Section 6. Place of Meeting. The board of directors of the corporation may hold meetings, both regular and special, either within or without the State of Delaware.
Section 7. First Meeting. The first meeting of each newly elected board of directors shall be held within ten (10) days following each annual meeting of the stockholders, at such time and place as shall be fixed by resolution of the board of directors prior to the annual meeting or by the consent in writing of all newly elected directors, and no notice of such meeting shall be necessary to the newly elected directors in order legally to constitute the meeting, provided a quorum shall be present. In the event of the failure of the board of directors to fix the time or place of such first meeting of the newly elected board of directors, or in the event such meeting is not held at the time and place so fixed by the board of directors, the meeting may be held at such time and place as shall be specified in a notice given as hereinafter provided for special meetings of the board of directors, or as shall be specified in a written waiver signed by all of the directors.
Section 8. Regular Meetings. Regular meetings of the board of directors may be held without notice at such time and at such place, if any, as shall from time to time be determined by the board.
12
Section 9. Special Meetings. Special meetings of the board may be called by the chairman of the board, the president, the secretary or any two directors on one (1) days written notice to each director, either personally, by mail, by facsimile, or by any other form of delivery of written communication, including electronic delivery. Notice shall include the time, place, if any, the means of remote communications, if any, by which a director may participate and be considered present at the meeting, and purpose or purposes of the meeting.
Section 10. Quorum and Voting. At all meetings of the board of directors, a majority of the total number of directors shall constitute a quorum for the transaction of business, and the vote of a majority of the directors present at any meeting at which there is a quorum shall be the act of the board of directors, except as may be otherwise specifically provided by statute or by the Certificate of Incorporation. If a quorum shall not be present at any meeting of the board of directors, the directors present thereat may adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum shall be present.
Section 11. Unanimous Consent in Lieu of Meeting. Unless otherwise restricted by the Certificate of Incorporation or these bylaws, any action required or permitted to be taken at any meeting of the board of directors or of any committee thereof may be taken without a meeting, if all members of the board or committee, as the case may be, consent thereto in writing or by electronic transmission, and the writing or writings or electronic transmission or electronic transmissions are filed with the minutes of proceedings of the board or committee.
Section 12. Telephonic Meetings. Unless otherwise restricted by the Certificate of Incorporation or these bylaws, members of the board of directors, or any committee designated by the board of directors, may participate in a meeting of the board or any committee by means of conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other, and such participation shall constitute presence in person at the meeting.
Section 13. Committees of Directors.
(A) Designation, Membership. The board of directors may, by resolution passed by a majority of the whole board, designate one or more committees, each committee to
13
consist of one or more of the directors of the corporation. The board may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee.
In the absence or disqualification of a member of a committee, and in the absence of a designation by the board of directors of an alternate member to replace the absent or disqualified member, the member or members thereof present at any meeting and not disqualified from voting, whether or not he, she or they constitute a quorum, may unanimously appoint another member of the board of directors to act at the meeting in the place of any such absent or disqualified member.
(B) Authority. Any such committee, to the extent provided in the resolution of the board of directors establishing such committee, in any subsequent resolution of the board of directors or in these bylaws, shall have and may exercise all the powers and authority of the board of directors in the management of the business and affairs of the corporation, and may authorize the seal of the corporation to be affixed to all papers which may require it; but no such committee shall have the power or authority in reference to any of the following: (1) amending the Certificate of Incorporation (except that a committee may, to the extent authorized in the resolution or resolutions providing for the issuance of shares of stock adopted by the board of directors as provided in Section 151(a) of the DGCL, fix the designations and any of the preferences or rights of such shares relating to dividends, redemption, dissolution, any distribution of assets of the corporation or the conversion into, or the exchange of such shares for, shares of any other class or classes or any other series of the same or any other class or classes of stock of the corporation or fix the number of shares of any series of stock or authorize the increase or decrease of the shares of any series), (2) adopting an agreement of merger or consolidation, (3) recommending to the stockholders the sale, lease or exchange of all or substantially all of the corporations property and assets, (4) recommending to the stockholders a dissolution of the corporation or a revocation of a dissolution, (5) amending the bylaws of the corporation, and (6) unless the resolution or the Certificate of Incorporation expressly so provide, no such committee shall have the power or authority to declare a dividend, to authorize the issuance of stock, or to adopt a certificate of ownership and merger.
14
Such committee or committees shall have such name or names as may be determined from time to time by resolution adopted by the board of directors.
(C) Tenure; Proceedings; and Reports. Each committee shall serve at the pleasure of the board of directors. The board of directors shall have the power to prescribe the manner in which proceedings of any such committee shall be conducted. In the absence of any such prescription, each committee shall have the power to prescribe the manner in which its proceedings shall be conducted. Unless the board of directors or such committee shall provide, the regular and special meetings of any such committee shall be governed by the provisions of this Article applicable to meetings and actions of the board of directors. Each committee shall keep regular minutes of its meetings and report the same to the board of directors when required.
Section 14. Compensation of Directors. Unless otherwise restricted by the Certificate of Incorporation or these bylaws, the board of directors shall have the authority to fix the compensation of directors. The directors may be paid their expenses, if any, of attendance at each meeting of the board of directors and may be paid a fixed sum for attendance at each meeting of the board of directors or a stated salary or retainer as director. No such payment shall preclude any director from serving the corporation in any other capacity and receiving compensation therefor. Members of special or standing committees may be allowed like compensation for attending committee meetings.
Section 15. Chairman of the Board. The board of directors may at any time choose from among its members a chairman of the board, who shall serve at the pleasure of the board. The chairman, if there be one, shall preside at all meetings of the stockholders and the board of directors and shall have such other powers and perform such other duties as may from time to time be assigned to him by the board of directors. If so designated by the board of directors, the chairman of the board shall be considered an executive officer of the corporation.
ARTICLE IV
NOTICES
Section 1. Delivery of Notices. Whenever, under the provisions of the DGCL or of the Certificate of Incorporation or of these bylaws, notice is required to be given to any director or
15
stockholder, such notice shall be given in writing, and may be delivered personally, by mail or, if consented to by the person to whom the notice is given, by electronic transmission. Any such consent shall be deemed revoked if: (i) the corporation is unable to deliver by electronic transmission two consecutive notices given by the corporation in accordance with such consent; and (ii) such inability becomes known to the Secretary or the Assistant Secretary or to the transfer agent or other person responsible for the giving of notice; provided, however, the inadvertent failure to treat such inability as a revocation shall not invalidate any meeting or other action.
All notices given by mail shall be addressed to such director or stockholder, at his, her or its address as it appears on the records of the corporation (unless any such director or stockholder shall have filed with the secretary of the corporation a written request that notices intended for him be mailed to some other address, in which case the notice shall be mailed to the address designated in such request), with postage thereupon prepaid, and such notice shall be deemed to be given at the time when the same shall be deposited in the United States mail. Electronic transmission as used herein means any form of communication, not directly involving the physical transmission of paper, that creates a record that may be retained, retrieved and reviewed by the recipient thereof, and that may be directly reproduced in paper form by such a recipient through an automated process, and includes but is not limited to facsimile telecommunication and electronic mail. Notice given by electronic transmission shall be deemed given: (i) if by facsimile communication, when directed to a number at which the person has consented to receive notice; (ii) if by electronic mail, when directed to an electronic mail address at which the person has consented to receive notice; (iii) if by a posting on an electronic network together with a separate notice to the person of such specific posting, upon the later of such posting and the giving of such separate notice; and (iv) if by any other form of electronic transmission, when directed to the person.
Section 2. Waiver of Notice. Whenever any notice is required to be given under the provisions of the statutes or of the Certificate of Incorporation or of these bylaws, a waiver thereof in writing (signed by the person or persons entitled to said notice) or by electronic transmission (authenticated if and as required by law), whether before or after the time stated therein, shall be deemed equivalent thereto. Attendance of a person at a meeting shall constitute
16
a waiver of notice of such meeting except when the person attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the stockholders, directors, or members of a committee of directors need be specified in any written waiver of notice unless so required by the Certificate of Incorporation or these bylaws.
ARTICLE V
OFFICERS
Section 1. Executive Officers. The executive officers of the corporation shall be a president, one or more vice-presidents (one or more of whom may be executive vice presidents, senior vice presidents or otherwise as may be designated by the board of directors), a treasurer, a secretary and such other officers as the board of directors may deem expedient, each of whom shall be elected annually by the board of directors at its first meeting after each annual meeting of stockholders and each of whom shall hold office at the pleasure of the board. Any number of offices may be held by the same person, unless the DGCL, the Certificate of Incorporation or these bylaws otherwise provide.
Section 2. Subordinate Officers. In addition to the officers appointed by the board of directors in accordance with Section 1 above, the board of directors may appoint such other officers and agents as it shall deem necessary, including one or more vice presidents, one or more assistant secretaries and one or more assistant treasurers, who shall hold their offices for such terms and shall exercise such powers and perform such duties as shall be determined from time to time by the board. Any such other officers or agents shall hold office at the pleasure of the board of directors. The board of directors may delegate to any officer of the corporation or any committee of the board of directors the power to appoint, remove and prescribe the term and duties of any officer provided for in this Section 2.
Section 3. Tenure and Removal; Resignation; Vacancies. The officers of the corporation shall hold office for such term as may be prescribed by the board of directors or until their successors are chosen and qualified. Except where otherwise expressly provided in a contract authorized by the board of directors, any officer may be removed at any time for cause or
17
without cause by the affirmative vote of a majority of the board of directors or, except in the case of an officer appointed by the board of directors, by any officer upon whom such power of removal may be conferred by the board of directors.
Any officer may resign at any time by giving written notice to the attention of the secretary of the corporation. Any resignation shall take effect at the date of receipt of the notice or at any later time specified in the notice; and, unless otherwise specified in the notice, the acceptance of the resignation shall not be necessary to make it effective.
Any vacancy occurring in any of the above offices of the corporation shall be filled by the board of directors or, except in the case of an officer chosen by the board of directors, by any officer upon whom such power may be conferred by the board of directors.
Section 4. Salaries. Unless otherwise provided by resolution passed by a majority of the whole Board, the salaries of all officers appointed by the board of directors pursuant to Section 1 above shall be fixed by the board of directors or a committee of the board of directors delegated with such authority.
Section 5. The President. The president shall be the chief executive officer of the corporation, subject to the control of the board of directors, and shall see that all orders and resolutions of the board of directors are carried into effect and shall have general and active supervision, direction and control of the business of the corporation and its officers, agents and employees. In the absence of the chairman of the board, or if there be no chairman, he shall preside at all meetings of the stockholders and directors.
Section 6. Powers of the President. The president shall have the power to execute, on behalf of the corporation, bonds, notes, deeds, mortgages, and any and all contracts, agreements and instruments of a contractual nature pertaining to matters which arise in the normal conduct and ordinary course of business of the corporation, or which arise in connection with matters which have been otherwise approved by the board of directors, except where the signing and execution thereof shall be expressly delegated by the board of directors to some other officer or agent of the corporation. He shall also perform such other duties as the board of directors shall from time to time prescribe.
18
Section 7. The Vice-Presidents. In the absence of the president or in the event of his inability to act, the vice-president (or in the event there be more than one vice-president, the vice-presidents in the order designated by the directors, or in the absence of any designation, then in the order of their election) shall perform the duties of the president, and when so acting, shall have all the powers of and be subject to all the restrictions upon the president. The vice-presidents shall perform such other duties and have such other powers as the board of directors may from time to time prescribe, and shall generally assist the president.
Section 8. The Secretary. The secretary shall attend all meetings of the board of directors and all meetings of the stockholders and record all votes and general proceedings of the meetings in a book to be kept for that purpose and shall perform like duties for the standing committees when required. He or she shall give, or cause to be given, notice of all meetings of the stockholders and special meetings of the board of directors, and shall perform such other duties as may be prescribed by the board of directors or president, under whose supervision he shall be. He or she shall have custody of the corporate seal of the corporation and he or she, or an assistant secretary, shall, when authorized by the board of directors, affix the same to any instrument requiring it and, when so affixed, it may be attested by his or her signature or by the signature of such assistant secretary. The board of directors may give general authority to any other officer to affix the seal of the corporation and to attest the affixing by his signature.
Section 9. Assistant and Secretaries. The assistant secretaries, if any, in the order determined by the board of directors (or if there be no such determination, then in the order of their election) shall, in the absence of the secretary or in the event of his inability to act, perform the duties and exercise the powers of the secretary and shall perform such other duties and have such other powers as the board of directors may from time to time prescribe.
Section 10. The Treasurer. The treasurer shall have the custody of the corporate funds and other valuable effects including securities, and shall keep full and accurate accounts of receipts and disbursements in books belonging to the corporation and shall deposit all monies and other valuable effects in the name and to the credit of the corporation in such depositories as may be designated by the board of directors. He or she shall disburse the funds of the corporation as may be ordered by the board of directors, taking proper vouchers for such
19
disbursements, and shall render to the president and the board of directors, at its regular meetings, or when the board of directors so requires, an account of all his or her transactions as treasurer of the financial condition of the corporation. If required by the board of directors, he shall give the corporation a bond for such term, in such sum, and with such surety or sureties as shall be satisfactory to the board of directors for the faithful performance of the duties of his office and for the restoration to the corporation, in case of his death, resignation, retirement or removal from office, of all books, papers, vouchers, money and other property of whatever kind in his possession or under his control belonging to the corporation.
Section 11. The Assistant Treasurers. The assistant treasurers, if any, in the order determined by the board of directors (or if there be no such determination, then in the order of their election) shall, in the absence of the treasurer or in the event of his inability to act, perform the duties and exercise the powers of the treasurer and shall perform such other duties and have other powers as the board of directors may from time to time prescribe.
ARTICLE VI
CERTIFICATES FOR SHARES; UNCERTIFICATED SHARES; RECORD DATE
Section 1. Form. The shares of stock of the corporation shall be represented by certificates, provided that the board of directors may provide by resolution or resolutions that some or all of any or all classes or series of the corporations stock shall be uncertificated shares. Any such resolution shall not apply to shares represented by a certificate until such certificate is surrendered to the corporation. Notwithstanding the adoption of any resolution providing for uncertificated shares, every holder of stock represented by certificates and upon request every holder of uncertificated shares shall be entitled to have a certificate, in such form as shall be determined by the board of directors and provided that each certificate is numbered consecutively and entered in the books of the corporation as they are issued. Each certificate shall exhibit the registered holders name and the number and class of shares, and shall be signed by, or in the name of the corporation by, the chairman or vice-chairman of the board of directors, or the president or a vice-president and by the treasurer or an assistant treasurer, or the secretary or an assistant secretary of the corporation, and shall bear the seal of the corporation or an engraved or printed facsimile thereof. Any or all of the signatures on the certificate may be a
20
facsimile. In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be issued by the corporation with the same effect as if he were such officer, transfer agent or registrar at the date of issue.
Section 2. Registered Stockholders. The corporation shall be entitled (1) to recognize the exclusive right of a person registered on its books as the owner of shares to receive dividends and notices of meetings of stockholders, and to vote as such owner, and (2) to hold liable for calls and assessments a person registered on its books as the owner of shares; and the corporation shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of any other person, whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of Delaware.
Section 3. Lost Certificates. The board of directors may direct a new certificate or certificates or uncertificated shares to be issued in place of any certificate or certificates theretofore issued by the corporation alleged to have been lost, stolen, or destroyed, upon the making of an affidavit of that fact by the person claiming the certificate of stock to be lost, stolen, or destroyed, and upon such other terms as the board of directors may prescribe. When authorizing such issue of a new certificate or certificates or uncertificated shares, the board of directors may, in its own discretion and as a condition precedent to the issuance thereof, require the owner of such lost, stolen or destroyed certificate or certificates, or his legal representative, to advertise the same in such manner as it shall require and/or to give the corporation a bond in such sum and with such surety or sureties as it may direct as indemnity against any claim that may be made against the corporation with respect to the certificate alleged to have been lost, stolen, or destroyed.
Section 4. Transfers of Stock. Shares of capital stock of the corporation shall be transferable in the manner prescribed by law or these bylaws. Shares of capital stock of the corporation shall only be transferred on the books of the corporation by the holder of record thereof or by such holders attorney duly authorized in writing, upon surrender to the corporation of the certificate or certificates representing such shares endorsed by the appropriate person or persons (or, with respect to uncertificated shares, by delivery of duly executed instructions or in
21
any other manner permitted by applicable law), with such evidence of the authenticity of such endorsement or execution, transfer, authorization and other matters as the corporation may reasonably require, and accompanied by all necessary stock transfer stamps.
Section 5. Fixing Record Date.
(A) In order that the corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof, or entitled to receive payment of any dividend or other distribution or allotment of any rights, or entitled to exercise any rights in respect to any change, conversion to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action, the board of directors may fix, in advance, a record date, which shall not be more than sixty (60) nor less than ten (10) days before the date of such meeting, nor more than sixty (60) days prior to any other action. If the board of directors shall fix a record date for determining the stockholders entitled to notice of a meeting of stockholders or any adjournment thereof, such date shall also be the record date for determining the stockholders entitled to vote at such meeting unless the board of directors determines, at the time it fixes such record date, that a later date on or before the date of the meeting shall be the date for making such determination.
(B) If no record date is fixed:
(1) The record date for determining stockholders entitled to a notice of or to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held.
(2) The record date for determining stockholders for any other purpose shall be at the close of business on the day on which the resolution of the board relating thereto is adopted.
(C) A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting, provided, however, that the board of directors may fix a new record date for the adjourned meeting.
22
ARTICLE VII
INDEMNIFICATION
Section 1. Right to Indemnification. Each person who was or is made a party or is threatened to be made a party to or is involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (hereinafter a proceeding), by reason of the fact that he or she, or a person of whom he or she is the legal representative, is or was a director or officer, of the corporation or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans, whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent or in any other capacity while serving as a director, officer, employee or agent, shall be indemnified and held harmless by the corporation to the fullest extent authorized by the DGCL, as the same exists or may hereafter be amended (but, in the case of any such amendment, only to the extent that such amendment permits the corporation to provide broader indemnification rights than said law permitted the corporation to provide prior to such amendment), against all expense, liability and loss (including attorneys fees, judgments, fines, ERISA excise taxes or penalties and amounts paid or to be paid in settlement) reasonably incurred or suffered by such person in connection therewith and such indemnification shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of his or her heirs, executors and administrators; provided, however, that, except as provided in Section 2 below, the corporation shall indemnify any such person seeking indemnification in connection with a proceeding (or part thereof) initiated by such person only if such proceeding (or part thereof) was authorized by the board of directors of the corporation. The right to indemnification conferred in this Section shall be a contract right and shall include the right to be paid by the corporation the expenses incurred in defending any such proceeding in advance of its final disposition; provided, however, that, if the DGCL requires, the payment of such expenses incurred by a director or officer in his or her capacity as a director or officer (and not in any other capacity in which service was or is rendered by such person while a director or officer, including, without limitation, service to an employee benefit plan) in advance of the final disposition of a proceeding, shall be made only upon delivery to the corporation of an undertaking, by or on behalf of such director or officer, to repay all amounts so advanced if it shall ultimately be
23
determined that such director or officer is not entitled to be indemnified under this Section or otherwise. The corporation may, by action of its board of directors, provide indemnification to employees and agents of the corporation with the same scope and effect as the foregoing indemnification of directors and officers.
Section 2. Right of Claimant to Bring Suit. If a claim under Section 1 of this Article VII is not paid in full by the corporation within thirty days after a written claim has been received by the corporation, the claimant may at any time thereafter bring suit against the corporation to recover the unpaid amount of the claim and, if successful in whole or in part, the claimant shall be entitled to be paid also the expense of prosecuting such claim. It shall be a defense to any such action (other than an action brought to enforce a claim for expenses incurred in defending any proceeding in advance of its final disposition where the required undertaking, if any is required, has been tendered to the corporation) that the claimant has not met the standards of conduct which makes it permissible under the DGCL for the corporation to indemnify the claimant for the amount claimed, but the burden of proving such defense shall be on the corporation. Neither the failure of the corporation (including its board of directors, independent legal counsel, or its stockholders) to have made a determination prior to the commencement of such action that indemnification of the claimant is proper in the circumstances because he or she has met the applicable standard of conduct set forth in the DGCL, nor an actual determination by the corporation (including its board of directors, independent legal counsel, or its stockholders) that the claimant has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that the claimant has not met the applicable standard of conduct.
Section 3. Non-Exclusivity of Rights. The right to indemnification and the payment of expenses incurred in defending a proceeding in advance of its final disposition conferred in this Article shall not be exclusive of any other right which any person may have or hereafter acquire under any statute, provision of these bylaws, the Certificate of Incorporation, agreement, vote of stockholders or disinterested directors or otherwise. In the event the corporation has an indemnification agreement with a director or officer of the corporation and the terms of such agreement are in conflict with the provisions of this Article VII, then, to the extent permitted by law, the provisions of such indemnification agreement shall control.
24
Section 4. Amendment or Repeal. The right to indemnification and the payment of expenses incurred in defending a proceeding in advance of its final disposition conferred in this Article shall not be eliminated or impaired by an amendment to such provision after the occurrence of the act or omission that is the subject of the proceeding for which indemnification or advancement of expenses is sought.
Section 5. Insurance. The corporation may maintain insurance, at its expense, to protect itself and any director, officer, employee or agent of the corporation or another corporation, partnership, joint venture, trust or other enterprise against any such expense, liability or loss, whether or not the corporation would have the power to indemnify such person against such expense, liability or loss under the DGCL.
ARTICLE VIII
FORUM FOR CERTAIN ACTIONS
Except for: (1) actions in which the Court of Chancery in the state of Delaware concludes that an indispensable party is not subject to the jurisdiction of the Delaware courts; and (2) actions in which a federal court has assumed exclusive jurisdiction of a proceeding, any derivative action brought by or on behalf of the corporation and any direct action brought by a stockholder against the corporation or any of its directors, officers or employees, alleging a violation of the DGCL, the Certificate of Incorporation or these bylaws or breach of fiduciary duties or other violation of Delaware decisional law relating to the internal affairs of the corporation, shall be brought in the Court of Chancery in the State of Delaware, which shall be the sole and exclusive forum for any such proceedings upon the approval of the board of directors of the corporation.
ARTICLE IX
GENERAL PROVISIONS
Section 1. Dividends. Dividends upon the capital stock of the corporation, subject to the provisions of the Certificate of Incorporation, if any, may be declared by the board of directors at any regular or special meeting, pursuant to law. Dividends may be paid in cash, in property, or in shares of the capital stock, subject to the provisions of the Certificate of Incorporation. Before
25
payment of any dividend, there may be set aside out of any funds of the corporation available for dividends such sum or sums as the directors from time to time, in their absolute discretion, think proper as a reserve or reserves to meet contingencies, or for equalizing dividends, or for repairing or maintaining any property of the corporation, or for such other purpose as the directors shall think conducive to the interest of the corporation, and the directors may modify or abolish any such reserve in the manner in which it was created.
Section 2. Execution of Corporate Contracts and Instruments. The board of directors, except as otherwise required by these bylaws, may authorize any officer or officers, or agent or agents, to enter into any contract or execute any instrument in the name of and on behalf of the corporation; such authority may be general or confined to specific instances.
Section 3. Checks. All checks or demands for money and notes of the corporation shall be signed by such officer or officers or such other person or persons as the board of directors may from time to time designate.
Section 4. Fiscal Year. The fiscal year of the corporation shall be fixed by resolution of the board of directors.
Section 5. Seal. The corporate seal shall have inscribed thereon the name of the corporation, the year of its organization and the words Corporate Seal, Delaware. The seal may be used by causing it or a facsimile thereof to be impressed or affixed or otherwise reproduced.
ARTICLE X
AMENDMENTS
Section 1. Power to Amend. These bylaws may be amended or repealed and any new bylaw may be adopted by vote of the holders of stock of the corporation entitled at the time to vote for the election of directors or by the board of directors at any regular or special meeting; provided, however, that any bylaw or amendment to the bylaws adopted by the board of directors may be amended or repealed, and any bylaw repealed by the board of directors may be reinstated, by the holders of stock of the corporation entitled at the time to vote for the election of directors.
26
Section 2. Amendment Affecting Election of Directors. If any bylaw regulating an impending election of directors is adopted, amended or repealed by the board of directors, there shall be set forth in the notice of the next meeting of stockholders for the election of directors the bylaw so adopted, amended or repealed, together with a concise statement of the changes made.
27
EXHIBIT 21
MICROSEMI CORPORATION SUBSIDIARIES
AS OF NOVEMBER 15, 2011
NAME OF MICROSEMI CORPORATION ENTITIES |
JURISDICTION | |
Microsemi Corp. Santa Ana |
Delaware | |
Microsemi Corp. Scottsdale |
Arizona | |
Microsemi Corp. Colorado |
Colorado | |
Microsemi Corp. Massachusetts |
Delaware | |
Microsemi Corp. Analog Mixed Signal Group |
Delaware | |
Microsemi Corp. Power Products Group |
Delaware | |
Microsemi Corp. RF Power Products |
Delaware | |
Microsemi Corp. Power Management Group Holding |
California | |
Microsemi Corp. Power Management Group |
California | |
Microsemi Corp. RF Integrated Solutions |
Delaware | |
Microsemi Corp. RF Diode Solutions |
Delaware | |
Micro RF Silicon, Inc. |
Delaware | |
Microsemi Defense Systems, Inc. |
California | |
Micro CML, Inc. |
Delaware | |
PowerDsine, Inc. |
New York | |
T.S.I. Microelectronics Corp. |
Massachusetts | |
Microsemi Real Estate, Inc. |
California | |
White Electronic Designs Corporation |
Indiana | |
Bowmar / ALI, Inc. |
Massachusetts | |
Panelview, Inc. |
Oregon | |
IDS Acquisition Corp. |
Arizona | |
Electronic Designs, Inc. |
Delaware | |
Arxan Defense Systems Inc. |
Delaware | |
Actel Corporation |
California | |
Microsemi Pan-Asia Corp. |
Nevada | |
Zulu Acquisition Co., LLC |
Delaware | |
Zarlink Semiconductor (U.S.) Inc. |
Delaware | |
Zarlink Semiconductor V.N. Inc |
California | |
Legerity International, Inc. |
Delaware | |
Microsemi Europe SARL |
France | |
Microsemi Corp. Mauritius |
Mauritius | |
Microsemi Corp. Semiconductor India Private Ltd. |
India | |
Microsemi Europe Ltd. |
United Kingdom | |
Microsemi Europe Srl. |
Italy | |
Microsemi Semiconductors Ltd. |
Ireland | |
Microsemi GmbH |
Germany | |
Microsemi Pan-Asia Hong Kong Ltd. |
Hong Kong | |
Actel Japan K.K. |
Japan | |
Microsemi Ireland, Ltd. |
Bermuda | |
Microsemi Ireland Trading, Ltd. |
Ireland | |
Microsemi Power Module Products, SAS |
France | |
Microsemi Corp. Analog Mixed Signal Group, Ltd. |
Israel | |
Microsemi Corp. International |
Cayman Islands | |
Microsemi Corp. Holding |
Cayman Islands | |
Microsemi Corp. Holding 2 |
Cayman Islands | |
Microsemi Israel, Ltd. |
Israel | |
Microsemi Macao Commercial Offshore Limited |
Macau | |
Shanghai Microsemi Semiconductor Co., Ltd. |
China | |
Microsemi (Hong Kong) Ltd. |
Hong Kong | |
Microsemi Corp. Japan |
Japan | |
Microsemi Semiconductors Manila (Philippines), Inc. |
Philippines | |
0916753 B.C. ULC |
Canada |
NAME OF MICROSEMI CORPORATION ENTITIES |
JURISDICTION | |
Zarlink Semiconductor, Inc. |
Canada | |
Zarlink Semiconductor Holdings Ltd. |
United Kingdom | |
Zarlink Semiconductor Limited |
United Kingdom | |
Zarlink Microelectronic Limited |
United Kingdom | |
Zarlink Semiconductor Overseas Limited |
United Kingdom | |
Zarlink Semiconductor AB |
Sweden | |
Zarlink Semiconductor S.A.R.L. |
France | |
Zarlink Semiconductor GmbH |
Germany | |
Zarlink Semiconductor XIC B.V. |
Netherlands | |
Zarlink Semiconductor (Asia) Pte. Ltd. |
Singapore | |
Zarlink Srl |
Italy | |
Plessey Italy Srl |
Italy | |
Zarlink K.K. |
Japan |
EXHIBIT 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 033-62561 and 333-34846) and the Registration Statements on Form S-8 (Nos. 333-171135, 333-175608, 333-82556, 333-35526, 333-24045, 033-62563, 033-63395, 033-16711, 333-129283, 333-135678, 333-140071, 333-150529, and 333-166701) of Microsemi Corporation of our report dated November 23, 2011 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Orange County, California
November 23, 2011
EXHIBIT 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a) AS ADOPTED
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, James J. Peterson, certify that:
1. I have reviewed this annual report on Form 10-K of Microsemi Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: November 23, 2011
/s/ James J. Peterson |
James J. Peterson |
President and Chief Executive Officer |
EXHIBIT 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO
SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a) AS ADOPTED
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, John W. Hohener, certify that:
1. I have reviewed this annual report on Form 10-K of Microsemi Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: November 23, 2011
/s/ John W. Hohener |
John W. Hohener |
Executive Vice President, Chief Financial Officer, Secretary and Treasurer |
EXHIBIT 32
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
(Pursuant to 18 U.S.C. 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002)
The undersigned, James J. Peterson, Chief Executive Officer, and John W. Hohener, Chief Financial Officer, of Microsemi Corporation, a Delaware corporation (the Company), each hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that
(1) | the accompanying periodic report containing financial statements filed by the Company with the Securities and Exchange Commission (the Report) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a)); and |
(2) | information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
IN WITNESS WHEREOF, the undersigned have executed this certificate which accompanies the Companys Annual Report on Form 10-K for the annual period ended October 2, 2011.
Dated: November 23, 2011 | /s/ James J. Peterson | |||
James J. Peterson, President and Chief Executive Officer | ||||
Dated: November 23, 2011 | /s/ John W. Hohener | |||
John W. Hohener, Executive Vice President, Chief Financial Officer, Secretary and Treasurer |
8.5FW*'@1`0$``00"`00"`0,$`P`````!$2$Q
M`A)!4E%A<8%"(C(#D6(3\*&Q(\'1 >$O#7;N\+5`[!L3NZ6!^+NA:HK]NL+XKVSKJ[%N:#XSH3N%@.*;-(S<"^`
M&`,MF<7ER26;<6PS>.H'7('43[6\G=[SJ=:R)0ZLU.:SG4HVRL2(+-W/7++9M4LEW8UR!J.[9[6)H7CA H+^F\[O`#]W>`&R=KC&=#$^$X6VIUR^5>P4NX0[.P5:
MTQ#^!L$)($,=E*1$FW4:/F3DI#$/Y:[=4Q1$IBF+UZE$!`!R2XUBM7#_`-M/
M@NSY'4NOM^.5++#26F]CS3U@H]M"Z*\I$7+6+".>"*\^H ^H#M=&+J'+37\0_+29103@FV;[9KB1GR
MVOIM9+H)W91&-64Z]!3Z],O6 *J)-Q'^&0N=);>,QC/U8NELNG
M=#J[/<5IZE'-;W49&09;)UO:):VUY>->M&\2Y._>5-=HQ4%TN#8I(U?L<'VZZG=PV%?3>I:E"[$@;C5H\U$M%1FDE
M;:K>P51 .D]X=KZT^=ZZ?HBY@_ENQ^^\=)[P[7UI\[UT_1%S!_+=C]]XZ
M3WAVOK3YWKI^B+F#^6['[[QTGO#M?6GSO73]$7,'\MV/WWCI/>':^M/G>NGZ
M(N8/Y;L?OO'2>\.U]:?.]=/T1 .D]X=KZT^=ZZ?HBY@_ENQ^^\=)
M[P[7UI\[UT_1%S!_+=C]]XZ3WAVOK6!SW,K .D]X=KZT^=ZZ?HBY@_ENQ^^\=)[P[7
MUI\[UT_1%S!_+=C]]XZ3WAVOK3YWKI^B+F#^6['[[QTGO#M?6GSO73]$7,'\
MMV/WWCI/>':^M/G>NGZ(N8/Y;L?OO'2>\.U]:?.]=/T1 .D]X=KZ
MT^=ZZ?HBY@_ENQ^^\=)[P[7UI\[UT_1%S!_+=C]]XZ3WAVOK3YWKI^B+F#^6
M['[[QTGO#M?6GSO73]$7,'\MV/WWCI/>':^M81;^9FX9"1HZM9X< .
MD]X=KZT^=ZZ?HBY@_ENQ^^\=)[P[7UI\[UT_1%S!_+=C]]XZ3WAVOK3YWKI^
MB+F#^6['[[QTGO#M?6GSO73]$7,'\MV/WWCI/>':^M/G>NGZ(N8/Y;L?OO'2
M>\.U]:?.]=/T1 .D]X=KZT^=ZZ?HBY@_ENQ^^\=)[P[7UI\[UT_1
M%S!_+=C]]XZ3WAVOK3YWKI^B+F#^6['[[QTGO#M?6L+O',S;TFQATJEPXY?1
M#QO::V]E%5-;L>UW76DJW6GHX/\`FRH][Z-*HF7P#[0_2'TY9QXS?E$MY7&E
M9I\[UT_1%S!_+=C]]Y.D]XO:^M/G>NGZ(N8/Y;L?OO'2>\.U]:?.]=/T1 .D]X=KZT^=ZZ?HBY@_ENQ^^\=)[P[7UI\[UT_1%S!_+=C]]XZ3WAVO
MK3YWKI^B+F#^6['[[QTGO#M?6GSO73]$7,'\MV/WWCI/>':^M/G>NGZ(N8/Y
M;L?OO'2>\.U]:?.]=/T1 .D]X=KZT^=ZZ?HBY@_ENQ^^\=)[P[7U
MI\[UT_1%S!_+=C]]XZ3WAVOK3YWKI^B+F#^6['[[QTGO#M?6L+V)S-V]+4Z:
MCZ3PWY?0MG<)-RQ .D]X=KZT^=ZZ?HBY@_ENQ^^\=)[P[7UI\[UT_1%S!_+=C]]XZ3WAVOK3
MYWKI^B+F#^6['[[QTGO#M?6GSO73]$7,'\MV/WWCI/>':^M/G>NGZ(N8/Y;L
M?OO'2>\.U]:?.]=/T1 .D]X=KZT^=ZZ?HBY@_ENQ^^\=)[P[7UI\
M[UT_1%S!_+=C]]XZ3WAVOK3YWKI^B+F#^6['[[QTGO#M?6GSO73]$7,'\MV/
MWWCI/>':^M8];>9^TI6K6.,JW#3EY#660@Y5E7I=QKEB5O&3;IDNC%R"YOBZ
MPE0:/3D4./8;H4H^`_1EG&9F>43M?6KOZG4M"NKMTT1JM^7H'(
M/D7#.DK!*,E!Z`_UWILAB2SCN1'O1.8YR3&)X:XW?*Z>8:,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#_]3O\8'J
M700=(+-72*3ELX240<-UTR+(+HJE$BJ*R2@&3524(80,4P"`@/0<#RBBDW22
M00230003(BBBB0J:2*290(FDDF0"D333(4`*4````.@8'LP&`P*^S/\`JFU[
M_D/MG_'NG%W+PFEN/=(3A7KY*YR^VZY;G*DJBJW(RB!KT;"1[OJ]34.8504$J
M7E]!`>N6SC)F
NXA07`%3<`0"'.0P!
M_5'%EFE)
>-O%_FOQ5TOM.:J&L:O?>1%!X_P"L]'8*5L]?8TE:6M
MENM>Z]PV,LB^>,6YH2`O&S$V1DUO3J2`U9,B8`FH4XK9H>6<<8..F_F5JTM'
M;4X^VFFNE-[37(;DMM^\[:H6S+!N6_UK5T[#T.4D4Z:L@UKC&,O$PP5BHAH@
M1C'MXHA2$*!1$[,Q;*F-5W=<9JK\S>2VRW50KS'3FR]"=>UMNV+#>ADY
MBES^ZY"[QKNLH!W-V?I[PS,8RR().A7/T[A`^2W2:ZJR/B'J"X:?1Y(-[9$,
MH=O?^5&U]F4U!B\8ND5Z/9T:VE`.Q28*')'G4+&J!Z8X$42`H=2AU#'*YQ]B
M+?YE7__0[_&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P/__1[_&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P/__2[_&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P/__3[_&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P/__4[_&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P/__5[_&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P/__6[_&`P*8H^X5P[
MMS&(/:HDH=,X>)3"'CA<5:.C7BI;,IM8V#0YUC9Z9!$^S][Z9THXI+3;FSJ5KASLBS-J9
M04+A/Q\$I;[6\.@FUKT`5\LD,E+.%'*8%13ZG$3AX>.#&4?7GF7Q6UK8-DU.
M\[ZUK7;5IYC3Y/:58>6)JI8J'';`EZ?`TM]98-IZB3C&EEE]@0B#50Z0%4-)
MMQZ]#@.%Q?A9G"&`P&`P(]9;7US([/G-+LK=$N=IUJH0U^G:0FHJ,U&4VPR3
M^'A;"Y2%($2Q\C)Q;A%,0.)A.D;J`8/JB6_\TN)6JML06BMD\C-/TC;]D&.)
M$:]LMY@HJR*K31VZ<&V=LW3L@13N?.[2"/1=F05?]X>G*IUPN+OA9S"&`P&!
MC-RNE.UU5YJ[[!ME9HM+K;(TC8K?
_N&E0
MTU2Z[)-+"BRLT$NJK&?`T%7DDJHBFT,OO'[6L"M
MS.2]O^V\\=QQNKBV.W\CZ%>'7%TO&9N[&-MEND)>!W7#:3E=MMGK:MGLKQM(
M*,U13*H43D'!IK\X;B/:<0VG&<,JU6MNCL4UBIFTM^TZ"-M8]E<7;^7U>W3>
M&.O$Y"1M_=8I:/;U`C1*/
ACQUISITIONS - Additional Information (Detail) (USD $) | 12 Months Ended | |||
---|---|---|---|---|
Jan. 02, 2011
Actel Corporation | Jul. 03, 2011
AML Communications, Inc | Jul. 03, 2011
Brijot Imaging Systems, Inc | Oct. 02, 2011
Business Acquisition Pro Forma Information | |
Significant Acquisitions and Disposals [Line Items] | ||||
Purchase price per share | $ 20.88 | |||
Cost of acquired entity cash paid per share | $ 2.50 | |||
Purchase price | $ 581,351,000 | $ 33,220,000 | $ 3,100,000 | |
Cost of goods sold | 5,900,000 | |||
Acquisition cost | 8,600,000 | |||
Credit facility issuance cost | 14,200,000 | |||
Non cash benefit of valuation allowance | $ 5,000,000 |
Reconciliation of Income Tax Computed at the Federal Statutary Rate to Actual Tax Expenses (Detail) (USD $) In Thousands | 12 Months Ended | ||
---|---|---|---|
Oct. 02, 2011 | Oct. 03, 2010 | Sep. 27, 2009 | |
Reconciliation of Statutory Federal Tax Rate [Line Items] | |||
Tax computed at federal statutory rate | $ 7,717 | $ 19,261 | $ (3,107) |
State taxes, net of federal impact | (7,023) | 2,147 | (2,495) |
Foreign income taxed at different rates | (9,830) | (14,621) | (22,969) |
Tax credits | (4,234) | (3,025) | (1,899) |
Stock award compensation | 347 | 3,288 | 3,225 |
Unrecognized tax benefits | 1,541 | 2,325 | 3,298 |
Imputed interest | 47 | 61 | 335 |
Executive compensation | 444 | 1,312 | 1,558 |
Non-deductible permanent items | 2,803 | 727 | |
Pre-acquisition loss carryforwards | (2,298) | ||
Other differences, net | (308) | 134 | 614 |
Valuation allowance | (21,604) | (15,616) | 39,389 |
Provision (benefit) for income taxes | $ (32,398) | $ (4,007) | $ 17,949 |
Goodwill and Intangible Assets, Net - Additional Information (Detail) (USD $) In Thousands | 12 Months Ended | ||
---|---|---|---|
Oct. 02, 2011 | Oct. 03, 2010 | Sep. 27, 2009 | |
Goodwill [Line Items] | |||
Amortization of intangible assets | $ 62,425 | $ 20,165 | $ 15,203 |
Restructuring Activities and Accrued Liabilities in the Consolidated Balance Sheets (Detail) (Other Facility, USD $) In Thousands | 12 Months Ended |
---|---|
Oct. 02, 2011 | |
Restructuring Reserve Disclosures [Abstract] | |
Beginning Balance | $ 1,600 |
Provisions | (15,800) |
Employee Severance | |
Restructuring Reserve Disclosures [Abstract] | |
Beginning Balance | 1,642 |
Provisions | 15,784 |
Cash expenditures | (14,586) |
Other non-cash settlement | (116) |
Ending Balance | $ 2,724 |
Components of Deferred Tax Assets (Liabilities) (Detail) (USD $) | Oct. 02, 2011 | Oct. 03, 2010 | Sep. 27, 2009 |
---|---|---|---|
Schedule of Deferred Income Tax Assets and Liabilities [Line Items] | |||
Accounts receivable, net | $ 1,159,000 | $ 1,161,000 | |
Inventories | 22,041,000 | 10,313,000 | |
Accrued employee benefit expenses | 6,209,000 | 2,603,000 | |
Net operating losses | 32,095,000 | 16,840,000 | |
Tax credits | 32,334,000 | 12,319,000 | |
Accrued other expenses | 9,296,000 | 4,343,000 | |
Deferred equity compensation | 12,075,000 | 8,683,000 | |
Property and equipment, net | (465,000) | 1,403,000 | |
Other assets | 7,822,000 | 3,826,000 | |
Total deferred tax assets | 122,566,000 | 61,491,000 | |
Intangible assets | (96,624,000) | (30,781,000) | |
Total deferred tax liabilities | (96,624,000) | (30,781,000) | |
Less valuation allowance | (18,086,000) | (37,604,000) | (28,446,000) |
Deferred Tax Assets (Liabilities), Net, Total | $ 7,856,000 | $ (6,893,000) |
COMMITMENTS AND CONTINGENCIES (Tables) | 12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 02, 2011 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Aggregate Undiscounted Future Minimum Rental Payments | The aggregate undiscounted future minimum rental payments under these leases are as follows (amounts in thousands):
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
Minimum Annual Payments | We have entered into agreements to buy material with certain vendors. The minimum annual payments are as follows (amounts in thousands):
|
CREDIT AGREEMENT AND DERIVATIVE INSTRUMENTS - Additional Information (Detail) In Millions, unless otherwise specified | 12 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov. 02, 2010
Senior Secured Credit Facility
USD ($) | Oct. 02, 2011
Senior Secured Credit Facility
Term Loan Facility
USD ($) | Nov. 02, 2010
Senior Secured Credit Facility
Term Loan Facility
USD ($) | Oct. 02, 2011
Senior Secured Credit Facility
Term Loan Facility
Fair Value, Inputs, Level 2
USD ($) | Oct. 02, 2011
Senior Secured Credit Facility
Revolving Credit Facility
USD ($) | Nov. 02, 2010
Senior Secured Credit Facility
Revolving Credit Facility
USD ($) | Oct. 02, 2011
Interest Rate Swap
Contract | Oct. 02, 2011
Interest Rate Swap
Group 1
USD ($) | Oct. 02, 2011
Interest Rate Swap
Group 2
USD ($) | Oct. 02, 2011
Interest Rate Swap
Group 3
USD ($) | Oct. 02, 2011
Foreign Exchange Forward
USD ($) | Oct. 02, 2011
Foreign Exchange Forward
CAD | |
Line of Credit Facility [Line Items] | ||||||||||||
Face amount | $ 425.0 | $ 375.0 | $ 50.0 | |||||||||
Amount borrowed under the facility | 372.2 | |||||||||||
Outstanding letter of credit | 0.4 | |||||||||||
Fair value outstanding term loan | 361.0 | |||||||||||
Change in fair value of principal outstanding | 11.2 | |||||||||||
Up front debt issuance and refinancing costs | 14.2 | |||||||||||
Number of derivative agreements | 3 | |||||||||||
Notional amount | 24.0 | 121.0 | 24.0 | |||||||||
Fixed rate | 1.49% | 1.83% | 2.21% | |||||||||
Derivative maturtiy period | 2 years | 3 years | 4 years | |||||||||
Foreign currency agreed upon purchase amount | 623.0 | |||||||||||
Foreign currency contract amount | 608.2 | |||||||||||
Derivatives, current liabilities | $ 11.7 |
Long-term Liabilities (Detail) (USD $) In Thousands | Oct. 02, 2011 | Oct. 03, 2010 |
---|---|---|
Debt Instrument [Line Items] | ||
Credit facility | $ 361,022 | |
Deferred tax liabilities | 35,568 | 19,513 |
Other long-term liabilities: | ||
Unrecognized tax benefits | 14,466 | 14,110 |
Accrued retirement | 4,109 | 3,813 |
Capital leases | 3,371 | 3,244 |
Interest rate swaps | 2,808 | |
Environmental | 314 | 314 |
Other | 8,352 | 1,570 |
Total long-term liabilities | 430,010 | 42,564 |
Current portion | (4,050) | (444) |
Long-term portion | $ 425,960 | $ 42,120 |
VALUATION AND QUALIFYING ACCOUNTS (Detail) (USD $) In Thousands | 12 Months Ended | ||
---|---|---|---|
Oct. 02, 2011 | Oct. 03, 2010 | Sep. 27, 2009 | |
Allowance for Doubtful Accounts | |||
Valuation and Qualifying Accounts Disclosure [Line Items] | |||
Balance at beginning of period | $ 1,978 | $ 2,302 | $ 1,731 |
Charged to costs and expenses | 690 | 425 | 712 |
Deductions- recoveries and write-offs | (519) | (749) | (141) |
Balance at end of period | 2,149 | 1,978 | 2,302 |
Tax Valuation Allowance | |||
Valuation and Qualifying Accounts Disclosure [Line Items] | |||
Balance at beginning of period | 37,604 | 53,220 | 13,831 |
Charged to costs and expenses | (21,604) | (15,616) | 39,389 |
Charged to other accounts | 2,086 | ||
Balance at end of period | $ 18,086 | $ 37,604 | $ 53,220 |
Net Sales by the Originating Geographic Area and Estimated End Market (Detail) (USD $) In Thousands | 3 Months Ended | 12 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 02, 2011 | Jul. 03, 2011 | Apr. 03, 2011 | Jan. 02, 2011 | Oct. 03, 2010 | Jun. 27, 2010 | Mar. 28, 2010 | Dec. 27, 2009 | Oct. 02, 2011 | Oct. 03, 2010 | Sep. 27, 2009 | |
Segment Reporting Disclosure [Line Items] | |||||||||||
Net Sales | $ 227,291 | $ 216,722 | $ 207,490 | $ 184,351 | $ 151,201 | $ 136,017 | $ 118,218 | $ 112,832 | $ 835,854 | $ 518,268 | $ 452,972 |
United States | |||||||||||
Segment Reporting Disclosure [Line Items] | |||||||||||
Net Sales | 508,145 | 243,822 | 215,611 | ||||||||
Europe | |||||||||||
Segment Reporting Disclosure [Line Items] | |||||||||||
Net Sales | 132,145 | 125,209 | 135,844 | ||||||||
Asia | |||||||||||
Segment Reporting Disclosure [Line Items] | |||||||||||
Net Sales | 195,564 | 149,237 | 101,517 | ||||||||
Defense And Security | |||||||||||
Segment Reporting Disclosure [Line Items] | |||||||||||
Net Sales | 299,503 | 208,098 | 170,653 | ||||||||
Aerospace | |||||||||||
Segment Reporting Disclosure [Line Items] | |||||||||||
Net Sales | 212,127 | 107,587 | 112,847 | ||||||||
Enterprise and Communication | |||||||||||
Segment Reporting Disclosure [Line Items] | |||||||||||
Net Sales | 148,792 | 116,369 | 70,102 | ||||||||
Industrial and Alternative Energy | |||||||||||
Segment Reporting Disclosure [Line Items] | |||||||||||
Net Sales | $ 175,432 | $ 86,214 | $ 99,370 |
ACQUISITIONS (Tables) | 12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 02, 2011 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Supplemental pro forma data | Supplemental pro forma data is as follows (amounts in thousands, except per share data):
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Actel Corporation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Calculation and Allocation of Consideration | The total consideration as shown in the table below is allocated to Actel’s tangible and intangible assets and liabilities based on their preliminary estimated fair values as of the date of the completion of the transaction. The consideration is allocated as follows (in thousands):
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Identifiable Intangible Assets and their Estimated Useful Lives | Identifiable intangible assets and their estimated useful lives are as follows (amounts in thousands):
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AML Communications, Inc | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Calculation and Allocation of Consideration | The total consideration as shown in the table below is allocated to AML’s tangible and intangible assets and liabilities based on their preliminary estimated fair values as of the date of the completion of the transaction. The consideration is allocated as follows (in thousands):
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Identifiable Intangible Assets and their Estimated Useful Lives | Identifiable intangible assets and their estimated useful lives are as follows (amounts in thousands):
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asic Advantage, Inc | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Calculation and Allocation of Consideration | The total consideration as shown in the table below is allocated to Asic Advantage’s tangible and intangible assets and liabilities based on their preliminary estimated fair values as of the date of the completion of the transaction. The consideration is allocated as follows (in thousands):
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Identifiable Intangible Assets and their Estimated Useful Lives | Identifiable intangible assets and their estimated useful lives are as follows (amounts in thousands):
|
Accrued Liabilities (Detail) (USD $) In Thousands | Oct. 02, 2011 | Oct. 03, 2010 |
---|---|---|
Schedule of Accrued Liabilities [Line Items] | ||
Payroll, bonus, accrued time off and other employee benefits | $ 41,264 | $ 18,021 |
Fair value of foreign currency forward | 11,675 | |
Restructuring and severance | 9,562 | 5,832 |
Licenses | 9,636 | 27 |
Outside services | 7,815 | 6,173 |
Interest | 4,037 | 8 |
Warranties | 2,945 | 1,094 |
Commissions | 2,692 | 2,106 |
Other | 11,452 | 3,791 |
Accrued Liabilities, Current, Total | $ 101,078 | $ 37,052 |
Supplemental Pro Forma Data (Detail) (USD $) In Thousands, except Per Share data | 12 Months Ended | |
---|---|---|
Oct. 02, 2011 | Oct. 03, 2010 | |
Net sales | $ 875,759 | $ 806,331 |
Net income (loss) | $ 106,317 | $ (89,868) |
Net income (loss) per share | ||
Basic | $ 1.27 | $ (1.11) |
Diluted | $ 1.24 | $ (1.11) |
SUBSEQUENT EVENT - Additional Information (Detail) | 1 Months Ended | 12 Months Ended | 12 Months Ended | 1 Months Ended | 1 Months Ended | 1 Months Ended | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 31, 2011
USD ($) | Oct. 31, 2011
Acquisition
Zarlink Semiconductor, Inc
CAD | Oct. 31, 2011
Acquisition
Zarlink Semiconductor, Inc
USD ($) | Oct. 02, 2011
Acquisition
Zarlink Semiconductor, Inc
USD ($) | Oct. 31, 2011
Acquisition
Zarlink Semiconductor, Inc
Subordinated Debentures Subject to Mandatory Redemption | Oct. 02, 2011
Minimum
Senior Secured Credit Facility
Revolving Credit Facility
Second Amendment | Oct. 31, 2011
Minimum
Second Amendment
Revolving Loans And Swingline
Base Rate | Oct. 31, 2011
Minimum
Second Amendment
Revolving Loans And Swingline
Eurodollar Rate Loans | Oct. 02, 2011
Maximum
Senior Secured Credit Facility
Revolving Credit Facility
Second Amendment | Oct. 31, 2011
Maximum
Second Amendment
Revolving Loans And Swingline
Base Rate | Oct. 31, 2011
Maximum
Second Amendment
Revolving Loans And Swingline
Eurodollar Rate Loans | Oct. 31, 2011
Senior Secured Credit Facility
Term Loan Facility
Second Amendment
USD ($) | Oct. 02, 2011
Senior Secured Credit Facility
Term Loan Facility
Second Amendment | Oct. 31, 2011
Senior Secured Credit Facility
Revolving Credit Facility
Second Amendment
USD ($) | Oct. 02, 2011
Senior Secured Credit Facility
Revolving Credit Facility
Second Amendment | Oct. 31, 2011
Senior Secured Credit Facility
Second Amendment
USD ($) | Oct. 02, 2011
Senior Secured Credit Facility
Second Amendment
Letter of Credit | Oct. 31, 2011
Term Loan Facility
Second Amendment
Base Rate | Oct. 31, 2011
Term Loan Facility
Second Amendment
Eurodollar Rate Loans | Oct. 31, 2011
Second Amendment
Federal Funds Rate
Base Rate | Oct. 31, 2011
Second Amendment
One-month Eurodollar Rate
Base Rate | Oct. 31, 2011
Second Amendment
Base Rate | Oct. 31, 2011
Second Amendment
Eurodollar Rate Loans | Oct. 02, 2011
Amended and Restated Credit Agreement
USD ($) | Oct. 31, 2011
Thailand Facilities
Entity | Nov. 02, 2010
Senior Secured Credit Facility
USD ($) | Oct. 02, 2011
Senior Secured Credit Facility
Term Loan Facility
USD ($) | Nov. 02, 2010
Senior Secured Credit Facility
Term Loan Facility
USD ($) | Nov. 02, 2010
Senior Secured Credit Facility
Revolving Credit Facility
USD ($) | |
Subsequent Event [Line Items] | |||||||||||||||||||||||||||||
Cost of acquired entity cash paid per share | 3.98 | ||||||||||||||||||||||||||||
Cost of acquired entity cash paid | $ 630,200,000 | ||||||||||||||||||||||||||||
Convertible rate | 6.00% | ||||||||||||||||||||||||||||
Maturity date | Sep. 30, 2012 | ||||||||||||||||||||||||||||
Face amount | 800,000,000 | 425,000,000 | 375,000,000 | 50,000,000 | |||||||||||||||||||||||||
Amount borrowed under the facility | 49,600,000 | 372,200,000 | |||||||||||||||||||||||||||
Expected quarterly interest payment | 12,600,000 | ||||||||||||||||||||||||||||
Basis points | 75.00% | 75.00% | 100.00% | 100.00% | 150.00% | 150.00% | 1.00% | ||||||||||||||||||||||
Applicable margin | 3.00% | 4.00% | 3.75% | 4.75% | 3.50% | 4.50% | |||||||||||||||||||||||
Rate description | The “Base Rate” is defined as a rate per annum equal to the greatest of (a) the prime rate, (b) 1/2 of 1% per annum above the federal funds effective rate, (c) the one-month Eurodollar Rate plus 1%, and (d) in the case of any term loans, 2.25%. | The “Eurodollar Rate” is defined as (a) the rate per annum offered for deposits of dollars for the applicable interest period that appears on Reuters Screen LIBOR01 Page as of 11:00 A.M., London, England time, two (2) business days prior to the first day of such interest period or (b) if no such offered rate exists, such rate will be the rate of interest per annum as determined by the administrative agent (rounded upwards, if necessary, to the nearest 1/100 of 1%) at which deposits of dollars in immediately available funds are offered at 11:00 A.M., London, England time, two (2) business days prior to the first day in the applicable interest period by major financial institutions reasonably satisfactory to the administrative agent in the London interbank market for such interest period and for an amount equal or comparable to the principal amount of the loans to be borrowed, converted or continued as Eurodollar Rate loans on such date of determination. In the case of term loans, the Eurodollar Rate will not be lower than 1.25%. | |||||||||||||||||||||||||||
Debt, stated rate | 2.25% | 1.25% | 0.50% | ||||||||||||||||||||||||||
Additional maximum borrowing capacity | 200,000,000 | ||||||||||||||||||||||||||||
Existing borrowing capacity | $ 100,000,000 | $ 800,000,000 | |||||||||||||||||||||||||||
Original issue discount rate | 2.00% | ||||||||||||||||||||||||||||
Upfront fee percentage | 0.25% | ||||||||||||||||||||||||||||
Commitment fee percentage | 0.25% | 0.625% | |||||||||||||||||||||||||||
Fronting fee percentage | 0.25% | ||||||||||||||||||||||||||||
Number of facilities forced to shutdown due to severe flooding | 2 | ||||||||||||||||||||||||||||
Percentage of total quarterly revenues | 5.00% | ||||||||||||||||||||||||||||
Subsequent event period | First quarter of fiscal year 2012 |
Description of Business and Summary of Significant Accounting Policies - Additional Information (Detail) (USD $) In Millions, unless otherwise specified | 12 Months Ended | ||
---|---|---|---|
Oct. 02, 2011 | Oct. 03, 2010 | Sep. 27, 2009 | |
Basis of Presentation [Line Items] | |||
Stock awards excluded from computation of diluted EPS | 7.3 | 7.4 | |
Percentage of net sales from international market | 36.00% | ||
Broomfield Facility | |||
Basis of Presentation [Line Items] | |||
Impairment of property, plant and equipment, held for sale | 1.7 | ||
Scottsdale Facility | |||
Basis of Presentation [Line Items] | |||
Impairment of long-lived assets for closure | 4.5 | ||
International | |||
Basis of Presentation [Line Items] | |||
Percentage of net sales from international market | 46.00% | 40.00% | 30.00% |
Provision for Income Taxes (Detail) (USD $) In Thousands | 12 Months Ended | ||
---|---|---|---|
Oct. 02, 2011 | Oct. 03, 2010 | Sep. 27, 2009 | |
Current: | |||
Federal | $ 314 | $ (17,830) | $ (10,791) |
State | 10 | 533 | 1,227 |
Foreign | 8,324 | 7,345 | 6,733 |
Deferred | |||
Federal | (24,679) | 5,352 | 13,708 |
State | (1,609) | 373 | 7,293 |
Foreign | (14,758) | 220 | (221) |
Provision (benefit) for income taxes | $ (32,398) | $ (4,007) | $ 17,949 |
Minimum Annual Payments (Detail) (USD $) In Thousands | Oct. 02, 2011 |
---|---|
Long-term Purchase Commitment [Line Items] | |
Total | $ 32,266 |
2011 | 27,397 |
2012 | 4,869 |
Thereafter |
Awards Granted, Weighted-Average Exercise Price, Weighted-Average Fair Value and Weighted-Average Assumptions Used in the Calculation of Compensation Expense (Detail) (USD $) | 12 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|
Oct. 02, 2011 | Oct. 03, 2010 | Sep. 27, 2009 | Oct. 02, 2011
Stock Options and Share Appreciation Rights
Year | Oct. 02, 2011
Restricted Stock Awards and Units | Oct. 03, 2010
Stock Option
Year | Sep. 27, 2009
Stock Option
Year | Oct. 03, 2010
Restricted Stock | Sep. 27, 2009
Restricted Stock | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||||
Number of awards | 3,132,241 | 1,876,113 | 27,601 | 8,800 | 1,399,589 | 1,370,667 | |||
Exercise price per award | $ 20.39 | $ 20.58 | $ 19.66 | $ 13.60 | $ 13.87 | $ 21.32 | |||
Fair value per award | $ 7.42 | $ 20.75 | $ 5.25 | $ 6.35 | $ 14.99 | $ 20.70 | |||
Risk free rate | 0.20% | 0.20% | 1.90% | ||||||
Expected dividend yield | 0.00% | 0.00% | 0.00% | ||||||
Expected life | 1.1 | 0.5 | 3.0 | ||||||
Expected volatility | 41.60% | 34.30% | 41.30% |
Reconciliation of Goodwill (Detail) (USD $) In Thousands | 12 Months Ended | |
---|---|---|
Oct. 02, 2011 | Oct. 03, 2010 | |
Goodwill [Line Items] | ||
Beginning balance | $ 270,832 | $ 222,731 |
Additions from acquisitions | 220,291 | 48,101 |
Post-acquisition adjustments | (44) | |
Ending balance | $ 491,079 | $ 270,832 |
INVENTORIES | 12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 02, 2011 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INVENTORIES |
Inventories are summarized as follows (amounts in thousands):
|
Summary of Stock Option Activity and Stock Appreciation Rights (Detail) (Employee Stock Option, USD $) | 12 Months Ended | ||
---|---|---|---|
Oct. 02, 2011 | Oct. 03, 2010 | Sep. 27, 2009 | |
Employee Stock Option | |||
Stock Options | |||
Outstanidng Beginning Balance | 9,226,158 | 10,662,986 | 11,772,050 |
Granted | 12,235 | 8,800 | |
Assumed from acquisition | 3,120,006 | 27,601 | |
Exercised | (2,154,508) | (464,458) | (276,487) |
Forfeited | (729,806) | (999,971) | (841,377) |
Outstanding Ending Balance | 9,474,085 | 9,226,158 | 10,662,986 |
Weighted average Exercise Price | |||
Outstanding Beginning Balance | $ 20.65 | $ 20.48 | $ 20.39 |
Granted | $ 23.69 | $ 21.32 | |
Assumed from acquisition | $ 13.56 | $ 13.87 | |
Exercised | $ 13.90 | $ 10.35 | $ 10.34 |
Forfeited | $ 20.88 | $ 23.43 | $ 22.60 |
Outstanding Ending Balance | $ 19.84 | $ 20.65 | $ 20.48 |